
<html lang="en"     class="pb-page"  data-request-id="747a3701-209d-4643-b3db-eb666c6865a4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2016.59.issue-1;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.5b01249"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors" /></meta><meta name="dc.Creator" content="Matthew A.  Schiffler" /></meta><meta name="dc.Creator" content="Stephen  Antonysamy" /></meta><meta name="dc.Creator" content="Shobha N.  Bhattachar" /></meta><meta name="dc.Creator" content="Kristina M.  Campanale" /></meta><meta name="dc.Creator" content="Srinivasan  Chandrasekhar" /></meta><meta name="dc.Creator" content="Bradley  Condon" /></meta><meta name="dc.Creator" content="Prashant V.  Desai" /></meta><meta name="dc.Creator" content="Matthew J.  Fisher" /></meta><meta name="dc.Creator" content="Christopher  Groshong" /></meta><meta name="dc.Creator" content="Anita  Harvey" /></meta><meta name="dc.Creator" content="Michael J.  Hickey" /></meta><meta name="dc.Creator" content="Norman E.  Hughes" /></meta><meta name="dc.Creator" content="Scott A.  Jones" /></meta><meta name="dc.Creator" content="Euibong J.  Kim" /></meta><meta name="dc.Creator" content="Steven L.  Kuklish" /></meta><meta name="dc.Creator" content="John G.  Luz" /></meta><meta name="dc.Creator" content="Bryan H.  Norman" /></meta><meta name="dc.Creator" content="Richard E.  Rathmell" /></meta><meta name="dc.Creator" content="John R.  Rizzo" /></meta><meta name="dc.Creator" content="Thomas W.  Seng" /></meta><meta name="dc.Creator" content="Stefan J.  Thibodeaux" /></meta><meta name="dc.Creator" content="Timothy A.  Woods" /></meta><meta name="dc.Creator" content="Jeremy S.  York" /></meta><meta name="dc.Creator" content="Xiao-Peng  Yu" /></meta><meta name="dc.Description" content="As part of a program aimed at the discovery of antinociceptive therapy for inflammatory conditions, a screening hit was found to inhibit microsomal prostaglandin E synthase-1 (mPGES-1) with an IC50..." /></meta><meta name="Description" content="As part of a program aimed at the discovery of antinociceptive therapy for inflammatory conditions, a screening hit was found to inhibit microsomal prostaglandin E synthase-1 (mPGES-1) with an IC50..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 18, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01249" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01249" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01249" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01249" /></link>
        
    
    

<title>Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01249" /></meta><meta property="og:title" content="Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0009.jpeg" /></meta><meta property="og:description" content="As part of a program aimed at the discovery of antinociceptive therapy for inflammatory conditions, a screening hit was found to inhibit microsomal prostaglandin E synthase-1 (mPGES-1) with an IC50 of 17.4 μM. Structural information was used to improve enzyme potency by over 1000-fold. Addition of an appropriate substituent alleviated time-dependent cytochrome P450 3A4 (CYP3A4) inhibition. Further structure–activity relationship (SAR) studies led to 8, which had desirable potency (IC50 = 12 nM in an ex vivo human whole blood (HWB) assay) and absorption, distribution, metabolism, and excretion (ADME) properties. Studies on the formulation of 8 identified 8·H3PO4 as suitable for clinical development. Omission of a lipophilic portion of the compound led to 26, a readily orally bioavailable inhibitor with potency in HWB comparable to celecoxib. Furthermore, 26 was selective for mPGES-1 inhibition versus other mechanisms in the prostanoid pathway. These factors led to the selection of 26 as a second clinical candidate." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01249"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01249">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01249&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01249&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01249&amp;href=/doi/10.1021/acs.jmedchem.5b01249" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 194-205</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01500" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01268" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+A.++Schiffler">Matthew A. Schiffler</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Antonysamy">Stephen Antonysamy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shobha+N.++Bhattachar">Shobha N. Bhattachar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristina+M.++Campanale">Kristina M. Campanale</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Srinivasan++Chandrasekhar">Srinivasan Chandrasekhar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bradley++Condon">Bradley Condon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Prashant+V.++Desai">Prashant V. Desai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+J.++Fisher">Matthew J. Fisher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Groshong">Christopher Groshong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anita++Harvey">Anita Harvey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Hickey">Michael J. Hickey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Norman+E.++Hughes">Norman E. Hughes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott+A.++Jones">Scott A. Jones</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Euibong+J.++Kim">Euibong J. Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+L.++Kuklish">Steven L. Kuklish</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+G.++Luz">John G. Luz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryan+H.++Norman">Bryan H. Norman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+E.++Rathmell">Richard E. Rathmell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+R.++Rizzo">John R. Rizzo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+W.++Seng">Thomas W. Seng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefan+J.++Thibodeaux">Stefan J. Thibodeaux</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+A.++Woods">Timothy A. Woods</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeremy+S.++York">Jeremy S. York</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiao-Peng++Yu">Xiao-Peng Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Lilly Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Eli Lilly Biotechnology Center, San Diego, California 92121, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Lilly Research Laboratories, A Division of Eli Lilly and Company, Windlesham, Surrey GU20 6PH, United Kingdom</span></div><div class="corresp-info"><strong>*</strong>M.A.S. E-mail: <a href="/cdn-cgi/l/email-protection#5221313a3b34343e37203f33123e3b3e3e2b7c313d3f"><span class="__cf_email__" data-cfemail="4437272c2d2222282136292504282d28283d6a272b29">[email protected]</span></a>. Tel: +1-317-433-4994.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01249&amp;href=/doi/10.1021%2Facs.jmedchem.5b01249" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 194–205</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 10, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 August 2015</li><li><span class="item_label"><b>Published</b> online</span>18 December 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01249" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01249</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D194%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMatthew%2BA.%2BSchiffler%252C%2BStephen%2BAntonysamy%252C%2BShobha%2BN.%2BBhattachar%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D1%26contentID%3Dacs.jmedchem.5b01249%26title%3DDiscovery%2Band%2BCharacterization%2Bof%2B2-Acylaminoimidazole%2BMicrosomal%2BProstaglandin%2BE%2BSynthase-1%2BInhibitors%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D205%26publicationDate%3DJanuary%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01249"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2715</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">38</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01249" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;A. Schiffler&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Antonysamy&quot;},{&quot;first_name&quot;:&quot;Shobha&quot;,&quot;last_name&quot;:&quot;N. Bhattachar&quot;},{&quot;first_name&quot;:&quot;Kristina&quot;,&quot;last_name&quot;:&quot;M. Campanale&quot;},{&quot;first_name&quot;:&quot;Srinivasan&quot;,&quot;last_name&quot;:&quot;Chandrasekhar&quot;},{&quot;first_name&quot;:&quot;Bradley&quot;,&quot;last_name&quot;:&quot;Condon&quot;},{&quot;first_name&quot;:&quot;Prashant&quot;,&quot;last_name&quot;:&quot;V. Desai&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;J. Fisher&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Groshong&quot;},{&quot;first_name&quot;:&quot;Anita&quot;,&quot;last_name&quot;:&quot;Harvey&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Hickey&quot;},{&quot;first_name&quot;:&quot;Norman&quot;,&quot;last_name&quot;:&quot;E. Hughes&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;A. Jones&quot;},{&quot;first_name&quot;:&quot;Euibong&quot;,&quot;last_name&quot;:&quot;J. Kim&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;L. Kuklish&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;G. Luz&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;H. Norman&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;E. Rathmell&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;R. Rizzo&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;W. Seng&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;J. Thibodeaux&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;A. Woods&quot;},{&quot;first_name&quot;:&quot;Jeremy&quot;,&quot;last_name&quot;:&quot;S. York&quot;},{&quot;first_name&quot;:&quot;Xiao-Peng&quot;,&quot;last_name&quot;:&quot;Yu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;194-205&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01249&quot;},&quot;abstract&quot;:&quot;As part of a program aimed at the discovery of antinociceptive therapy for inflammatory conditions, a screening hit was found to inhibit microsomal prostaglandin E synthase-1 (mPGES-1) with an IC50 of 17.4 μM. Structural information was used to improve enzyme potency by over 1000-fold. Addition of an appropriate substituent alleviated time-dependent cytochrome P450 3A4 (CYP3A4) inhibition. Further structure–activity relationship (SAR) studies led to 8, which had desirable potency (IC50 = 12 nM in an ex vivo human whole blood (HWB) assay) and absorption, distribution, metabolism, and excretion (ADME) properties. Studies on the formulation of 8 identified 8·H3PO4 as suitable for clinical development. Omission of a lipophilic portion of the compound led to 26, a readily orally bioavailable inhibitor with potency in HWB comparable to celecoxib. Furthermore, 26 was selective for mPGES-1 inhibition versus other mechanisms in the prostanoid pathway. These factors led to the selection of 26 as a second clinical candi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01249&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01249" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01249&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01249" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01249&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01249" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01249&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01249&amp;href=/doi/10.1021/acs.jmedchem.5b01249" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01249" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01249" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01249%26sid%3Dliteratum%253Aachs%26pmid%3D26653180%26genre%3Darticle%26aulast%3DSchiffler%26date%3D2016%26atitle%3DDiscovery%2Band%2BCharacterization%2Bof%2B2-Acylaminoimidazole%2BMicrosomal%2BProstaglandin%2BE%2BSynthase-1%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D1%26spage%3D194%26epage%3D205%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291342" title="Absorption">Absorption</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/jmcmar.2016.59.issue-1/20160114/jmcmar.2016.59.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">As part of a program aimed at the discovery of antinociceptive therapy for inflammatory conditions, a screening hit was found to inhibit microsomal prostaglandin E synthase-1 (<i>m</i>PGES-1) with an IC<sub>50</sub> of 17.4 μM. Structural information was used to improve enzyme potency by over 1000-fold. Addition of an appropriate substituent alleviated time-dependent cytochrome P450 3A4 (CYP3A4) inhibition. Further structure–activity relationship (SAR) studies led to <b>8</b>, which had desirable potency (IC<sub>50</sub> = 12 nM in an <i>ex vivo</i> human whole blood (HWB) assay) and absorption, distribution, metabolism, and excretion (ADME) properties. Studies on the formulation of <b>8</b> identified <b>8·H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub> as suitable for clinical development. Omission of a lipophilic portion of the compound led to <b>26</b>, a readily orally bioavailable inhibitor with potency in HWB comparable to celecoxib. Furthermore, <b>26</b> was selective for <i>m</i>PGES-1 inhibition versus other mechanisms in the prostanoid pathway. These factors led to the selection of <b>26</b> as a second clinical candidate.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65512" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65512" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For millennia, it has been known that willow bark possesses analgesic properties.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> However, only in the 19th century was the active component, salicylic acid, identified,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and only much later did related research reveal that reduction in systemic PGE<sub>2</sub> levels correlated with an analgesic effect.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> Therapies indirectly modulating PGE<sub>2</sub> through inhibition of COX enzymes include such well-known and widely available drugs as aspirin,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> naproxen, and ibuprofen.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> These drugs nonselectively inhibit both COX-1, a constitutive enzyme, and COX-2, which is induced during the inflammatory response.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In recent years, selective COX-2 inhibitors have entered the market as treatments for pain.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a></div><div class="NLM_p">However, in addition to suppressing PGE<sub>2</sub> production, COX-2 inhibition disrupts the downstream balance of TXA<sub>2</sub> and PGI<sub>2</sub> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), which is thought to lead to an increased risk of thrombotic events.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Such observations have, in fact, led to the withdrawal of COX-2 inhibitors such as rofecoxib and valdecoxib from the market.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Therefore, inhibition of targets further downstream in the prostaglandin pathway might be desirable.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> One such approach would entail direct inhibition of a PGE<sub>2</sub> synthase.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Prostaglandin synthesis pathway.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Microsomal prostaglandin E synthase-1 (<i>m</i>PGES-1) is a 17-kDa membrane-bound, glutathione-dependent isomerase, which, like COX-2, is induced during the inflammatory response.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> It is one of three enzymes known to convert PGH<sub>2</sub> to PGE<sub>2</sub>; the other two (<i>m</i>PGES-2 and <i>c</i>PGES) are constitutively expressed enzymes,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and evidence has emerged that <i>m</i>PGES-2 does not in fact produce PGE<sub>2</sub><i>in vivo</i>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Therefore, it has been hypothesized that selective inhibition of <i>m</i>PGES-1 could alleviate the nociception that accompanies inflammation while limiting the disruption of normal PGE<sub>2</sub> synthesis.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Indeed, much effort has been made to discover <i>m</i>PGES-1 inhibitors.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20 ref21 ref22 ref23">(16-23)</a><a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a> illustrates some examples of such compounds. Imidazophenanthrolines such as MF-63 (<b>1</b>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> aryl indoles such as <b>2</b>,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and oxicams such as PF-9184 (<b>3</b>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> have each been shown to inhibit <i>m</i>PGES-1. In addition, an <i>m</i>PGES-1 inhibitor known as GRC-27864 has entered clinical trials for inflammatory pain.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Examples of Known <i>m</i>PGES-1 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For the above reasons, we set out to identify an inhibitor of <i>m</i>PGES-1. We tested potency in a microsomal prep enzyme inhibition assay, and we measured PGE<sub>2</sub> and PGI<sub>2</sub> by EIA in hIL-1β-stimulated A549 cells to further evaluate potency and selectivity against other enzymes in the prostaglandin pathway.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> It has been shown for COX-2 inhibitors that the IC<sub>80</sub> in an <i>ex vivo</i> LPS-stimulated human whole blood (HWB) assay (determined by measuring inhibition of PGE<sub>2</sub> response) correlates with efficacious <i>in vivo</i> therapeutic concentrations.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Therefore, we elected to evaluate our compounds by an analogous assay, using PGE<sub>2</sub> as a biomarker. Additionally in this assay, we measured TXB<sub>2</sub> and PGF<sub>2α</sub> as selectivity readouts.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p last">Celecoxib has been reported<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> to have a HWB IC<sub>50</sub> of 540 ± 70 nM.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In humans, a 200 mg oral dose of celecoxib results in a plasma drug concentration exceeding this IC<sub>50</sub> value for 8–12 h.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Our aim was to find a selective <i>m</i>PGES-1 inhibitor amenable to a dosing regimen that would produce a similar or superior relationship of exposure to HWB potency.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27877" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27877" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In a screen of compounds from the Lilly collection, <b>4</b> (<a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>) was identified in the enzyme assay as an <i>m</i>PGES-1 inhibitor (IC<sub>50</sub> = 17.4 μM ×/÷ 1.25 (<i>n</i> = 2)).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The X-ray cocrystal structure of <b>4</b> with <i>m</i>PGES-1<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> revealed a hydrogen bond between the benzamide nitrogen and His53 and showed that the C(5)–C(6) region of the A ring projected toward a cleft in the enzyme surface (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><figure id="cht2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Initial Screening Hit</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal structures of <i>m</i>PGES-1 with <b>4</b> (A) and <b>5</b> (B). Ligands, key side chains, and glutathione cofactors are highlighted with thick bonds. Some atoms are omitted for clarity. H-bond distances are given in Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Subsequent SAR studies revealed that an imidazole was a preferred replacement for the thiazole. We then sought to leverage the C(5)–C(6) region to gain additional potency. Incorporation of a C(5) substituent led to <b>5</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), which contained a pendant amide. It was notable that in the X-ray structure of <b>5</b>, Gln36 and Arg52 had folded toward the ligand to participate in hydrogen-bonding interactions that were absent in <b>4</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of <i>m</i>PGES-1 Inhibitors <b>5</b>–<b>10</b> Compared with Reference Compounds <b>1</b> and <b>2</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0007.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="​" /></col><col align="char" char="​" /></col><col align="char" char="×" /></col><col align="char" char="×" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char="​"><i>m</i>PGES-1 IC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="b">b</a> (nM)</th><th class="colsep0 rowsep0" align="center" char="​">A549 PGE<sub>2</sub> IC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="b">b</a> (nM)</th><th class="colsep0 rowsep0" align="center" char="×">HWB PGE<sub>2</sub> IC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="b">b</a> (nM)</th><th class="colsep0 rowsep0" align="center" char="×">HWB PGE<sub>2</sub> IC<sub>80</sub><a class="ref internalNav" href="#t1fn1" aria-label="b">b</a> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">microsomal CYP3A4 inh @10 μM (%)</th><th class="colsep0 rowsep0" align="center" char=".">microsomal CYP3A4 TDI @10 μM (%)</th><th class="colsep0 rowsep0" align="center" char="."><i>c</i>logP<a class="ref internalNav" href="#t1fn3" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="​">5.3 ×/÷ 1.51 (239)</td><td class="colsep0 rowsep0" align="char" char="​">76 ×/÷ 2.16 (234)</td><td class="colsep0 rowsep0" align="char" char="×">676 ×/÷ 1.96 (61)</td><td class="colsep0 rowsep0" align="char" char="×">3.65 ×/÷ 2.23 (52)</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#tbl1-fn2" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">5.58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char="​">19.5 ×/÷ 1.84 (318)</td><td class="colsep0 rowsep0" align="char" char="​">1230 ×/÷ 1.21 (12)</td><td class="colsep0 rowsep0" align="char" char="×"><a class="ref internalNav" href="#tbl1-fn2" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="×"><a class="ref internalNav" href="#tbl1-fn2" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#tbl1-fn2" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char="​"><3 (2)</td><td class="colsep0 rowsep0" align="char" char="​">19 ×/÷ 1.59 (2)</td><td class="colsep0 rowsep0" align="char" char="×">338 ×/÷ 1.65 (6)</td><td class="colsep0 rowsep0" align="char" char="×">994 ×/÷ 1.57 (6)</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">4.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char="​"><3 (3)</td><td class="colsep0 rowsep0" align="char" char="​">37 ×/÷ 1.04 (2)</td><td class="colsep0 rowsep0" align="char" char="×">29 ×/÷ 2.06 (5)</td><td class="colsep0 rowsep0" align="char" char="×">146 ×/÷ 2.46 (5)</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">72</td><td class="colsep0 rowsep0" align="char" char=".">3.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char="​"><3 (5)</td><td class="colsep0 rowsep0" align="char" char="​">39 ×/÷ 1.43 (2)</td><td class="colsep0 rowsep0" align="char" char="×">91 ×/÷ 1.58 (5)</td><td class="colsep0 rowsep0" align="char" char="×">480 ×/÷ 2.35 (5)</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">3.45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char="​">0.9 ×/÷ 1.80 (10)<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="​">12 ×/÷ 1.55 (4)</td><td class="colsep0 rowsep0" align="char" char="×">12 ×/÷ 1.94 (11)</td><td class="colsep0 rowsep0" align="char" char="×">69 ×/÷ 1.72 (11)</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">3.72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char="​">10.3 ×/÷ 1.53 (5)</td><td class="colsep0 rowsep0" align="char" char="​">98 ×/÷ 1.08 (2)</td><td class="colsep0 rowsep0" align="char" char="×">374 ×/÷ 1.49 (3)</td><td class="colsep0 rowsep0" align="char" char="×">991 ×/÷ 1.52 (3)</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">3.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="​">74 ×/÷ 1.17 (2)</td><td class="colsep0 rowsep0" align="char" char="​">720 (1)</td><td class="colsep0 rowsep0" align="char" char="×"><a class="ref internalNav" href="#tbl1-fn2" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="×"><a class="ref internalNav" href="#tbl1-fn2" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">2.48</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Not applicable.</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last">Values are reported as geometric means with geometric standard deviations. Number of replicates is in parentheses.</p></div><div class="footnote" id="t1fn2"><sup>c</sup><p class="last">Twelve values of <3 nM were not factored into this calculation.</p></div><div class="footnote" id="tbl1-fn2"><sup>d</sup><p class="last">Not tested.</p></div><div class="footnote" id="t1fn3"><sup>e</sup><p class="last">Calculated using Marvin and calculator plugin freeware (<a href="http://www.chemaxon.com" class="extLink">www.chemaxon.com</a>, ChemAxon Kft, Budapest, Hungary).</p></div></div></div><div class="NLM_p">Despite the strong enzyme potency of <b>5</b>, the IC<sub>50</sub> shifted by at least 2 orders of magnitude between the enzyme and the HWB assay. We supposed that decreasing the lipophilicity would attenuate this shift. Indeed, substitution with a nitrogen atom at an appropriate location in the A ring (<b>6</b>) lessened the enzyme-to-HWB potency shift by approximately an order of magnitude.</div><div class="NLM_p">Compounds <b>5</b> and <b>6</b> had sufficient activity in HWB to be of further interest. In contrast to celecoxib, these analogues suppressed neither PGI<sub>2</sub> formation in the A549 assay nor TXB<sub>2</sub> or PGF<sub>2α</sub> production in HWB.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Additionally, <b>8</b> was at least 10 000-fold selective against COX-1 and COX-2 (no inhibition of either enzyme observed at 10 μM).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Taken together, these biochemical outcomes were consistent with selective inhibition of <i>m</i>PGES-1.</div><div class="NLM_p">While neither <b>5</b> nor <b>6</b> exhibited >50% inhibition at 10 μM in <i>in vitro</i> microsomal CYP inhibition assays, they did display <i>in vitro</i> TDI of CYP3A4 at 10 μM. This indicated the potential for DDIs over prolonged dosing, a risk we wished to mitigate.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> It was found that adding a substituent to the imidazole would lower the potential for TDI (see analogues <b>7</b>–<b>10</b>.)</div><div class="NLM_p">Although <b>7</b> seemed suitable in many respects, we embarked on further studies aimed at maximizing the activity in HWB. Ultimately, replacement of the distal chlorine with a trifluoromethyl group to furnish <b>8</b> improved the HWB potency by nearly an order of magnitude. Lower homologues of the isobutyramide (<b>9</b>, <b>10</b>) were less potent. Therefore, our interest turned to additional studies of the potency, selectivity, and ADME properties of <b>8</b>.</div><div class="NLM_p">Against <i>h</i>ERG, <b>8</b> had a measurable IC<sub>50</sub> and <i>K</i><sub>i</sub> (82.6 μM and 41.3 μM, respectively), but the HWB IC<sub>80</sub> of 69 nM meant that the therapeutic plasma concentration of <b>8</b> was likely to be such that a sufficient margin should exist between <i>h</i>ERG activity and <i>m</i>PGES-1 activity to afford low risk of QT prolongation.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Upon testing against a CEREP panel of receptors and ion channels, <b>8</b> did not display any activity that would be deemed to present an undue risk.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">Compound <b>8</b> was active in dog whole blood (DWB IC<sub>50</sub> = 139 nM ×/÷ 1.76 and IC<sub>80</sub> = 703 nM ×/÷ 2.37 (<i>n</i> = 16)). However, in a rat <i>m</i>PGES-1 enzyme assay, <b>8</b> had an IC<sub>50</sub> of 33.9 μM ×/÷ 1.94 (<i>n</i> = 3).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> This drastic species selectivity was similar to known observations with other classes of <i>m</i>PGES-1 inhibitors.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p">Inhibitor <b>8</b> was subjected to a dog PK experiment (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The bioavailability was found to be 37%, and at an oral dose of 2 mg/kg, a plasma concentration exceeding 200 nM was sustained for 24 h. This, taken with the known correlation between <i>ex vivo</i> IC<sub>80</sub> and efficacious plasma concentration,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> gave us preclinical evidence even in the absence of a <i>per se in vivo</i> efficacy study that a clinically relevant exposure could be achieved at an acceptably low dose.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0015.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. PK of <b>8</b> in dog after 2 mg/kg po dosing (solid diamonds, <i>n</i> = 3) and 0.5 mg/kg iv dosing (hollow diamonds, <i>n</i> = 3). Diamonds indicate geometric means, and error bars represent geometric standard deviations of measured values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, the slow absorption and low FasSIF solubility of <b>8</b> (0.007 mg/mL) prompted us to evaluate enablement options for the compound in order to facilitate dose escalation studies to assess safety without reaching a barrier of dose-limited exposure due to dissolution-limited absorption. While measured thermodynamic solubility in FaSSIF is a valuable initial indicator of the oral absorption potential of compounds, it can sometimes be misleading because it is a result of extended hours of mixing in that medium and not necessarily representative of the <i>in vivo</i> gastrointestinal environment. For basic compounds that have a conjugate acid p<i>K</i><sub>a</sub> of approximately 4.5 or greater, it is sometimes possible to enhance dissolution rate through salt formation and then briefly sustain metastable supersaturation at the site of absorption.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Accordingly, depending on the extent and duration of supersaturation, absorption can be significantly improved.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p">This approach works best for compounds that do not rapidly crystallize or precipitate under biorelevant conditions. From a dynamic dissolution test that mimicked the transfer of orally dosed compound from the stomach to the duodenum,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> it was evident that the phosphate salt of <b>8</b> had a tendency to dissolve faster than the free base and remain amorphous for an extended period of time (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). Indeed, <i>in vivo</i> PK studies in beagle dog after a 60 mg/kg PO dose showed that <b>8</b>·<b>H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub> was more rapidly absorbed than the free base, resulting in higher plasma concentrations and reduced variability at every time point through 24 h (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Furthermore, this salt form had acceptable solid state properties. The melting point (190.4 °C), hygroscopicity (<0.5% weight gain when subjected to RH values up to 95%), and physical stability (stable for 2 weeks at 70 °C/75% RH and for 4 weeks at 40 °C/75% RH) all were suitable for development. Therefore, <b>8</b>·<b>H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub> was selected as a clinical candidate.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0016.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Time-dependent exposure profile of <b>8</b> and <b>8·H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub> in a dynamic dissolution test in artificial stomach (A) and artificial duodenum (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0001.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. PK of <b>8</b> (solid diamonds, <i>n</i> = 6) and <b>8·H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub> (hollow diamonds, <i>n</i> = 6) in dog after 60 mg/kg po dosing. Diamonds indicate geometric means, and error bars represent geometric standard deviations of measured values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthesis of <b>8·H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub> was achieved as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Aminoimidazole <b>12</b> was prepared by bromination of ketone <b>13</b> to give <b>14</b>,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> which was cyclized with 2-aminopyrimidine to furnish <b>15</b>. This was then subjected to the action of hydroxylamine,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> which cleaved the pyrimidine to reveal <b>12</b>. The core of <b>16</b> was constructed by a modified Hantzsch pyridine synthesis. Condensation of <b>17</b><a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> with triethylorthoformate provided <b>18</b>, which was warmed in the presence of 3-dimethylaminoprop-2-enenitrile<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> to give pyridine <b>19</b> after acid-promoted elimination of dimethylamine. Reduction of the nitrile, followed by acylation of the resulting amine and <i>in situ</i> saponification of the ester, gave <b>16</b>.</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>8·H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Br<sub>2</sub>, AcOH, 92%; (b) 2-aminopyrimidine, NaHCO<sub>3</sub>, <i>i</i>-PrOH, 80 °C, 22%; (c) NH<sub>2</sub>OH, EtOH, 82 °C, 95%; (d) (EtO)<sub>3</sub>CH, Ac<sub>2</sub>O, 90–100 °C, 86%; (e) (CH<sub>3</sub>)<sub>2</sub>NCH═CHCN, 60–65 °C, then NH<sub>4</sub>OAc, 60–65 °C, 85%; (f) H<sub>2</sub>, Pd/C, Boc<sub>2</sub>O, EtOH, Et<sub>3</sub>N, then HCl, 1,4-dioxane, MTBE, 66%; (g) <i>i</i>-PrCOCl, Et<sub>3</sub>N, toluene, then LiOH(aq), 70%; (h) T3P, NMM, EtOAc, 65–75 °C, 64%; (i) H<sub>3</sub>PO<sub>4</sub>, CH<sub>3</sub>CN, H<sub>2</sub>O, 79%.</p></p></figure><div class="NLM_p">To complete the synthesis, <b>12</b> and <b>16</b> were coupled using T3P to furnish <b>8</b>. Generally with unprotected 2-aminoimidazoles, we observed a kinetic preference for acylation of either one of the ring nitrogens versus the exocyclic nitrogen, so heating was required to induce isomerization to the N(2)-acylated product. Lastly, <b>8</b> was treated with H<sub>3</sub>PO<sub>4</sub> to give the phosphate salt.</div><div class="NLM_p">While <b>8·H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub> was suitable for clinical development, we sought a second molecule with improved physical properties.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> We hypothesized that omitting the largely exposed lipophilic ring of <b>8</b> would improve solubility, bioavailability, and absorption while maintaining the critical hydrogen bonding interactions with the enzyme (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Therefore, we prepared <b>20</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). This analogue had only single-digit micromolar potency in our enzyme assay, but it efficiently translated this activity to the <i>ex vivo</i> HWB PGE<sub>2</sub> assay. Furthermore, <b>20</b> did not demonstrate significant activity in a CYP3A4 TDI assay (20% inhibition after 30 min at 10 μM). Although <b>20</b> contained an unsubstituted imidazole, a known risk factor for CYP inhibition,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> we reasoned that the lower molecular weight and lipophilicity of <b>20</b><i>vis-à-vis</i> analogues <b>5</b>–<b>10</b> likely limited the affinity of the former for CYP enzymes.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0002.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray cocrystal structure of mPGES-1 with <b>8</b>. Ligand, key side chains, and glutathione cofactor are highlighted with thick bonds. Some atoms are omitted for clarity. H-bond distances are given in Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of Unsubstituted 2-Aminoimidazole <i>m</i>PGES-1 Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0008.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="×" /></col><col align="char" char="​" /></col><col align="char" char="×" /></col><col align="char" char="×" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="×"><i>m</i>PGES-1 IC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (μM)</th><th class="colsep0 rowsep0" align="center" char="​">A549 PGE<sub>2</sub> IC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (μM)</th><th class="colsep0 rowsep0" align="center" char="×">HWB PGE<sub>2</sub> IC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (μM)</th><th class="colsep0 rowsep0" align="center" char="×">HWB PGE<sub>2</sub> IC<sub>80</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>c</i>logP<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>20</b></td><td class="colsep0 rowsep0" align="center">CF<sub>2</sub>H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center"><i>i-</i>Pr</td><td class="colsep0 rowsep0" align="char" char="×">2.46 ×/÷ 1.13 (3)</td><td class="colsep0 rowsep0" align="char" char="​">3.15 ×/÷ 1.60 (2)</td><td class="colsep0 rowsep0" align="char" char="×">4.61 ×/÷ 1.46 (5)</td><td class="colsep0 rowsep0" align="char" char="×">31.0 ×/÷ 5.19 (5)</td><td class="colsep0 rowsep0" align="char" char=".">2.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>21</b></td><td class="colsep0 rowsep0" align="center">CF<sub>2</sub>H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">(<i>S</i>)-<i>s</i>-Bu</td><td class="colsep0 rowsep0" align="char" char="×">1.12 ×/÷ 1.05 (2)</td><td class="colsep0 rowsep0" align="char" char="​">8.86 ×/÷ 2.18 (2)</td><td class="colsep0 rowsep0" align="char" char="×">10.5 ×/÷ 1.08 (2)</td><td class="colsep0 rowsep0" align="char" char="×">21.1 ×/÷ 1.08 (2)</td><td class="colsep0 rowsep0" align="char" char=".">2.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>22</b></td><td class="colsep0 rowsep0" align="center">CF<sub>2</sub>H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="char" char="×">0.676 ×/÷ 1.18 (2)</td><td class="colsep0 rowsep0" align="char" char="​">3.25 ×/÷ 1.43 (2)</td><td class="colsep0 rowsep0" align="char" char="×">1.43 ×/÷ 2.08 (2)</td><td class="colsep0 rowsep0" align="char" char="×">33.7 ×/÷ 1.16 (2)</td><td class="colsep0 rowsep0" align="char" char=".">2.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>23</b></td><td class="colsep0 rowsep0" align="center">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="char" char="×">1.08 ×/÷ 1.07 (2)</td><td class="colsep0 rowsep0" align="char" char="​">3.23 ×/÷ 1.50 (2)</td><td class="colsep0 rowsep0" align="char" char="×">2.14 ×/÷ 1.64 (3)</td><td class="colsep0 rowsep0" align="char" char="×">10.5 ×/÷ 1.93 (3)</td><td class="colsep0 rowsep0" align="char" char=".">3.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>24</b></td><td class="colsep0 rowsep0" align="center">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="char" char="×">3.11 ×/÷ 1.35 (2)</td><td class="colsep0 rowsep0" align="char" char="​">4.62 ×/÷ 2.72 (4)</td><td class="colsep0 rowsep0" align="char" char="×">2.43 ×/÷ 2.47 (3)</td><td class="colsep0 rowsep0" align="char" char="×">9.08 ×/÷ 1.31 (3)</td><td class="colsep0 rowsep0" align="char" char=".">2.89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>25</b></td><td class="colsep0 rowsep0" align="center">Br</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="char" char="×">0.198 ×/÷ 1.26 (3)</td><td class="colsep0 rowsep0" align="char" char="​">0.284 ×/÷ 1.52 (2)</td><td class="colsep0 rowsep0" align="char" char="×">0.607 ×/÷ 1.96 (3)</td><td class="colsep0 rowsep0" align="char" char="×">2.39 ×/÷ 1.43 (3)</td><td class="colsep0 rowsep0" align="char" char=".">3.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>26</b></td><td class="colsep0 rowsep0" align="center">Cl</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="char" char="×">0.241 ×/÷ 1.38 (6)</td><td class="colsep0 rowsep0" align="char" char="​">0.870 ×/÷ 1.55 (5)</td><td class="colsep0 rowsep0" align="char" char="×">0.744 ×/÷ 1.46 (6)</td><td class="colsep0 rowsep0" align="char" char="×">2.44 ×/÷ 1.80 (6)</td><td class="colsep0 rowsep0" align="char" char=".">2.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>27</b></td><td class="colsep0 rowsep0" align="center">Cl</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center"><i>t</i>-Am</td><td class="colsep0 rowsep0" align="char" char="×">0.385 ×/÷ 1.4 (2)</td><td class="colsep0 rowsep0" align="char" char="​">1.23 ×/÷ 1.10 (2)</td><td class="colsep0 rowsep0" align="char" char="×">0.853 ×/÷ 1.50 (3)</td><td class="colsep0 rowsep0" align="char" char="×">9.37 ×/÷ 1.87 (3)</td><td class="colsep0 rowsep0" align="char" char=".">3.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>28</b></td><td class="colsep0 rowsep0" align="center">Cl</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center"><i>i-</i>Pr</td><td class="colsep0 rowsep0" align="char" char="×">0.885 ×/÷ 1.32 (2)</td><td class="colsep0 rowsep0" align="char" char="​">2.77 ×/÷ 1.56 (3)</td><td class="colsep0 rowsep0" align="char" char="×">0.792 ×/÷ 1.51 (2)</td><td class="colsep0 rowsep0" align="char" char="×">8.80 ×/÷ 1.34 (2)</td><td class="colsep0 rowsep0" align="char" char=".">2.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>29</b></td><td class="colsep0 rowsep0" align="center">Cl</td><td class="colsep0 rowsep0" align="center">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"><i>i-</i>Pr</td><td class="colsep0 rowsep0" align="char" char="×">2.32 ×/÷ 1.14 (2)</td><td class="colsep0 rowsep0" align="char" char="​">8.85 ×/÷ 1.13 (2)</td><td class="colsep0 rowsep0" align="char" char="×">13.0 ×/÷ 1.69 (3)</td><td class="colsep0 rowsep0" align="char" char="×">132 ×/÷ 2.13 (3)</td><td class="colsep0 rowsep0" align="char" char=".">2.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>30</b></td><td class="colsep0 rowsep0" align="center">Cl</td><td class="colsep0 rowsep0" align="center">F</td><td class="colsep0 rowsep0" align="center"><i>i-</i>Pr</td><td class="colsep0 rowsep0" align="char" char="×">3.67 ×/÷ 1.03 (2)</td><td class="colsep0 rowsep0" align="char" char="​">>10 (2)</td><td class="colsep0 rowsep0" align="char" char="×">9.53 ×/÷ 1.89 (3)</td><td class="colsep0 rowsep0" align="char" char="×">57.4 ×/÷ 4.29 (3)</td><td class="colsep0 rowsep0" align="char" char=".">2.57</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Values are reported as geometric means with geometric standard deviations. Number of replicates is in parentheses.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Calculated using Marvin and calculator plugin freeware (<a href="http://www.chemaxon.com" class="extLink">www.chemaxon.com</a>, ChemAxon Kft, Budapest, Hungary).</p></div></div></div><div class="NLM_p">In rats, <b>20</b> was found to be orally bioavailable (<i>F</i> = 100%) and rapidly absorbed (<i>t</i><sub>max,po</sub> = 15 min) with low clearance (CL<sub>iv</sub> = 26.1 mL/(min·kg)) and <i>V</i><sub>dss</sub> (2.27 L/kg). The efficient translation of enzyme activity to HWB, combined with the PK properties of <b>20</b>, encouraged us to pursue an SAR study of these smaller analogues (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_p">Increasing the bulk of the amide (<b>21</b>, <b>22</b>) resulted in a slight potency improvement. In a study of substitution at the C(2) position (<b>23</b>–<b>26</b>), halogen atoms proved to be optimal. On the 2-chloro system, further increasing the bulk of the amide provided no potency advantage (<b>27</b>). Scaling the benzylic substituent back to an isobutyramide (<b>28</b>) reduced potency in the A549 IC<sub>50</sub> and HWB IC<sub>80</sub> assays, suggesting along with the comparison of <b>20</b> and <b>22</b> that a pivalamide was optimal. Substitution at the C(4) position tended to decrease potency (<b>29</b>, <b>30</b>).</div><div class="NLM_p">None of the analogues <b>20</b>–<b>30</b> decreased PGI<sub>2</sub> production in A549 cells up to 10 μM or PGF<sub>2α</sub> or TXB<sub>2</sub> production in HWB up to 30 μM, suggesting that these compounds did not have COX inhibitory activity.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Indeed, compound <b>26</b> was inactive against COX-1 and COX-2 (9% inhibition at 100 μM and 16% at 30 μM, respectively)).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Therefore, it was concluded that the PGE<sub>2</sub> reduction exhibited by <b>26</b> resulted from selective <i>m</i>PGES-1 inhibition.</div><div class="NLM_p">For this SAR study, most cores that were not commercially available could be prepared by Tscherniac–Einhorn alkylation.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> For example, <i>o</i>-toluic acid (<b>31,</b><a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) was treated with <i>N</i>-(hydroxymethyl)pivalamide in the presence of sulfuric acid to furnish a separable mixture of <b>32</b> and <b>33</b>, and then <b>33</b> was carried forward to <b>24</b>. Although this chemistry was not regioselective, it enabled facile exploration of C(2) and C(4) substituents by providing rapid access to the requisite functionalized benzoic acids.</div><figure id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>t</i>-BuCONHCH<sub>2</sub>OH, H<sub>2</sub>SO<sub>4</sub>, rt, then chromatographic separation, 27% of <b>32</b> and 28% of <b>33</b>; (b) 2-aminoimidazole monosulfate, BOP, Et<sub>3</sub>N, DMF, 60 °C, 87%.</p></p></figure><div class="NLM_p">Of the analogues in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, <b>25</b> and <b>26</b> had the lowest HWB IC<sub>80</sub> values. Between these two compounds, <b>26</b> had the lower molecular weight and <i>c</i>logP, so it was selected for further evaluation.</div><div class="NLM_p">Against <i>h</i>ERG, <b>26</b> had no significant measurable activity (−4% and 14% inhibition at 10 μM and 100 μM, respectively). However, the decreased <i>m</i>PGES potency of <b>26</b> and the high <i>h</i>ERG IC<sub>50</sub> of <b>8</b> prevented a meaningful comparison between <b>8</b> and <b>26</b> in this regard. However, on the basis of these data, <b>26</b> was not expected to carry a significant QT prolongation risk. Compound <b>26</b> did not display any significant activity against a CEREP panel of receptors and ion channels.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">Similarly to <b>8</b>, compound <b>26</b> was active in dog whole blood (DWB IC<sub>50</sub> = 0.555 μM ×/÷ 1.90 and IC<sub>80</sub> = 1.84 μM ×/÷ 2.06 (<i>n</i> = 5)) but had substantially less potency in the rat <i>m</i>PGES-1 assay (IC<sub>50</sub> > 1000 μM) than in the human enzyme assay. With the potential to use the dog as an on-target species, we studied the PK properties of <b>26</b> in dog (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).</div><div class="NLM_p">In dogs, it was found that <b>26</b> was readily orally bioavailable when administered as an aqueous suspension of crystalline material (<i>F</i> = 60% ×/÷ 1.17 after 0.5 mg/kg po and iv dosing, <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A).</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0003.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. PK of <b>26</b> in dog (A) after 0.5 mg/kg po dosing (solid diamonds, <i>n</i> = 3) and 0.5 mg/kg iv dosing (hollow diamonds, <i>n</i> = 3) and (B) after 2 mg/kg po dosing (<i>n</i> = 3). Diamonds indicate geometric means, and error bars represent geometric standard deviations of measured values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">After a 2 mg/kg po dose (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B), plasma concentrations exceeding 1 μM were achieved in less than 15 min and sustained for at least 8 h. Compound <b>26</b> exhibited relatively little exposure variability between animals; the geometric SD for plasma concentration was ≤2.0 at all time points in both dog PK studies. The desirable PK properties of <b>26</b>, along with its potency in HWB and selectivity for <i>m</i>PGES-1, informed us in our selection of <b>26</b> as a clinical candidate.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> It was notable that the superior physicochemical properties and reduced exposure variability of <b>26</b> compared with <b>8</b> sufficiently compensated for reduced potency to make <b>26</b> a viable molecule to test in the clinic.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p">A larger-scale synthesis of <b>26</b> proceeded straightforwardly from commercially available <b>34</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Acylation of the amine with pivaloyl chloride furnished <b>35</b>. Saponification of the crude ester gave <b>36</b>, which was coupled with 2-aminoimidazole with heating to furnish <b>26</b> in ca. 81% yield over three steps. We viewed the simplicity of this synthesis as a potential advantage for the development of <b>26</b>.</div><figure id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>t</i>-BuCOCl, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (b) LiOH, H<sub>2</sub>O, 1,4-dioxane, rt, 1 h, then HCl<sub>(aq)</sub>, 97% (2 steps); (c) 2-aminoimidazole monosulfate, TBTU, DIEA, DMF, 80 °C, 18 h, 83%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21450" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21450" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">SAR efforts guided by structural insights yielded two clinical candidates, <b>8</b>·<b>H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub> and <b>26</b>, with different profiles. While <b>8</b>·<b>H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub> was significantly more potent in the enzyme and HWB assays, <b>26</b> had an improved pharmacokinetic profile in dog while still exhibiting a HWB IC<sub>50</sub> for PGE<sub>2</sub> suppression comparable to that of celecoxib. Based on the known PK/PD relationship with COX-2 inhibitors, this pair of compounds was expected to offer insight into the validity of <i>m</i>PGES-1 inhibition as a mechanism for analgesia in human patients.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42471" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42471" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Methods</h3><div class="NLM_p">All reagents and anhydrous solvents were obtained from commercial sources and used without further purification unless noted otherwise. <sup>1</sup>H NMR spectra were recorded on a Bruker 300 MHz spectrometer, a Bruker 400 MHz spectrometer, a Bruker 500 MHz spectrometer, or a Varian 400 MHz spectrometer. <sup>1</sup>H NMR chemical shifts are reported in ppm with the solvent as the internal standard (DMSO-<i>d</i><sub>5</sub> 2.49 ppm, CHCl<sub>3</sub> 7.26 ppm). <sup>13</sup>C NMR chemical shifts are reported in ppm with the solvent as the internal standard (DMSO-<i>d</i><sub>6</sub> 39.52 ppm). <sup>19</sup>F NMR chemical shifts are reported in ppm relative to an external standard of CFCl<sub>3</sub>. <sup>31</sup>P NMR chemical shifts are reported in ppm relative to an external standard of 85% H<sub>3</sub>PO<sub>4</sub>.</div><div class="NLM_p last">Compounds were analyzed for purity by HPLC and HPLC-MS, and unless otherwise stated, purities of synthesized compounds were all found to be >95% by the following HPLC method: Agilent 1100 HPLC with VWD detectors, Waters Exterra MS 4.6 mm × 150 mm × 3.5 μm C<sub>18</sub> column; eluent 0.1% formic acid in a gradient of 5% to 100% CH<sub>3</sub>CN in water over 3.75 min; flow rate 1.0 mL/min; column temperature 50 °C; λ 300 and 214 nm.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 2-Bromo-1-(4-(trifluoromethyl)phenyl)-1-propanone (<b>14</b>)</h3><div class="NLM_p last">At room temperature, a mixture of 4-(trifluoromethyl)propiophenone (<b>13</b>, 100 g, 494 mmol) and glacial acetic acid (200 mL) was treated with a solution of bromine (79 g, 494 mmol) in glacial acetic acid (200 mL) over the course of 60 min. After the end of the addition, the mixture was stirred for 1.5 h, then was quenched with cold water (<5 °C, 1.2 L) and stirred for 3 h at between 0 and 5 °C. The resulting slurry was filtered, washed with water (10–15 °C, 1 L), and dried under reduced pressure at between 25 and 30 °C for 15 h to furnish <b>14</b> (128.1 g, 92% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.13 (d, <i>J</i> = 8.3 Hz, 2H), 7.76 (d, <i>J</i> = 8.3 Hz, 2H), 5.26 (q, <i>J</i> = 6.7 Hz, 1H), 1.93 (d, <i>J</i> = 6.3 Hz, 2H).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 2-Methyl-3-(4-(trifluoromethyl)phenyl)imidazo[1,2-<i>a</i>]pyrimidine (<b>15</b>)</h3><div class="NLM_p last">A mixture of <b>14</b> (100 g, 356 mmol), 2-aminopyrimidine (33.9 g, 356 mmol), NaHCO<sub>3</sub> (59.8 g, 811 mmol), and toluene (500 mL) was heated to between 90 and 100 °C for 24 h with stirring. The mixture was cooled to between 40 and 45 °C, and the product was isolated by vacuum distillation. The distillate was cooled to between 25 and 30 °C, treated with water (1 L), and stirred for 4 h. The solids were collected by filtration, washed with a 9:1 (v/v) mixture of hexanes and MTBE (200 mL), and dried in a vacuum oven at between 45 and 50 °C to furnish <b>15</b> (35.4 g, 35% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.86 (dd, <i>J</i> = 6.9, 1.9 Hz, 1H), 8.56 (dd, <i>J</i> = 4.2, 2.0 Hz, 1H), 8.07 (d, <i>J</i> = 8.8 Hz, 2H), 7.84 (d, <i>J</i> = 8.7 Hz, 2H), 7.11 (dd, <i>J</i> = 6.9, 4.0 Hz, 1H), 2.69 (s, 3H). LC/MS (ESI<sup>+</sup>): (<i>m</i>/<i>z</i>) 278 (M + H)<sup>+</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 4-Methyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-imidazol-2-amine (<b>12</b>)</h3><div class="NLM_p last">A mixture of <b>15</b> (180 g, 649 mmol), EtOH (1.4 L), and hydroxylamine (159 mL, 2.60 mol) was stirred at 82 °C for 48 h, then cooled and concentrated to dryness. The residue was diluted with CH<sub>2</sub>Cl<sub>2</sub> (1.5 L) and washed with water (2 × 500 mL) and saturated aqueous NaCl (500 mL). The organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to give a yellow gum. This was subjected to flash chromatography on silica gel, eluting with a gradient of 0% to 25% (2% NH<sub>3</sub> in CH<sub>3</sub>OH) in CH<sub>2</sub>Cl<sub>2</sub>, to furnish <b>12</b> as a yellow foam (150.3 g, 96% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.42 (ABq, <i>J</i><sub>AB</sub> = 8.9 Hz, Δδ<sub>AB</sub> = 0.058, 4H), 6.48 (v br s, 3H), 2.16 (s, 3H). LC/MS (ESI<sup>+</sup>): (<i>m</i>/<i>z</i>) 242 (M + H)<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 2-(Difluoromethyl)-5-(isobutyramidomethyl)-<i>N</i>-(4-methyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-imidazol-2-yl)nicotinamide (<b>8</b>)</h3><div class="NLM_p last">A mixture of <b>16</b> (230 g, 845 mmol), <b>12</b> (281 g, 845 mmol), NMM (428 g, 4.22 mol), and EtOAc (2.5 L) was stirred between 15 and 25 °C for 1 h, then treated with propylphosphonic anhydride (50% w/w in EtOAc, 1.88 kg, 2.95 mol) over the course of 17 min, maintaining the internal temperature below 40 °C. The addition vessel was rinsed with EtOAc (415 mL), which was added to the reaction vessel. The mixture was stirred for one additional hour, then was warmed to between 65 and 75 °C with stirring overnight. The mixture was cooled to between 15 and 25 °C and diluted with EtOAc, then washed with water (2 × 2 L), 1 N aqueous HCl (2 × 2 L), saturated aqueous NaCl (2 × 2 L), 10% (w/w) aqueous Na<sub>2</sub>CO<sub>3</sub> (2 × 2 L), and deionized water (2 × 2 L). The organic phase was concentrated under reduced pressure until solids appeared (at a volume of <i>ca</i>. 4 L), then absolute EtOH (3 L) was added, and the mixture was concentrated to a volume of ca. 3 L. Absolute EtOH (1 L) was added, and the mixture was stirred at between 65 and 75 °C for 30 min, then at between 15 and 25 °C for 63 h. The slurry was cooled to between −5 and −15 °C with stirring for 2 h, then the solids were isolated by filtration, rinsed with cold (−10 °C) absolute EtOH (420 mL), and dried in a 50 °C vacuum oven for two nights to furnish <b>8</b> (268 g, 64% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.08 (br s, 2H), 8.65 (s, 1H), 8.40 (t, <i>J</i> = 5.6 Hz, 1H), 8.06 (s, 1H), 7.81 (A of ABq, d, <i>J</i> = 8.1 Hz, 2H), 7.73 (B of ABq, d, <i>J</i> = 8.1 Hz, 2H), 7.35 (v br t, <i>J</i> = 54 Hz, 1H), 4.38 (d, <i>J</i> = 5.6 Hz, 2H), 2.46 (s, 3H), 2.44 (septet, <i>J</i> = 6.8 Hz, 1H), 1.04 (d, <i>J</i> = 6.8 Hz, 6H). <sup>13</sup>C{<sup>1</sup>H} NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 176.4, 165.5, 149.4, 147.7 (t, <i>J</i> = 22.0 Hz), 141.1 (br s), 138.1 (br s), 137.1, 135.8, 130.7 (br s), 125.9 (q, <i>J</i> = 31.9 Hz), 125.7, 125.4 (q, <i>J</i> = 3.7 Hz), 124.5 (q, <i>J</i> = 271.4 Hz), 122.3 (br s), 111.5 (t, <i>J</i> = 238.4 Hz), 34.0, 19.5, 11.2. <sup>19</sup>F{<sup>1</sup>H} NMR (376.5 MHz, DMSO-<i>d</i><sub>6</sub>): δ −60.7, −115.0. <sup>31</sup>P NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): no signal. LC/MS (ESI<sup>+</sup>): (<i>m</i>/<i>z</i>) 496 (M + H)<sup>+</sup>, 518 (M + Na)<sup>+</sup>, 534 (M + K)<sup>+</sup>. HRMS calcd for C<sub>23</sub>H<sub>23</sub>F<sub>5</sub>N<sub>5</sub>O<sub>2</sub> (M + H)<sup>+</sup>: 496.1772, found 496.1771. Anal. Calcd for C<sub>23</sub>H<sub>22</sub>F<sub>5</sub>N<sub>5</sub>O<sub>2</sub>: C, 55.75; H, 4.48; N, 14.14. Found: C, 55.53; H, 4.43; N, 14.11.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 2-(Difluoromethyl)-5-(isobutyramidomethyl)-<i>N</i>-(4-methyl-5-(4-(trifluoromethyl)phenyl)-1<i>H</i>-imidazol-2-yl)nicotinamide Phosphoric Acid Salt (<b>8·H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub>)</h3><div class="NLM_p last">To a mixture of <b>8</b> (250 g, 505 mmol) in CH<sub>3</sub>CN (5 L) was added a solution of 85% H<sub>3</sub>PO<sub>4</sub> (110.7 g, 960 mmol) in deionized water (1 L). The mixture was heated to between 60 and 70 °C, then filtered through a 1.2 μM filter capsule. The filtrate was heated to between 55 and 65 °C, then was stirred at ambient temperature overnight. The mixture was cooled to 5 °C and stirred at that temperature for 2 h. The resulting solids were collected by filtration and rinsed with cold (0–10 °C) CH<sub>3</sub>CN (2 × 475 mL), followed by cold (0–10 °C) deionized water (2 × 475 mL). The wet solids were slurried with deionized water (2.5 L) at room temperature for 2 h, then collected by filtration and rinsed with the filtrate (3×), followed by deionized water (1.25 L). The solids were dried at 110 °C under reduced pressure to furnish <b>8·H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub> as a pale yellow solid (237 g, 79% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.65 (d, <i>J</i> = 1.8 Hz, 1H), 8.42 (t, <i>J</i> = 5.8 Hz, 1H), 8.06 (s, 1H), 7.81 (A of ABq, d, <i>J</i> = 8.1 Hz, 2H), 7.73 (B of ABq, d, <i>J</i> = 8.1 Hz, 2H), 7.35 (t, <i>J</i> = 54.1 Hz, 1H), 4.38 (d, <i>J</i> = 5.6 Hz, 2H), 2.46 (s, 3H), 2.45 (septet, <i>J</i> = 6.9 Hz, 1H), 1.04 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C{<sup>1</sup>H} NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 176.5, 165.5, 149.5, 147.7 (t, <i>J</i> = 22.0 Hz), 141.1, 137.9, 137.2, 135.8, 130.7 (t, <i>J</i> = 3.7 Hz), 127.6, 126.1, 125.9 (q, <i>J</i> = 31.9 Hz), 125.4 (q, <i>J</i> = 3.7 Hz), 124.5 (q, <i>J</i> = 271.4 Hz), 122.4, 111.5 (t, <i>J</i> = 238.4 Hz), 34.0, 19.5, 11.2. <sup>19</sup>F{<sup>1</sup>H} NMR (376.5 MHz, DMSO-<i>d</i><sub>6</sub>): δ −60.7, −115.0. <sup>31</sup>P NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ −0.7. HRMS calcd for C<sub>23</sub>H<sub>23</sub>F<sub>5</sub>N<sub>5</sub>O<sub>2</sub> (M)<sup>+</sup>: 496.1772, found 496.1755. Anal. Calcd for C<sub>23</sub>H<sub>24</sub>F<sub>5</sub>N<sub>5</sub>O<sub>6</sub>P: C, 46.55; H, 4.25; F, 16.01; N, 11.80. Found: C, 46.63; H, 4.22; F, 16.30; N, 11.91.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-Chloro-5-(pivalamidomethyl)benzoic Acid (<b>36</b>)</h3><div class="NLM_p last">A thermally controlled reactor was charged with methyl 5-(aminomethyl)-2-chlorobenzoate hydrochloride (<b>34</b>, 700 g, 2.96 mol), dichloromethane (4.90 L), and <i>N,N</i>-diisopropylethylamine (1.45 L, 8.30 mol). Pivaloyl chloride (436 mL, 3.56 mol) was added at such a rate that the internal temperature did not rise above 21 °C. The resulting solution was stirred at room temperature for 1 h. Then, the mixture was quenched with saturated aqueous NaHCO<sub>3</sub> (10 L) and extracted with dichloromethane (2 × 1000 mL). The combined organic extracts were dried over sodium sulfate and filtered. The filtrate was concentrated under reduced pressure to furnish crude <b>35</b> as a straw-colored oil. This was dissolved in 1,4-dioxane (5.25 L) and treated with water (3.15 L) and LiOH·H<sub>2</sub>O (408 g, 9.62 mol) and stirred at room temperature for 1 h. The mixture was then treated with 5.0 M aqueous HCl (3 L) (<i><b>Caution!</b> Exotherm!</i>) and concentrated under reduced pressure to remove ca. 6 L of volatile material. The resulting suspension was cooled to 10 °C, and the solids were isolated by filtration, washed with water (8 L), and dried on the sinter for 3 h. The solids were then dried in a 40 °C vacuum oven for 48 h to furnish <b>36</b> as a free-flowing white solid (775 g, 97% yield over two steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.32 (s, 1H), 8.13 (t, <i>J</i> = 5.8 Hz, 1H), 7.62 (d, <i>J</i> = 2.4 Hz, 1H), 7.47 (d, <i>J</i> = 8.3 Hz, 1H), 7.34 (dd, <i>J</i> = 8.3, 2.0 Hz, 1H), 4.25 (d, <i>J</i> = 5.8 Hz, 2H), 1.11 (s, 9H). LC/MS (ESI<sup>+</sup>): (<i>m</i>/<i>z</i>) (<sup>35</sup>Cl/<sup>37</sup>Cl) 270/272 (M + H)<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-Chloro-<i>N</i>-(1<i>H</i>-imidazol-2-yl)-5-(pivalamidomethyl)benzamide (<b>26</b>)</h3><div class="NLM_p last">A thermally controlled reaction vessel containing <b>36</b> (420 g, 1.56 mol), 2-aminoimidazole monosulfate (349 g, 1.87 mol), and DMF (2.94 L) was treated with <i>o</i>-benzotriazol-1-yl-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate (722 g, 2.18 mol) and then DIEA (869 mL, 4.98 mol) and heated to an internal temperature of 80 °C for 18 h. Then, the reaction mixture was cooled to 10 °C, added to ice water (14 L), and stirred for 90 min. The resulting solids were collected by filtration and air-dried for 24 h, then dried further in a 50 °C vacuum oven for 24 h. The resulting solid material was slurried in isopropanol (7 L), heated to an internal temperature of 73 °C for 3 h, and cooled to 10 °C, and the solids were isolated by filtration. The resulting material was air-dried for 24 h, then dried further in a 55 °C vacuum oven for 48 h to furnish <b>26</b> as a fine, off-white solid (435 g, 83% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.83 (br s, 2H), 8.12 (t, <i>J</i> = 6.0 Hz, 1H), 7.46 (d, <i>J</i> = 8.3 Hz, 1H), 7.39 (d, <i>J</i> = 1.7 Hz, 1H), 7.30 (dd, <i>J</i> = 8.3, 2.0 Hz, 1H), 6.72 (br s, 2H), 4.26 (d, <i>J</i> = 5.9 Hz, 2H), 1.11 (s, 9H). <sup>13</sup>C{<sup>1</sup>H} NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 177.6, 165.6, 141.3, 139.5, 135.7, 129.6, 129.5, 128.1, 127.6, 118.1 (v br s), 41.4, 38.0, 27.4. LC/MS (ESI<sup>+</sup>): (<i>m</i>/<i>z</i>) (<sup>35</sup>Cl/<sup>37</sup>Cl) 335/337 (M + H)<sup>+</sup>. HRMS calcd. for C<sub>16</sub>H<sub>20</sub>ClN<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup>: 335.1275, found 335.1274. Anal. Calcd for C<sub>16</sub>H<sub>19</sub>ClN<sub>4</sub>O<sub>2</sub>: C, 57.40; H, 5.72; N, 16.73; Cl, 10.59; O, 9.56. Found: C, 57.27; H, 5.64; N, 16.79; Cl, 10.59, O, 9.57.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Biological Assays</h3><div id="sec4_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>m</i>PGES-1 Enzyme Inhibition Assays</h4><div class="NLM_p">Human or rat <i>m</i>PGES-1 (Invitrogen; Cat. no. 97002RG, clone ID 6374722) was subcloned into pcDNA3.1 and transiently expressed in 293E cells. Microsomes were prepared from cell pellets based on published methods.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Pellets were brought up in homogenization buffer (15 mM Tris-HCl, pH 8.0; 0.25 M sucrose; 0.1 mM EDTA; 1 mM glutathione) and sonicated 5 × 30 s on ice. Homogenate was centrifuged at 5000<i>g</i> for 10 min at 4 °C. The supernatant fraction was decanted, loaded into Beckman Quick-Seal tubes, and centrifuged at 150 000<i>g</i> for 90 min at 4 °C. The supernatant fraction was discarded by decantation, and the pellets were resuspended in assay buffer (10 mM sodium phosphate (pH 7.0), 10% glycerol, and 2.5 mM glutathione Complete Protese Inhibitor Cocktail (Roche)). Protein concentration was determined using the Pierce Coomassie Plus reagent.</div><div class="NLM_p last">For the enzyme assay, the microsomes were diluted into assay buffer, and 14 μL/well was added to 384 well plates. Compound dilution plates (Nunc Catalog no. 249944) were generated on a Tecan Evo, and 4 μL/well was added to the assay plates. PGH<sub>2</sub> was diluted into assay buffer immediately prior to use, and 7 μL/well was added. Final concentrations were 6.52 μg/mL of microsomes and 1.67 μM PGH<sub>2</sub>. After a 2.5 min incubation at room temperature, 5 μL/well of 1 mg/mL SnCl<sub>2</sub> in 0.5 N HCl<sub>(aq)</sub> was added to stop the reaction. Five microliters of the reaction was transferred to a 384 well plate containing 0.1% aqueous formic acid (45 μL) for mass spectrometry dilution, then the plates were stored at −20 °C. The plates were analyzed for PGE<sub>2</sub> using standard LC/MS/MS analysis (Biocius Lifesciences, Wakefield, MA, USA).</div></div><div id="sec4_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Cell-Based Assay</h4><div class="NLM_p last">Human epithelial lung carcinoma cell line A549 was purchased from ATCC (CCL-185) and was maintained in Kaighn’s F12 + 10% FBS, 5% CO<sub>2</sub>. For the assay, cells were plated at 40 000/well in 96-well Falcon plates, 24 h prior to treatment. Compounds were diluted in DMSO and were added at 1 μL/well, <i>n</i> = 2, to give seven concentrations each. Cells were pretreated 30 min at 37 °C, 5% CO<sub>2</sub>. rhIL-1β (R&D Systems) was added to give 0.2 ng/mL final. The treatment period was ∼18 h. The conditioned medium was assayed for levels of PGE<sub>2</sub> and 6-keto PGF<sub>1α</sub> by EIA (Cayman). The IC<sub>50</sub>s were calculated using Graphpad Prism nonlinear regression sigmoidal dose response curve fitting. Data are the geometric mean ×/÷ geometric standard deviation of the indicated number of determinations.</div></div><div id="sec4_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Human Whole Blood Assay</h4><div class="NLM_p">With informed consent, blood was collected from normal volunteer donors into sodium heparin vacutainer tubes. Donors had not taken NSAIDs, aspirin, celecoxib, or glucocorticoids within 2 weeks of the donation. All tubes from each donor were pooled into 250 mL Corning conical centrifuge tubes, and 436.5 μL/well was distributed into deep well polypropylene plates. Test compounds were diluted in DMSO to 100× the final concentration, and 4.5 μL/well in duplicate or triplicate was added to give 7 point curves. The blood was pretreated at 37 °C, 5% CO<sub>2</sub>, in a humidified atmosphere, loosely covered with a silicone cap mat, for 30 min, after which 9 μL/well of a solution of 5 mg/mL of lipopolysaccharide (LPS) (Sigma 0111:B4) in 1 mg/mL bovine serum albumin (BSA)/PBS was added to give a final LPS concentration of 100 μg/mL. The plates were incubated for 20–24 h, loosely covered, at 37 °C, 5% CO<sub>2</sub>, in a humidified atmosphere, on an orbital shaker at approximately 100 rpm. The plates were tightly sealed with silicone cap mats and chilled on ice for approximately 1 h. Then, the plates were centrifuged at 1800<i>g</i> for 10 min at 4 °C in an Eppendorf 5810R centrifuge. Plasma was removed from the cell layer using the Rainin L200 with sterile filtered tips and transferred to v-bottom polypropylene plates. A 100 μL portion was quantitatively transferred to Costar cluster tube blocks, and 400 μL/well of the methanol stop reagent and of each of the internal standards PGE<sub>2</sub>-<i>d</i><sub>4</sub>, PGF<sub>2α</sub>-<i>d</i><sub>4</sub>, and TXB<sub>2β</sub>-<i>d</i><sub>4</sub> was added. Samples were vortexed for 5 min and placed at −20 °C for at least 1 h. Samples were centrifuged for 10 min at 4000 rpm in an Eppendorf 5810R.</div><div class="NLM_p last">Solid phase extraction was performed using Waters HLB 30 mg/bed 96 well plates on a vacuum manifold: (1) the matrix was washed with methanol (1 mL), followed by 0.1% formic acid in water (1 mL); (2) 400 μL of sample was applied along with 0.1% formic acid in water (900 μL) and allowed to bind for 5 min; (3) the matrix was washed with 0.1% formic acid in water (600 μL), followed by 80/20 water/methanol (600 μL); (4) the products were eluted with EtOAc (2 × 500 μL); (5) the samples were dried under nitrogen and reconstituted in 75/25 water/acetonitrile with 0.1% formic acid (50 μL). The products were analyzed by LC-MS/MS.</div></div><div id="sec4_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Dog Whole Blood Assay</h4><div class="NLM_p last">Dog whole blood was obtained from Covance (Greenfield, Indiana). All tubes from each donor were pooled and kept on ice. To 96-well Falcon 3072 plates, 98 μL of blood was added per well. Test compounds were diluted in DMSO to 100× the final concentration, and 1 μL/well in duplicate or triplicate was added to each well to give 7 point curves. The blood was pretreated with compounds at 37 °C, 5% CO<sub>2</sub>, in a humidified atmosphere for 30 min, after which 1 μL/well of a solution of 0.1 mg/mL of lipopolysaccharide (LPS) (Sigma, serotype 0111:B4) in 0.1% bovine serum albumin (BSA)/PBS was added to give a final LPS concentration of 1 μg/mL. The plates were incubated for 5 h at 37 °C, 5% CO<sub>2</sub>, in a humidified atmosphere. After incubation, the plates were chilled on ice for approximately 10 min. Then, the plates were centrifuged at 1800<i>g</i> for 10 min at 4 °C in an Eppendorf 5810R centrifuge. Plasma was removed from the cell layer and transferred to v-bottom polypropylene plates. Plasma samples were assayed for PGE<sub>2</sub> at 1:50 dilution using PGE<sub>2</sub> Express EIA assay kit (Cayman Chemical). The plates were read at <i>A</i><sub>412</sub> on a plate reader (Molecular Devices Versamax) using SOFTmaxPRO (v. 4.3.1) software. IC<sub>50</sub> values were calculated using Graphpad Prism nonlinear regression, sigmoidal dose response curve fitting.</div></div><div id="sec4_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> CYP3A4 Inhibition Assay</h4><div class="NLM_p">Incubation samples were prepared by adding 150 μL of a solution of microsomes (protein concentration 66.8 μg/mL, adjusted to pH 7.4 with phosphate buffer) and 2 μL of a 1 mM (90:10 CH<sub>3</sub>CN/DMSO) solution of test compound and mixed well. Samples were preincubated for approximately 10 min at approximately 37 °C. Following the preincubation period, the reaction was initiated with the addition of 50 μL of a solution of NADPH (2 mM), containing marker substrates bufuralol (40 μM), midazolam (20 μM), and diclofenac (40 μM) in Milli-Q water. Final incubation volume was 200 μL, which contained 10 μM test compound, 10 μM bufuralol, 5 μM midazolam, 10 μM diclofenac, 0.5 mM NADPH, and 0.05 mg/mL protein.</div><div class="NLM_p last">The reaction mixture was incubated for 3 min at approximately 37 °C, after which a 70 μL aliquot was taken from the reaction mixture and quenched by addition to 60 μL of an acetonitrile solution containing 1-hydroxybufuralol maleate-<i>d</i><sub>9</sub> (0.12 μM), α-hydroxymidazolam-<i>d</i><sub>4</sub> (0.17 μM), and [<sup>13</sup>C<sub>6</sub>]-4′-hydroxydiclofenac (0.19 μM). The reaction mixture was centrifuged at approximately 4000 rpm for 15 min at approximately 5 °C. Following centrifugation, the samples were analyzed by LC-MS/MS using the following method: LC column, Javelin Betasil C<sub>18</sub> (20 mm × 2 mm); mobile phase A, 98.5:1:0.5 Milli-Q H<sub>2</sub>O/CH<sub>3</sub>OH/1 M NH<sub>4</sub>HCO<sub>3</sub> (v/v); mobile phase B, 99:1 CH<sub>3</sub>OH/1 M NH<sub>4</sub>HCO<sub>3</sub> (v/v); stepwise gradient from 98% mobile phase A/2% mobile phase B to 2% mobile phase A/98% mobile phase B over 0.85 min. MS/MS method: collision gas, 10 psi; curtain gas, 40 psi; ion source gas 1, 55 psi; ion source gas 2, 70 psi; ionspray voltage, 1500 V; source temperature, 700 °C; entrance potential, 10 V. Samples were analyzed for metabolites and internal standards with their respective mass transitions: 1-OH-bufuralol (278.1/186.1), 1-OH-bufuralol-<i>d</i><sub>9</sub> (287.1/186.1), 1-OH-midazolam (342.1/203.1), 1-OH-midazolam-<i>d</i><sub>4</sub> (346.1/203.1), 4-OH-diclofenac (312.2/231.2), and 4-OH-diclofenac-<i>d</i><sub>6</sub> (318.2/231.2). Area ratios (metabolite area/stable label metabolite internal standard) were determined for incubations with inhibitor and compared with incubations containing solvent only (vehicle control). Percent inhibition was calculated by 100 – (area ratio with test compound/area ratio vehicle control × 100).</div></div><div id="sec4_9_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> CYP3A4 Time-Dependent Inhibition Assay</h4><div class="NLM_p">Incubation samples were prepared by adding 178 μL of a solution of microsomes (protein concentration 56.18 μg/mL, adjusted to pH 7.4 with phosphate buffer) and mixing well. These were preincubated for approximately 12 min at approximately 37 °C. Following the preincubation period, the inactivation reaction was initiated with the addition of 2 μL of a 1 mM 90:10 CH<sub>3</sub>CN/DMSO solution of inhibitor and 20 μL of a solution of NADPH (10 mM) in a pH 7.4 aqueous (100 mM) phosphate buffer to give a final concentration of 10 μM test compound, 1 mM NADPH, and 0.5 mg/mL microsomes.</div><div class="NLM_p">Separately, two activity plates (one each for a 0 min and a 30 min time point) were prepared containing 95 μL of a solution of NADPH (1 mM) and midazolam (100 μM) in a pH 7.4 aqueous (100 mM) phosphate buffer and preincubated at 37 °C for approximately 12 min. These were called plate 0 and plate 30, respectively.</div><div class="NLM_p">Immediately upon preparation of the inactivation sample, a 5 μL aliquot was taken and added to plate 0 and incubated at 37 °C for 1 min. This was quenched by the addition of 50 μL of an acetonitrile solution of α-hydroxymidazolam-<i>d</i><sub>4</sub> (0.17 μM).</div><div class="NLM_p">After incubation for 30 min, a 5 μL aliquot of the inactivation sample was taken and added to plate 30 and incubated at 37 °C for 1 min. This was quenched by the addition of 50 μL of an acetonitrile solution of α-hydroxymidazolam-<i>d</i><sub>4</sub> (0.17 μM).</div><div class="NLM_p last">The reaction mixtures were centrifuged at approximately 4000 rpm for 15 min at approximately 5 °C. Following centrifugation, the samples were analyzed by LC-MS/MS using the following method: LC column, Javelin Betasil C<sub>18</sub> (20 mm × 2 mm); mobile phase A, 95:5 Milli-Q H<sub>2</sub>O/1 M NH<sub>4</sub>HCO<sub>3</sub> (v/v); mobile phase B, 95:5 CH<sub>3</sub>OH/1 M NH<sub>4</sub>HCO<sub>3</sub> (v/v); gradient, 0.3 min at 95:5 mobile phase A/mobile phase B; ramp to 5:95 mobile phase A/mobile phase B over 1.0 min; hold at 5:95 mobile phase A/mobile phase B for 0.5 min. MS method: MRM at 342.1/203.1 (1-OH-midazolam) and 346.1/203.1 (α-hydroxymidazolam-<i>d</i><sub>4</sub>) using TurboIon spray under positive ion conditions; nebulizer gas, 12 psi; curtain gas, 8 psi; ionspray voltage, 2500 V; source temperature, 500 °C; declustering potential, 26 V; focusing potential, 100 V; entrance potential, 4 V; dwell time, 200 ms. Area ratios (metabolite area/stable label metabolite internal standard) were determined for 30 min inactivation incubations with inhibitor and compared with incubations containing solvent only (vehicle control). Percent inhibition was calculated by 100 – (area ratio 30 min inactivation/area ratio 0 min inactivation ×100).</div></div><div id="sec4_9_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Solubility Assays</h4><div class="NLM_p last">The test compound (2 mg) was treated with the solubility medium (FasSIF or 0.1 N aqueous HCl, 1.0 mL) and agitated at 25 rpm at room temperature for 24 h. The resulting slurry was centrifuged at 14000 rpm (16873 rcf) with a 0.45 μm centrifugal filter for 2 min. The pH of the filtrate was measured, and the concentration of dissolved drug was measured by HPLC analysis.</div></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>In Vivo</i> Studies</h3><div class="NLM_p">The pharmacokinetic and plasma exposure animal experiments are protocol driven studies. All procedures in the protocols are in compliance with the U.S. Department of Agriculture (USDA) Animal Welfare Act (9CFR Parts 1, 2, and 3); the Guide for the Care and Use of Laboratory Animals from the Institute of Laboratory Animal Resources, National Academy Press, Washington, DC, 1996; and the National Institutes of Health, Office of Laboratory Animal Welfare.</div><div id="sec4_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Pharmacokinetic</h4><div class="NLM_p last">Male Beagle dogs (9.2–12.7 kg, <i>N</i> = 3/dose group) were administered test compounds as an intravenous (bolus) solution and oral (gavage) suspension. Blood (approximately 1 mL/time point) was collected from the jugular vein at 0.08 (IV only), 0.25, 0.5, 1, 2, 4, 8, 12, and 24 h postdose into tubes containing EDTA anticoagulant. Blood samples were centrifuged (3000 rpm for 10 min at 4 °C); plasma was removed and stored at approximately −60 °C until analyzed. Plasma concentrations of test compounds were determined using an LC/MS-MS bioanalytical method (test compound concentration curve range = 1–5000 ng/mL).</div></div><div id="sec4_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Plasma Exposure (Free Base vs Phosphate Salt Comparison)</h4><div class="NLM_p last">Male Beagle dogs (9.1–12.7 kg, <i>N</i> = 6/dose group) were administered test compounds as oral (gavage) suspensions. The phosphate salt dose was corrected to give the dose as free base equivalents. Blood (approximately 1 mL/time point) was collected from the jugular vein at 0.25, 0.5, 1, 2, 4, 8, 12, 24, and 48 h postdose into tubes containing EDTA anticoagulant. Blood samples were centrifuged (3000 rpm for 10 min at 4 °C); plasma was removed and stored at approximately −20 °C until analyzed. Plasma concentrations of test compounds were determined using an LC/MS-MS bioanalytical method (test compound, as free base, concentration curve range = 1–20000 ng/mL).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01249">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78266" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78266" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01249" class="ext-link">10.1021/acs.jmedchem.5b01249</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Procedures for the preparation of <b>5</b>–<b>7</b>, <b>9</b>–<b>10</b>, <b>20</b>–<b>25</b>, and <b>27</b>–<b>30</b>, crystallization and structural determination, A549 assay PGI<sub>2</sub> data, HWB assay TXB<sub>2</sub> and PGF<sub>2α</sub> data, and CEREP panel results (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01249/suppl_file/jm5b01249_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01249/suppl_file/jm5b01249_si_001.pdf">jm5b01249_si_001.pdf (2.47 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors are available from the Protein Data Bank with accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BQG">5BQG</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BQH">5BQH</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BQI">5BQI</a> for <i>m</i>PGES-1/<b>4</b>, <i>m</i>PGES-1/<b>5</b>, and <i>m</i>PGES-1/<b>8</b> binary complexes, respectively.</p><div class="testing" data-doi="10.1021/acs.jmedchem.5b01249" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew A. Schiffler</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#205343484946464c45524d41604c494c4c590e434f4d"><span class="__cf_email__" data-cfemail="205343484946464c45524d41604c494c4c590e434f4d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Antonysamy</span> - <span class="hlFld-Affiliation affiliation">Eli
Lilly Biotechnology Center, San
Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shobha N. Bhattachar</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristina M. Campanale</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Srinivasan Chandrasekhar</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bradley Condon</span> - <span class="hlFld-Affiliation affiliation">Eli
Lilly Biotechnology Center, San
Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Prashant V. Desai</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew J. Fisher</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Groshong</span> - <span class="hlFld-Affiliation affiliation">Eli
Lilly Biotechnology Center, San
Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anita Harvey</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Hickey</span> - <span class="hlFld-Affiliation affiliation">Eli
Lilly Biotechnology Center, San
Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Norman E. Hughes</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott A. Jones</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Euibong J. Kim</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven L. Kuklish</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John G. Luz</span> - <span class="hlFld-Affiliation affiliation">Eli
Lilly Biotechnology Center, San
Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan H. Norman</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard E. Rathmell</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Windlesham, Surrey GU20
6PH, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John R. Rizzo</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas W. Seng</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan J. Thibodeaux</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy A. Woods</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeremy S. York</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao-Peng Yu</span> - <span class="hlFld-Affiliation affiliation">Lilly
Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Indiana 46285, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><sup>⊥</sup>(S.C. and A.H.) Retired.<br /></br></div></li></ul></div><div class="ack" id="ACK-d42e3824-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78680" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78680" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Jeffrey Nissen for valuable synthetic contributions, Ashley Sloan and Robin Kizer for obtaining data in the enzyme assay, and Dan Mudra and Mike Mohutsky for helping to prepare the <a href="/doi/suppl/10.1021/acs.jmedchem.5b01249/suppl_file/jm5b01249_si_001.pdf" class="ext-link">Supporting Information</a>. The authors gratefully acknowledge dog live phase support from Covance and bioanalytical support from Advion (now a part of Quintiles). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i38" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i38"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i39" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i39"> Abbreviations</h2><tr><td class="NLM_term">A<sub>412</sub></td><td class="NLM_def"><p class="first last">absorbance at λ = 412 nm</p></td></tr><tr><td class="NLM_term">BOP</td><td class="NLM_def"><p class="first last">(benzotriazol-1-yloxy)tris (dimethylamino)phosphonium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CL<sub>iv</sub></td><td class="NLM_def"><p class="first last">clearance after iv dosing</p></td></tr><tr><td class="NLM_term"><i>c</i>PGES</td><td class="NLM_def"><p class="first last">cytosolic prostaglandin E synthase</p></td></tr><tr><td class="NLM_term">DHPC</td><td class="NLM_def"><p class="first last">1,2-diheptanoyl-<i>sn</i>-glycero-3-phosphocholine</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DWB</td><td class="NLM_def"><p class="first last">dog whole blood</p></td></tr><tr><td class="NLM_term">EIA</td><td class="NLM_def"><p class="first last">enzyme immune assay</p></td></tr><tr><td class="NLM_term">FasSIF</td><td class="NLM_def"><p class="first last">fasted state simulated intestinal fluid</p></td></tr><tr><td class="NLM_term">GTT</td><td class="NLM_def"><p class="first last">glutathione (reduced form)</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">HLB</td><td class="NLM_def"><p class="first last">hydrophilic–lipophilic balance</p></td></tr><tr><td class="NLM_term">HWB</td><td class="NLM_def"><p class="first last">human whole blood</p></td></tr><tr><td class="NLM_term">inh</td><td class="NLM_def"><p class="first last">inhibition</p></td></tr><tr><td class="NLM_term"><i>m</i>PGES</td><td class="NLM_def"><p class="first last">microsomal prostaglandin E synthase</p></td></tr><tr><td class="NLM_term">MRM</td><td class="NLM_def"><p class="first last">multiple reaction monitoring</p></td></tr><tr><td class="NLM_term">NMM</td><td class="NLM_def"><p class="first last">4-methylmorpholine</p></td></tr><tr><td class="NLM_term">NT</td><td class="NLM_def"><p class="first last">not tested</p></td></tr><tr><td class="NLM_term">PGD</td><td class="NLM_def"><p class="first last">prostaglandin D</p></td></tr><tr><td class="NLM_term">PGE</td><td class="NLM_def"><p class="first last">prostaglandin E</p></td></tr><tr><td class="NLM_term">PGF</td><td class="NLM_def"><p class="first last">prostaglandin F</p></td></tr><tr><td class="NLM_term">PGG</td><td class="NLM_def"><p class="first last">prostaglandin G</p></td></tr><tr><td class="NLM_term">PGH</td><td class="NLM_def"><p class="first last">prostaglandin H</p></td></tr><tr><td class="NLM_term">PGI</td><td class="NLM_def"><p class="first last">prostaglandin I</p></td></tr><tr><td class="NLM_term">rcf</td><td class="NLM_def"><p class="first last">relative centrifugal force</p></td></tr><tr><td class="NLM_term">RH</td><td class="NLM_def"><p class="first last">relative humidity</p></td></tr><tr><td class="NLM_term">rhIL-1β</td><td class="NLM_def"><p class="first last">recombinant human interleukin 1β</p></td></tr><tr><td class="NLM_term">rpm</td><td class="NLM_def"><p class="first last">rotations per minute</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">T3P</td><td class="NLM_def"><p class="first last">propylphosphonic anhydride</p></td></tr><tr><td class="NLM_term">TBTU</td><td class="NLM_def"><p class="first last">2-(1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate</p></td></tr><tr><td class="NLM_term">TDI</td><td class="NLM_def"><p class="first last">time-dependent CYP inhibition</p></td></tr><tr><td class="NLM_term">TXA</td><td class="NLM_def"><p class="first last">thromboxane A</p></td></tr><tr><td class="NLM_term">TXB</td><td class="NLM_def"><p class="first last">thromboxane B</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>d,ss</sub></td><td class="NLM_def"><p class="first last">steady-state volume of distribution</p></td></tr><tr><td class="NLM_term">VWD</td><td class="NLM_def"><p class="first last">variable wavelength detector</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Stone, E.</span><span> </span><span class="NLM_article-title">An Account of the Success of the Bark of the Willow in the Cure of Agues</span> <span class="citation_source-journal">Philos. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1763</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span><span class="refDoi"> DOI: 10.1098/rstl.1763.0033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1098%2Frstl.1763.0033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1763&pages=195-200&author=E.+Stone&title=An+Account+of+the+Success+of+the+Bark+of+the+Willow+in+the+Cure+of+Agues&doi=10.1098%2Frstl.1763.0033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1098%2Frstl.1763.0033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstl.1763.0033%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DE.%26atitle%3DAn%2520Account%2520of%2520the%2520Success%2520of%2520the%2520Bark%2520of%2520the%2520Willow%2520in%2520the%2520Cure%2520of%2520Agues%26jtitle%3DPhilos.%2520Trans.%26date%3D1763%26volume%3D53%26spage%3D195%26epage%3D200%26doi%3D10.1098%2Frstl.1763.0033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Norn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Permin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, E.</span><span> </span><span class="NLM_article-title">From willow bark to acetylsalicylic acid</span> <span class="citation_source-journal">Dansk Medicinhistorisk Årbog</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=79-98&author=S.+Nornauthor=H.+Perminauthor=P.+R.+Kruseauthor=E.+Kruse&title=From+willow+bark+to+acetylsalicylic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNorn%26aufirst%3DS.%26aulast%3DPermin%26aufirst%3DH.%26aulast%3DKruse%26aufirst%3DP.%2BR.%26aulast%3DKruse%26aufirst%3DE.%26atitle%3DFrom%2520willow%2520bark%2520to%2520acetylsalicylic%2520acid%26jtitle%3DDansk%2520Medicinhistorisk%2520%25C3%2585rbog%26date%3D2009%26volume%3D37%26spage%3D79%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Piria, R.</span><span> </span><span class="NLM_article-title">Untersuchungen über das Salicin und die daraus entstehenden Producte</span> <span class="citation_source-journal">Ann. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1839</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1002/jlac.18390300203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1002%2Fjlac.18390300203" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1839&pages=151-185&author=R.+Piria&title=Untersuchungen+%C3%BCber+das+Salicin+und+die+daraus+entstehenden+Producte&doi=10.1002%2Fjlac.18390300203"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fjlac.18390300203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlac.18390300203%26sid%3Dliteratum%253Aachs%26aulast%3DPiria%26aufirst%3DR.%26atitle%3DUntersuchungen%2520%25C3%25BCber%2520das%2520Salicin%2520und%2520die%2520daraus%2520entstehenden%2520Producte%26jtitle%3DAnn.%2520Pharm.%26date%3D1839%26volume%3D30%26spage%3D151%26epage%3D185%26doi%3D10.1002%2Fjlac.18390300203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Vane, J. R.</span><span> </span><span class="NLM_article-title">Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs</span> <span class="citation_source-journal">Nature New Biology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span><span class="refDoi"> DOI: 10.1038/newbio231232a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1038%2Fnewbio231232a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=5284360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaE3MXltVyjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1971&pages=232-235&author=J.+R.+Vane&title=Inhibition+of+Prostaglandin+Synthesis+as+a+Mechanism+of+Action+for+Aspirin-like+Drugs&doi=10.1038%2Fnewbio231232a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs</span></div><div class="casAuthors">Vane, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London), New Biology</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">232-5</span>CODEN:
                <span class="NLM_cas:coden">NNBYA7</span>;
        ISSN:<span class="NLM_cas:issn">0369-4887</span>.
    </div><div class="casAbstract">Indomethacin (I) aspirin (II), and Na salicylate inhibited the generation of prostaglandin F2α (PGF2α)-like activity by guinea pig lung prepns.  Thus, on a wt. basis, I was 23-times more potent than II as an inhibitor of PGF2α, and on a molar basis 47-times more potent.  Na salicylate was less potent than II as an inhibitor of PGF2α-like activity and there was much more variation in the results.  Similar results were obtained when the activity of the samples were assayed on rat stomach strips in terms of prostaglandin E2 (PGE2).  Hydrocortisone (50 μg/ml) inhibited PGF2α and PGE2-like activity <20%; morphine (50 μg/ml) or mepyramine (50 μg/ml) had no effect.  Some of the therapeutic effects of Na salicylate and II-like drugs may be due to inhibition of the synthesis of prostaglandins.  Incubation of lung homogenates with arachidonic acid for 30 min increased PGF2α-like activity by 220-520 ng/ml and PGE2-like activity by 100-500 ng/ml.  The ID50 values for I was 0.27 μg/ml, whereas that for II was 6.3 μg/ml.  None of the drugs tested decreased the contractions of the assay tissues (rat stomach strips and colons) induced by the prostaglandins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSuOCB-VIpVrVg90H21EOLACvtfcHk0lhN9ZHXv18gvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXltVyjur4%253D&md5=20de9e860c4f6bb6fb8b46530dd8aaa6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnewbio231232a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnewbio231232a0%26sid%3Dliteratum%253Aachs%26aulast%3DVane%26aufirst%3DJ.%2BR.%26atitle%3DInhibition%2520of%2520Prostaglandin%2520Synthesis%2520as%2520a%2520Mechanism%2520of%2520Action%2520for%2520Aspirin-like%2520Drugs%26jtitle%3DNature%2520New%2520Biology%26date%3D1971%26volume%3D231%26spage%3D232%26epage%3D235%26doi%3D10.1038%2Fnewbio231232a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Smith, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, A. L.</span><span> </span><span class="NLM_article-title">Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets</span> <span class="citation_source-journal">Nature New Biology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span><span class="refDoi"> DOI: 10.1038/newbio231235a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1038%2Fnewbio231235a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=5284361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaE3MXkvFOhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1971&pages=235-237&author=J.+B.+Smithauthor=A.+L.+Willis&title=Aspirin+Selectively+Inhibits+Prostaglandin+Production+in+Human+Platelets&doi=10.1038%2Fnewbio231235a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Aspirin selectively inhibits prostaglandin production in human platelets</span></div><div class="casAuthors">Smith, J. B.; Willis, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London), New Biology</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">235-7</span>CODEN:
                <span class="NLM_cas:coden">NNBYA7</span>;
        ISSN:<span class="NLM_cas:issn">0369-4887</span>.
    </div><div class="casAbstract">Aspirin (I) (0.01-10.0 μg/ml) markedly decreased the production of prostaglandins F2α and E2 by 3-14C-labeled 5-hydroxytryptamine creatinine sulfate (5-HT) treated human platelets although it had no effect on the release of 5-HT, β-N-acetyl glucosamidase, or phospholipase A1.  I (0.3 μg/ml) inhibited the production of prostaglandin by 50%.  Indomethacin (II) was ∼10-times more potent than I, whereas Na salicylate was ∼10-times less potent.  Hydrocortisone (100 μg/ml) had no effect.  I (600 mg) inhibited the production of prostaglandins in the platelet in a system in which "the release reaction" induced by thrombin (5 units/ml) was impaired.  II (50 mg) taken by 2 volunteers, and II (100 mg) taken by 1 volunteer inhibited the production of prostaglandins by 51, 64, and 83%, resp., without affecting the release of lysosomal enzymes.  No change in the production of prostaglandins was found in platelets of 1 individual given 60 mg codeine or 2 untreated controls.  The finding that the production of prostaglandins is inhibited by I, while the release of phospholipase A is unaffected, strongly suggests that one action of I on platelets is inhibition of the conversion of arachidonic acid into prostaglandins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreUmLyWeiTCLVg90H21EOLACvtfcHk0lhUmH_skY6m3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXkvFOhsr0%253D&md5=5aaae4920427d85d276c84d38ccaa3fa</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnewbio231235a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnewbio231235a0%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BB.%26aulast%3DWillis%26aufirst%3DA.%2BL.%26atitle%3DAspirin%2520Selectively%2520Inhibits%2520Prostaglandin%2520Production%2520in%2520Human%2520Platelets%26jtitle%3DNature%2520New%2520Biology%26date%3D1971%26volume%3D231%26spage%3D235%26epage%3D237%26doi%3D10.1038%2Fnewbio231235a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ferreira, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vane, J. R.</span><span> </span><span class="NLM_article-title">Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen</span> <span class="citation_source-journal">Nature New Biology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span><span class="refDoi"> DOI: 10.1038/newbio231237a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1038%2Fnewbio231237a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=5284362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaE3MXkvFOjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1971&pages=237-240&author=S.+H.+Ferreiraauthor=S.+Moncadaauthor=J.+R.+Vane&title=Indomethacin+and+Aspirin+abolish+Prostaglandin+Release+from+the+Spleen&doi=10.1038%2Fnewbio231237a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Indomethacin and aspirin abolish prostaglandin release from the spleen</span></div><div class="casAuthors">Ferreira, S. H.; Moncada, S.; Vane, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London), New Biology</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">237-9</span>CODEN:
                <span class="NLM_cas:coden">NNBYA7</span>;
        ISSN:<span class="NLM_cas:issn">0369-4887</span>.
    </div><div class="casAbstract">Adrenaline bitartrate (I) (200 ng/min or 6-10 mg/ml during 3 min) infusion into the perfusion dog spleen increased splenic perfusion pressures, contracted the spleen, and increased prostaglandin output, chiefly prostaglandin E2.  Indomethacin (II) (0.37 μg/ml) infusions into the spleen did not decrease splenic wt. or change the splenic perfusion pressure.  The increase in prostaglandin output induced by I infusion, however, was abolished.  In sep. expts., II (4 μg/ml for 15 min and 750 ng/ml for 15 min) completely abolished prostaglandin output.  In these expts., after the II infusion was stopped, there was a gradual return of prostaglandin output induced by I infusion, which reached at least 60% of the initial output within 1-3 hr and sometimes 100%.  Aspirin was much less effective as an inhibitor of prostaglandin release, i.e., at 15 μg/ml, there was 60% inhibition and at 40 μg/ml (2 expts.), there was 75 and 100% inhibition.  Na salicylate (20 and 40 μg/ml) (2 expts.) and hydrocortisone dihydrogen succinate (2 or 25 μg/ml) did not change the prostaglandin output induced by I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNurGG3-yqlLVg90H21EOLACvtfcHk0lhUmH_skY6m3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXkvFOjur4%253D&md5=1651bcb0653f9d27358a46b2f96ec76a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnewbio231237a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnewbio231237a0%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DS.%2BH.%26aulast%3DMoncada%26aufirst%3DS.%26aulast%3DVane%26aufirst%3DJ.%2BR.%26atitle%3DIndomethacin%2520and%2520Aspirin%2520abolish%2520Prostaglandin%2520Release%2520from%2520the%2520Spleen%26jtitle%3DNature%2520New%2520Biology%26date%3D1971%26volume%3D231%26spage%3D237%26epage%3D240%26doi%3D10.1038%2Fnewbio231237a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Burch, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanford, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majerus, P. W.</span><span> </span><span class="NLM_article-title">Inhibition of platelet prostaglandin synthetase by oral aspirin</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span><span class="refDoi"> DOI: 10.1172/JCI108941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1172%2FJCI108941" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1978&pages=314-319&author=J.+W.+Burchauthor=N.+Stanfordauthor=P.+W.+Majerus&title=Inhibition+of+platelet+prostaglandin+synthetase+by+oral+aspirin&doi=10.1172%2FJCI108941"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1172%2FJCI108941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI108941%26sid%3Dliteratum%253Aachs%26aulast%3DBurch%26aufirst%3DJ.%2BW.%26aulast%3DStanford%26aufirst%3DN.%26aulast%3DMajerus%26aufirst%3DP.%2BW.%26atitle%3DInhibition%2520of%2520platelet%2520prostaglandin%2520synthetase%2520by%2520oral%2520aspirin%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1978%26volume%3D61%26spage%3D314%26epage%3D319%26doi%3D10.1172%2FJCI108941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Laneuville, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuer, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeWitt, D. L.</span><span> </span><span class="NLM_article-title">Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs</span> <span class="citation_source-journal">J. Pharmacol Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=7965814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaK2MXisVyjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1994&pages=927-934&author=O.+Laneuvilleauthor=D.+K.+Breuerauthor=D.+L.+DeWitt&title=Differential+inhibition+of+human+prostaglandin+endoperoxide+H+synthases-1+and+-2+by+nonsteroidal+anti-inflammatory+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs</span></div><div class="casAuthors">Laneuville, Odette; Breuer, Debra K.; Dewitt, David L.; Hla, Tim; Funk, Colin D.; Smith, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">927-34</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">We developed an in vitro expression system for accurate kinetic analyses of the inhibition of the human prostaglandin H synthase isoenzymes (hPGHS-1 and -2) by nonsteroidal anti-inflammatory drugs (NSAIDs).  Assays of instantaneous inhibition in which enzyme, 10 μM arachidonate, and an NSAID were mixed simultaneously were used to det. apparent affinities of 14 common NSAIDs for hPGHS-1 and hPGHS-2.  All NSAIDs except salicylate had appreciable apparent affinities (IC50 ≤ 100 μM) for hPGHS-1.  Most NSAIDs also exhibited appreciable affinities toward hPGHS-2, but three prominent exceptions were indomethacin, piroxicam and phenylbutazone.  We subsequently performed measurements of time-dependent inhibition in which either (a) enzyme and an NSAID were preincubated before substrate was added to initiate the reactions or (b) recovery of activity after time-dependent inhibition was measured using intact cells preincubated with various NSAIDs.  Indomethacin, flurbiprofen, meclofenamate and diclofenac, but not ibuprofen, piroxicam or phenylbutazone, caused time-dependent inhibition of both hPGHS-1 and -2 in vitro.  For cells pretreated with flurbiprofen or meclofenamate, hPGHS-2 activities, but not hPGHS-1 activities, were recovered relatively rapidly; with indomethacin, recoveries of hPGHS-1 and hPGHS-2 activities were both slow.  HPGHS-2 is thought to be the target of NSAIDs acting as anti-inflammatory agents.  However, our results indicate that neither measurements of affinities of NSAIDs for hPGHS-2 conducted in vitro with 10 μM arachidonate nor measurements of time-dependent inhibition of hPGH-2 always predict whether a compd. (e.g., piroxicam or phenylbutazone) has anti-inflammatory activity in vivo.  We propose that the most inclusive approach for screening for hPGH-2-selective NSAIDs is to preincubate intact cells that express hPGHS-2 with potential inhibitors and then measure prostanoid prodn. from arachidonate mobilized from endogenous lipids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoItue73glLlbVg90H21EOLACvtfcHk0lhFsfnfYdbEzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXisVyjs74%253D&md5=4212b87a0a395263dab9fe38e7062dc4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaneuville%26aufirst%3DO.%26aulast%3DBreuer%26aufirst%3DD.%2BK.%26aulast%3DDeWitt%26aufirst%3DD.%2BL.%26atitle%3DDifferential%2520inhibition%2520of%2520human%2520prostaglandin%2520endoperoxide%2520H%2520synthases-1%2520and%2520-2%2520by%2520nonsteroidal%2520anti-inflammatory%2520drugs%26jtitle%3DJ.%2520Pharmacol%2520Exp.%2520Ther.%26date%3D1994%26volume%3D271%26spage%3D927%26epage%3D934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Seibert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masferrer, J. L.</span><span> </span><span class="NLM_article-title">Role of inducible cyclooxygenase (COX-2) in inflammation</span> <span class="citation_source-journal">Receptor</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=8038702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaK2cXksl2lsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=17-23&author=K.+Seibertauthor=J.+L.+Masferrer&title=Role+of+inducible+cyclooxygenase+%28COX-2%29+in+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Role of inducible cyclooxygenase (COX-2) in inflammation</span></div><div class="casAuthors">Seibert, Karen; Masferrer, Jaime L.</div><div class="citationInfo"><span class="NLM_cas:title">Receptor</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-23</span>CODEN:
                <span class="NLM_cas:coden">RECEE5</span>;
        ISSN:<span class="NLM_cas:issn">1052-8040</span>.
    </div><div class="casAbstract">A review, with 26 refs.  Nonsteroidal anti-inflammatory drugs (NSAIDs) are potent anti-inflammatory agents that act through the inhibition of the cyclooxygenase (COX) enzyme and the subsequent inhibition of prostaglandins at the site of inflammation.  Unfortunately, inhibition of gastrointestinal or renal prostaglandins is assocd. with mechanism-based toxicities that limit the usefulness of these otherwise potent and efficacious drugs.  Recently two forms of the COX enzyme have been identified: COX-1, which is constitutively expressed in many cells and tissues, and COX-2, which is selectively induced by proinflammatory cytokines at the site of inflammation.  The discovery of a second COX enzyme led to the hypothesis that toxicity assocd. with the clin. useful NSAIDs is caused by the inhibition of COX-1, whereas the anti-inflammatory properties were caused by the inhibition of inducible COX-2.  In support of this hypothesis, expression of the inducible COX-2 enzyme is selectively blocked by the potent anti-inflammatory drug dexamethasone.  Selective inhibition of COX-2 may produce superior anti-inflammatory drugs with substantial safety over existing NSAIDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFIZ3CemiSK7Vg90H21EOLACvtfcHk0lhFsfnfYdbEzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksl2lsb4%253D&md5=f01419c191dbbfb76522eb60e910634b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeibert%26aufirst%3DK.%26aulast%3DMasferrer%26aufirst%3DJ.%2BL.%26atitle%3DRole%2520of%2520inducible%2520cyclooxygenase%2520%2528COX-2%2529%2520in%2520inflammation%26jtitle%3DReceptor%26date%3D1994%26volume%3D4%26spage%3D17%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Hawkey, C. J.</span><span> </span><span class="NLM_article-title">Cox-2 Inhibitors</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span><span class="refDoi"> DOI: 10.1016/S0140-6736(98)12154-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1016%2FS0140-6736%2898%2912154-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=9929039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaK1MXhsF2lsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=1999&pages=307-314&author=C.+J.+Hawkey&title=Cox-2+Inhibitors&doi=10.1016%2FS0140-6736%2898%2912154-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">COX-2 inhibitors</span></div><div class="casAuthors">Hawkey, C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">9149</span>),
    <span class="NLM_cas:pages">307-314</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Ltd.</span>)
        </div><div class="casAbstract">A review with 75 refs.  In the past 100 yr aspirin has demonstrated its value as an analgesic, anti-inflammatory, and antithrombotic agent.  However, by 1938, it was clear that aspirin was gastrotoxic.  Non-steroidal anti-inflammatory drugs (NSAIDs), developed since the 1960s, failed to achieve the goal of "a safer aspirin".  The demonstration that inhibition of prostaglandin synthesis via a cyclo-oxygenase (COX) enzyme was central to both the therapeutic and toxic effects of aspirin and non-aspirin NSAIDs appeared to establish the principle of no gain without pain.  This link may have been broken by drugs that selectively inhibit the inducible COX-2 enzyme.  The COX enzyme is now a target of drug interventions against the inflammatory process.  Might the "safe aspirin" be here at last.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEghq0hjl727Vg90H21EOLACvtfcHk0lhFsfnfYdbEzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhsF2lsrw%253D&md5=8f1066e83b41674fbde81632c8fb0d79</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2898%2912154-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252898%252912154-2%26sid%3Dliteratum%253Aachs%26aulast%3DHawkey%26aufirst%3DC.%2BJ.%26atitle%3DCox-2%2520Inhibitors%26jtitle%3DLancet%26date%3D1999%26volume%3D353%26spage%3D307%26epage%3D314%26doi%3D10.1016%2FS0140-6736%2898%2912154-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Chen, Y.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jobanputra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry-Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. S.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation</span> <span class="citation_source-journal">Health Technology Assessment</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span><span class="refDoi"> DOI: 10.3310/hta12110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.3310%2Fhta12110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=1-278&author=Y.-F.+Chenauthor=P.+Jobanputraauthor=P.+Bartonauthor=S.+Bryanauthor=A.+Fry-Smithauthor=G.+Harrisauthor=R.+S.+Taylor&title=Cyclooxygenase-2+selective+non-steroidal+anti-inflammatory+drugs+%28etodolac%2C+meloxicam%2C+celecoxib%2C+rofecoxib%2C+etoricoxib%2C+valdecoxib+and+lumiracoxib%29+for+osteoarthritis+and+rheumatoid+arthritis%3A+a+systematic+review+and+economic+evaluation&doi=10.3310%2Fhta12110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3310%2Fhta12110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3310%252Fhta12110%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.-F.%26aulast%3DJobanputra%26aufirst%3DP.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DBryan%26aufirst%3DS.%26aulast%3DFry-Smith%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DG.%26aulast%3DTaylor%26aufirst%3DR.%2BS.%26atitle%3DCyclooxygenase-2%2520selective%2520non-steroidal%2520anti-inflammatory%2520drugs%2520%2528etodolac%252C%2520meloxicam%252C%2520celecoxib%252C%2520rofecoxib%252C%2520etoricoxib%252C%2520valdecoxib%2520and%2520lumiracoxib%2529%2520for%2520osteoarthritis%2520and%2520rheumatoid%2520arthritis%253A%2520a%2520systematic%2520review%2520and%2520economic%2520evaluation%26jtitle%3DHealth%2520Technology%2520Assessment%26date%3D2008%26volume%3D12%26spage%3D1%26epage%3D278%26doi%3D10.3310%2Fhta12110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Moncada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vane, J. R.</span><span> </span><span class="NLM_article-title">Interrelationships between prostacyclin and thromboxane A2</span> <span class="citation_source-journal">Ciba Found. Symp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1002/9780470720615.ch9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1002%2F9780470720615.ch9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2008&pages=165-183&author=S.+Moncadaauthor=J.+R.+Vane&title=Interrelationships+between+prostacyclin+and+thromboxane+A2&doi=10.1002%2F9780470720615.ch9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2F9780470720615.ch9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470720615.ch9%26sid%3Dliteratum%253Aachs%26aulast%3DMoncada%26aufirst%3DS.%26aulast%3DVane%26aufirst%3DJ.%2BR.%26atitle%3DInterrelationships%2520between%2520prostacyclin%2520and%2520thromboxane%2520A2%26jtitle%3DCiba%2520Found.%2520Symp.%26date%3D2008%26volume%3D78%26spage%3D165%26epage%3D183%26doi%3D10.1002%2F9780470720615.ch9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Sun, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, J. L.</span><span> </span><span class="NLM_article-title">Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1859</span><span class="NLM_x">–</span> <span class="NLM_lpage">1866</span><span class="refDoi"> DOI: 10.1185/030079907X210561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1185%2F030079907X210561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=17605893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFejtrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2007&pages=1859-1866&author=S.+X.+Sunauthor=K.+Y.+Leeauthor=C.+T.+Bertramauthor=J.+L.+Goldstein&title=Withdrawal+of+COX-2+selective+inhibitors+rofecoxib+and+valdecoxib%3A+impact+on+NSAID+and+gastroprotective+drug+prescribing+and+utilization&doi=10.1185%2F030079907X210561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization</span></div><div class="casAuthors">Sun, Shawn X.; Lee, Kwan Y.; Bertram, Carl T.; Goldstein, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1859-1866</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Objective: Cyclo-oxygenase-2 (COX-2) inhibitors rofecoxib and valdecoxib were withdrawn from the market because of their assocn. with cardiovascular problems.  There is a lack of information on the impact of the COX-2 inhibitors withdrawal on the prescribing and utilization of related drugs.  The main objective of this study was to evaluate to what extent prescriptions of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) and gastroprotective drugs changed after the removal of the two COX-2 inhibitors.  Research design and methods: A segmented regression of interrupted time series approach was used to analyze prescription data from July 1, 2003 through Dec. 31, 2005 from a pharmacy claims database maintained by a large pharmacy benefit manager (PBM).  Patients continuously eligible for the pharmacy benefit but not enrolled in COX-2 or proton pump inhibitor (PPI) Step Care programs during the study period were included.  The no. of prescriptions per thousand patients per mo for targeted drugs were analyzed and compared.  Results: A total of 175193 patients were included in the anal.  After the withdrawal of the COX-2 inhibitor, the av. monthly non-selective NSAID and PPI prescriptions per thousand patients increased from 13.96 to 19.63 (a change of 40.62%, p < 0.0001) and from 38.67 to 43.33 (a change of 12.05%, p<0.0001) resp., whereas COX-2 prescriptions decreased by 54.51% (from 23.61 to 10.74, p<0.0001).  Among non-selective NSAIDs, the five drugs with highest percentage increase were meloxicam (167.12%, from 1.46 to 3.90, p<0.0001), etodolac (72.06%, from 0.68 to 1.17, p<0.0001), piroxicam (58.33%, from 0.36 to 0.57, p<0.0001), nabumetone (52.38%, from 1.26 to 1.92, p<0.0001), and diclofenac (37.89%, from 1.61 to 2.22, p<0.0001).  Limitations: This study was restricted to patients with employer-sponsored drug coverage which might not be representative of the national population.  Since over-the-counter (OTC) PPI, non-selective NSAID and H2RA were not captured in our claims data, we were unable to examine whether and to what extent the utilization of these drugs has changed.  Addnl., the direct impact of these changes on population based outcomes is unknown.  Conclusions: After the withdrawal of COX-2 inhibitors rofecoxib and valdecoxib, there were significant increases in non-selective NSAID and PPI prescriptions but not H2RA and misoprostol.  Given the safety concerns with the NSAIDs, further studies are warranted regarding the clin. outcomes assocd. with the increased use of non-selective NSAIDs with or without gastroprotective agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLU1QxLNxUO7Vg90H21EOLACvtfcHk0lgh6SOgDmMb7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFejtrvF&md5=46096744585c471611e7e5de2bc0ed28</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1185%2F030079907X210561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F030079907X210561%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BX.%26aulast%3DLee%26aufirst%3DK.%2BY.%26aulast%3DBertram%26aufirst%3DC.%2BT.%26aulast%3DGoldstein%26aufirst%3DJ.%2BL.%26atitle%3DWithdrawal%2520of%2520COX-2%2520selective%2520inhibitors%2520rofecoxib%2520and%2520valdecoxib%253A%2520impact%2520on%2520NSAID%2520and%2520gastroprotective%2520drug%2520prescribing%2520and%2520utilization%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2007%26volume%3D23%26spage%3D1859%26epage%3D1866%26doi%3D10.1185%2F030079907X210561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobsson, P. J.</span><span> </span><span class="NLM_article-title">Membrane prostaglandin E synthase-1: a novel therapeutic target</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1124/pr.59.3.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1124%2Fpr.59.3.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=17878511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ahsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2007&pages=207-224&author=B.+Samuelssonauthor=R.+Morgensternauthor=P.+J.+Jakobsson&title=Membrane+prostaglandin+E+synthase-1%3A+a+novel+therapeutic+target&doi=10.1124%2Fpr.59.3.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane prostaglandin E synthase-1: a novel therapeutic target</span></div><div class="casAuthors">Samuelsson, Bengt; Morgenstern, Ralf; Jakobsson, Per-Johan</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-224</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Prostaglandin E2 (PGE2) is the most abundant prostaglandin in the human body.  It has a large no. of biol. actions that it exerts via four types of receptors, EP1-4.  PGE2 is formed from arachidonic acid by cyclooxygenase (COX-1 and COX-2)-catalyzed formation of prostaglandin H2 (PGH2) and further transformation by PGE synthases.  The isomerization of the endoperoxide PGH2 to PGE2 is catalyzed by three different PGE synthases, viz. cytosolic PGE synthase (cPGES) and two membrane-bound PGE synthases, mPGES-1 and mPGES-2.  Of these isomerases, cPGES and mPGES-2 are constitutive enzymes, whereas mPGES-1 is mainly an induced isomerase.  CPGES uses PGH2 produced by COX-1 whereas mPGES-1 uses COX-2-derived endoperoxide.  MPGES-2 can use both sources of PGH2.  MPGES-1 is a member of the membrane assocd. proteins involved in eicosanoid and glutathione metab. (MAPEG) superfamily.  It requires glutathione as an essential cofactor for its activity.  MPGES-1 is up-regulated in response to various proinflammatory stimuli with a concomitant increased expression of COX-2.  The coordinate increased expression of COX-2 and mPGES-1 is reversed by glucocorticoids.  Differences in the kinetics of the expression of the two enzymes suggest distinct regulatory mechanisms for their expression.  Studies, mainly from disruption of the mPGES-1 gene in mice, indicate key roles of mPGES-1-generated PGE2 in female reprodn. and in pathol. conditions such as inflammation, pain, fever, anorexia, atherosclerosis, stroke, and tumorigenesis.  These findings indicate that mPGES-1 is a potential target for the development of therapeutic agents for treatment of several diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquliKs3pT-37Vg90H21EOLACvtfcHk0lgXTwuWufgOQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ahsr3P&md5=700ba869963fd456d18eb68965e673c7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fpr.59.3.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.59.3.1%26sid%3Dliteratum%253Aachs%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DMorgenstern%26aufirst%3DR.%26aulast%3DJakobsson%26aufirst%3DP.%2BJ.%26atitle%3DMembrane%2520prostaglandin%2520E%2520synthase-1%253A%2520a%2520novel%2520therapeutic%2520target%26jtitle%3DPharmacol.%2520Rev.%26date%3D2007%26volume%3D59%26spage%3D207%26epage%3D224%26doi%3D10.1124%2Fpr.59.3.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Jakobsson, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorén, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span> </span><span class="NLM_article-title">Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">7220</span><span class="NLM_x">–</span> <span class="NLM_lpage">7225</span><span class="refDoi"> DOI: 10.1073/pnas.96.13.7220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1073%2Fpnas.96.13.7220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10377395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaK1MXltVOrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=7220-7225&author=P.-J.+Jakobssonauthor=S.+Thor%C3%A9nauthor=R.+Morgensternauthor=B.+Samuelsson&title=Identification+of+human+prostaglandin+E+synthase%3A+A+microsomal%2C+glutathione-dependent%2C+inducible+enzyme%2C+constituting+a+potential+novel+drug+target&doi=10.1073%2Fpnas.96.13.7220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target</span></div><div class="casAuthors">Jakobsson, Per-Johan; Thoren, Staffan; Morgenstern, Ralf; Samuelsson, Bengt</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">7220-7225</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Human prostaglandin (PG) E synthase (EC 5.3.99.3) is a member of a recently recognized protein superfamily consisting of membrane assocd. proteins involved in eicosanoid and glutathione metab. (the MAPEG family).  Previous designations of the protein are PIG12 and MGST1-L1.  PGE synthase was expressed in Escherichia coli, and both cytosolic and membrane fractions were prepd.  Western blot anal. specifically detected a 15- to 16-kDa protein in the membrane fraction.  Both fractions were incubated with prostaglandin H2 in the presence or absence of reduced glutathione.  The membrane but not the cytosolic fraction was found to possess high glutathione-dependent PGE synthase activity (0.25 μmol/min/mg).  The human tissue distribution was analyzed by Northern blot anal.  High expression of PGE synthase mRNA was detected in A549 and HeLa cancer cell lines.  Intermediate level of expression was demonstrated in placenta, prostate, testis, mammary gland, and bladder whereas low mRNA expression was obsd. in several other tissues.  A549 cells have been used as a model system to study cyclooxygenase-2 induction by IL-1β.  If A549 cells were grown in the presence of IL-1β, a significant induction of the PGE synthase was obsd. by Western blot anal.  Also, Western blot anal. specifically detected a 16-kDa protein in sheep seminal vesicles.  In summary, we have identified a human membrane bound PGE synthase.  The enzyme activity is glutathione-dependent, and the protein expression is induced by the proinflammatory cytokine IL-1β.  PGE synthase is a potential novel target for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZGo96GT36n7Vg90H21EOLACvtfcHk0lgXTwuWufgOQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVOrtb0%253D&md5=72e7b564853d3d9f13d2c2a113c5323c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.13.7220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.13.7220%26sid%3Dliteratum%253Aachs%26aulast%3DJakobsson%26aufirst%3DP.-J.%26aulast%3DThor%25C3%25A9n%26aufirst%3DS.%26aulast%3DMorgenstern%26aufirst%3DR.%26aulast%3DSamuelsson%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520human%2520prostaglandin%2520E%2520synthase%253A%2520A%2520microsomal%252C%2520glutathione-dependent%252C%2520inducible%2520enzyme%252C%2520constituting%2520a%2520potential%2520novel%2520drug%2520target%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D7220%26epage%3D7225%26doi%3D10.1073%2Fpnas.96.13.7220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Chang, H.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuillet, E. J.</span><span> </span><span class="NLM_article-title">Identification and development of mPGES-1 inhibitors: where we are at?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1909</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span><span class="refDoi"> DOI: 10.4155/fmc.11.136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.4155%2Ffmc.11.136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=22023034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGku77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=1909-1934&author=H.-H.+Changauthor=E.+J.+Meuillet&title=Identification+and+development+of+mPGES-1+inhibitors%3A+where+we+are+at%3F&doi=10.4155%2Ffmc.11.136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and development of mPGES-1 inhibitors: where we are at?</span></div><div class="casAuthors">Chang, Hui-Hua; Meuillet, Emmanuelle J.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1909-1934</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Microsomal prostaglandin E synthase-1 (mPGES-1) is the terminal synthase responsible for the synthesis of the pro-tumorigenic prostaglandin E2 (PGE2). mPGES-1 is overexpressed in a wide variety of cancers.  Since its discovery in 1997 by Bengt Samuelsson and collaborators, the enzyme has been the object of over 200 peer-reviewed articles.  Although today mPGES-1 is considered a validated and promising therapeutic target for anticancer drug discovery, challenges in inhibitor design and selectivity are such that up to this date there are only a few published records of small-mol. inhibitors targeting the enzyme and exhibiting some in vivo anticancer activity.  This review summarizes the structures, and the in vitro and in vivo activities of these novel mPGES-1 inhibitors.  Challenges that have been encountered are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK1gwT4lhJiLVg90H21EOLACvtfcHk0lgXTwuWufgOQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGku77I&md5=cf98f2d5951c19b4941abf36038fb915</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.4155%2Ffmc.11.136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.11.136%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DH.-H.%26aulast%3DMeuillet%26aufirst%3DE.%2BJ.%26atitle%3DIdentification%2520and%2520development%2520of%2520mPGES-1%2520inhibitors%253A%2520where%2520we%2520are%2520at%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D1909%26epage%3D1934%26doi%3D10.4155%2Ffmc.11.136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><div class="note"><p class="first last">See</p></div><span class="NLM_contrib-group">Takusagawa, F.</span><span> </span><span class="NLM_article-title">Microsomal prostaglandin E synthase type 2 (mPGES2) is a glutathione-dependent heme protein, and dithiothreitol dissociates the bound heme to produce active prostaglandin E2 synthase in vitro</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">10166</span><span class="NLM_x">–</span> <span class="NLM_lpage">10175</span><div class="note"><p class="first last">and references therein.</p></div><span class="refDoi"> DOI: 10.1074/jbc.M112.418475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1074%2Fjbc.M112.418475" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=10166-10175&author=F.+Takusagawa&title=Microsomal+prostaglandin+E+synthase+type+2+%28mPGES2%29+is+a+glutathione-dependent+heme+protein%2C+and+dithiothreitol+dissociates+the+bound+heme+to+produce+active+prostaglandin+E2+synthase+in+vitro&doi=10.1074%2Fjbc.M112.418475"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.418475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.418475%26sid%3Dliteratum%253Aachs%26aulast%3DTakusagawa%26aufirst%3DF.%26atitle%3DMicrosomal%2520prostaglandin%2520E%2520synthase%2520type%25202%2520%2528mPGES2%2529%2520is%2520a%2520glutathione-dependent%2520heme%2520protein%252C%2520and%2520dithiothreitol%2520dissociates%2520the%2520bound%2520heme%2520to%2520produce%2520active%2520prostaglandin%2520E2%2520synthase%2520in%2520vitro%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D10166%26epage%3D10175%26doi%3D10.1074%2Fjbc.M112.418475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Singh Bahia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar Katare, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silakari, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silakari, P.</span><span> </span><span class="NLM_article-title">Inhibitors of Microsomal Prostaglandin E2 Synthase-1 Enzyme as Emerging Anti-Inflammatory Candidates</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1002/med.21306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1002%2Fmed.21306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=25019142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVagurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=825-855&author=M.+Singh+Bahiaauthor=Y.+Kumar+Katareauthor=O.+Silakariauthor=B.+Vyasauthor=P.+Silakari&title=Inhibitors+of+Microsomal+Prostaglandin+E2+Synthase-1+Enzyme+as+Emerging+Anti-Inflammatory+Candidates&doi=10.1002%2Fmed.21306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Microsomal Prostaglandin E2 Synthase-1 Enzyme as Emerging Anti-Inflammatory Candidates</span></div><div class="casAuthors">Singh Bahia, Malkeet; Kumar Katare, Yogesh; Silakari, Om; Vyas, Bhawna; Silakari, Pragati</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">825-855</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Cyclooxygenases (COX-1 and COX-2) catalyze the conversion of arachidonic acid (AA) into PGH2 that is further metabolized by terminal prostaglandin (PG) synthases into biol. active PGs, for example, prostaglandin E2 (PGE2), prostacyclin I2 (PGI2), thromboxane A2 (TXA2), prostaglandin D2 (PGD2), and prostaglandin F2 alpha (PGF2α).  Among them, PGE2 is a widely distributed PG in the human body, and an important mediator of inflammatory processes.  The successful modulation of this PG provides a beneficial strategy for the potential anti-inflammatory therapy.  For instance, nonsteroidal anti-inflammatory agents (NSAIDs), both classical nonselective (cNSAIDs) and the selective COX-2 inhibitors (coxibs) attenuate the generation of PGH2 from AA that in turn reduces the synthesis of PGE2 and modifies the inflammatory conditions.  However, the long-term use of these agents causes severe side effects due to the nonselective inhibition of other PGs, such as PGI2 and TXA2, etc.  Microsomal prostaglandin E2 synthase-1 (mPGES-1), a downstream PG synthase, specifically catalyzes the biosynthesis of COX-2-derived PGE2 from PGH2, and describes itself as a valuable therapeutic target for the treatment of acute and chronic inflammatory disease conditions.  Therefore, the small mol. inhibitors of mPGES-1 would serve as a beneficial anti-inflammatory therapy, with reduced side effects that are usually assocd. with the nonselective inhibition of PG biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU4wyO_mJTBrVg90H21EOLACvtfcHk0lg0A8drMv412g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVagurk%253D&md5=d130be77b4ae504b144df0ceda613e0c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fmed.21306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21306%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%2BBahia%26aufirst%3DM.%26aulast%3DKumar%2BKatare%26aufirst%3DY.%26aulast%3DSilakari%26aufirst%3DO.%26aulast%3DVyas%26aufirst%3DB.%26aulast%3DSilakari%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520Microsomal%2520Prostaglandin%2520E2%2520Synthase-1%2520Enzyme%2520as%2520Emerging%2520Anti-Inflammatory%2520Candidates%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2014%26volume%3D34%26spage%3D825%26epage%3D855%26doi%3D10.1002%2Fmed.21306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Abdul-Malik, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akasaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, K. H.</span><span> </span><span class="NLM_article-title">Current Advances of Microsomal Prostaglandin E Synthase-1 as a Target in Inflammation and Cancer</span> <span class="citation_source-journal">Am. J. Integrative Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=2-11&author=H.+M.+Abdul-Malikauthor=H.+Akasakaauthor=K.+H.+Ruan&title=Current+Advances+of+Microsomal+Prostaglandin+E+Synthase-1+as+a+Target+in+Inflammation+and+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Malik%26aufirst%3DH.%2BM.%26aulast%3DAkasaka%26aufirst%3DH.%26aulast%3DRuan%26aufirst%3DK.%2BH.%26atitle%3DCurrent%2520Advances%2520of%2520Microsomal%2520Prostaglandin%2520E%2520Synthase-1%2520as%2520a%2520Target%2520in%2520Inflammation%2520and%2520Cancer%26jtitle%3DAm.%2520J.%2520Integrative%2520Med.%26date%3D2013%26volume%3D3%26spage%3D2%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giroux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiral, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducharme, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesen, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méthot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audoly, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span> </span><span class="NLM_article-title">MF63 [2-(6-chloro-1H-phenanthro [9,10-d] imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">754</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1124/jpet.108.138776</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1124%2Fjpet.108.138776" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=18524979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVGqurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2008&pages=754-763&author=D.+Xuauthor=S.+E.+Rowlandauthor=P.+Clarkauthor=A.+Girouxauthor=B.+C%C3%B4t%C3%A9author=S.+Guiralauthor=M.+Salemauthor=Y.+Ducharmeauthor=R.+W.+Friesenauthor=N.+M%C3%A9thotauthor=J.+Manciniauthor=L.+Audolyauthor=D.+Riendeau&title=MF63+%5B2-%286-chloro-1H-phenanthro+%5B9%2C10-d%5D+imidazol-2-yl%29-isophthalonitrile%5D%2C+a+selective+microsomal+prostaglandin+E+synthase-1+inhibitor%2C+relieves+pyresis+and+pain+in+preclinical+models+of+inflammation&doi=10.1124%2Fjpet.108.138776"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation</span></div><div class="casAuthors">Xu, Daigen; Rowland, Steven E.; Clark, Patsy; Giroux, Andre; Cote, Bernard; Guiral, Sebastien; Salem, Myriam; Ducharme, Yves; Friesen, Richard W.; Methot, Nathalie; Mancini, Joseph; Audoly, Laurent; Riendeau, Denis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">754-763</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Microsomal prostaglandin E synthase-1 (mPGES-1) is a terminal prostaglandin E2 (PGE2) synthase in the cyclooxygenase pathway.  Inhibitors of mPGES-1 may block PGE2 prodn. and relieve inflammatory symptoms.  To test the hypothesis, we evaluated the antipyretic and analgesic properties of a novel and selective mPGES-1 inhibitor, MF63 [2-(6-chloro-1H-phenanthro-[9,10-d]imidazol-2-yl)isophthalonitrile], in animal models of inflammation.  MF63 potently inhibited the human mPGES-1 enzyme (IC50 = 1.3 nM), with a high degree (>1000-fold) of selectivity over other prostanoid synthases.  In rodent species, MF63 strongly inhibited guinea pig mPGES-1 (IC50 = 0.9 nM) but not the mouse or rat enzyme.  When tested in the guinea pig and a knock-in (KI) mouse expressing human mPGES-1, the compd. selectively suppressed the synthesis of PGE2, but not other prostaglandins inhibitable by nonsteroidal anti-inflammatory drugs (NSAIDs), yet retained NSAID-like efficacy at inhibiting lipopolysaccharide-induced pyresis, hyperalgesia, and iodoacetate-induced osteoarthritic pain.  In addn., MF63 did not cause NSAID-like gastrointestinal toxic effects, such as mucosal erosions or leakage in the KI mice or nonhuman primates, although it markedly inhibited PGE2 synthesis in the KI mouse stomach.  Our data demonstrate that mPGES-1 inhibition leads to effective relief of both pyresis and inflammatory pain in preclin. models of inflammation and may be a useful approach for treating inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiuE_hD_RJhbVg90H21EOLACvtfcHk0lj7akHphC2gaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVGqurnK&md5=3f13b177e1cd540833be0fe2abce290c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.138776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.138776%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DRowland%26aufirst%3DS.%2BE.%26aulast%3DClark%26aufirst%3DP.%26aulast%3DGiroux%26aufirst%3DA.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DB.%26aulast%3DGuiral%26aufirst%3DS.%26aulast%3DSalem%26aufirst%3DM.%26aulast%3DDucharme%26aufirst%3DY.%26aulast%3DFriesen%26aufirst%3DR.%2BW.%26aulast%3DM%25C3%25A9thot%26aufirst%3DN.%26aulast%3DMancini%26aufirst%3DJ.%26aulast%3DAudoly%26aufirst%3DL.%26aulast%3DRiendeau%26aufirst%3DD.%26atitle%3DMF63%2520%255B2-%25286-chloro-1H-phenanthro%2520%255B9%252C10-d%255D%2520imidazol-2-yl%2529-isophthalonitrile%255D%252C%2520a%2520selective%2520microsomal%2520prostaglandin%2520E%2520synthase-1%2520inhibitor%252C%2520relieves%2520pyresis%2520and%2520pain%2520in%2520preclinical%2520models%2520of%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D326%26spage%3D754%26epage%3D763%26doi%3D10.1124%2Fjpet.108.138776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aspiotis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gareau, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiral, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juteau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méthot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesen, R. W.</span><span> </span><span class="NLM_article-title">Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3352</span><span class="NLM_x">–</span> <span class="NLM_lpage">3355</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.05.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1016%2Fj.bmcl.2005.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=15953724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVCmurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3352-3355&author=D.+Riendeauauthor=R.+Aspiotisauthor=D.+Ethierauthor=Y.+Gareauauthor=E.+L.+Grimmauthor=J.+Guayauthor=S.+Guiralauthor=H.+Juteauauthor=J.+A.+Manciniauthor=N.+M%C3%A9thotauthor=J.+Rubinauthor=R.+W.+Friesen&title=Inhibitors+of+the+inducible+microsomal+prostaglandin+E2+synthase+%28mPGES-1%29+derived+from+MK-886&doi=10.1016%2Fj.bmcl.2005.05.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886</span></div><div class="casAuthors">Riendeau, Denis; Aspiotis, Renee; Ethier, Diane; Gareau, Yves; Grimm, Erich L.; Guay, Jocelyne; Guiral, Sebastien; Juteau, Helene; Mancini, Joseph A.; Methot, Nathalie; Rubin, Joel; Friesen, Richard W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3352-3355</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of potent and selective inhibitors of the inducible microsomal PGE2 synthase (mPGES-1) has been developed based on the indole FLAP inhibitor MK-886.  Compds. 23 and 30 inhibit mPGES-1 with potencies in the low nanomolar range and with selectivities of at least 100-fold compared to their inhibition of mPGES-2, thromboxane synthase and binding affinity to FLAP.  They also block the prodn. of PGE2 in cell based assays but with a decreased potency and more limited selectivity compared to the enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHu0Wz8iNsdbVg90H21EOLACvtfcHk0lj7akHphC2gaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVCmurc%253D&md5=5da7bd8d4f5f725dd6624f5867ca7853</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DAspiotis%26aufirst%3DR.%26aulast%3DEthier%26aufirst%3DD.%26aulast%3DGareau%26aufirst%3DY.%26aulast%3DGrimm%26aufirst%3DE.%2BL.%26aulast%3DGuay%26aufirst%3DJ.%26aulast%3DGuiral%26aufirst%3DS.%26aulast%3DJuteau%26aufirst%3DH.%26aulast%3DMancini%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9thot%26aufirst%3DN.%26aulast%3DRubin%26aufirst%3DJ.%26aulast%3DFriesen%26aufirst%3DR.%2BW.%26atitle%3DInhibitors%2520of%2520the%2520inducible%2520microsomal%2520prostaglandin%2520E2%2520synthase%2520%2528mPGES-1%2529%2520derived%2520from%2520MK-886%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3352%26epage%3D3355%26doi%3D10.1016%2Fj.bmcl.2005.05.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Mbalaviele, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweifel, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathialagan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mnich, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemirovskiy, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gierse, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masferrer, J. L.</span><span> </span><span class="NLM_article-title">Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1445</span><span class="NLM_x">–</span> <span class="NLM_lpage">1454</span><span class="refDoi"> DOI: 10.1016/j.bcp.2010.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1016%2Fj.bcp.2010.01.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=1445-1454&author=G.+Mbalavieleauthor=A.+M.+Pauleyauthor=A.+F.+Shafferauthor=B.+S.+Zweifelauthor=S.+Mathialaganauthor=S.+J.+Mnichauthor=O.+V.+Nemirovskiyauthor=J.+Carterauthor=J.+K.+Gierseauthor=J.+L.+Wangauthor=M.+L.+Vazquezauthor=W.+M.+Mooreauthor=J.+L.+Masferrer&title=Distinction+of+microsomal+prostaglandin+E+synthase-1+%28mPGES-1%29+inhibition+from+cyclooxygenase-2+inhibition+in+cells+using+a+novel%2C+selective+mPGES-1+inhibitor&doi=10.1016%2Fj.bcp.2010.01.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DMbalaviele%26aufirst%3DG.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DShaffer%26aufirst%3DA.%2BF.%26aulast%3DZweifel%26aufirst%3DB.%2BS.%26aulast%3DMathialagan%26aufirst%3DS.%26aulast%3DMnich%26aufirst%3DS.%2BJ.%26aulast%3DNemirovskiy%26aufirst%3DO.%2BV.%26aulast%3DCarter%26aufirst%3DJ.%26aulast%3DGierse%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DJ.%2BL.%26aulast%3DVazquez%26aufirst%3DM.%2BL.%26aulast%3DMoore%26aufirst%3DW.%2BM.%26aulast%3DMasferrer%26aufirst%3DJ.%2BL.%26atitle%3DDistinction%2520of%2520microsomal%2520prostaglandin%2520E%2520synthase-1%2520%2528mPGES-1%2529%2520inhibition%2520from%2520cyclooxygenase-2%2520inhibition%2520in%2520cells%2520using%2520a%2520novel%252C%2520selective%2520mPGES-1%2520inhibitor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D1445%26epage%3D1454%26doi%3D10.1016%2Fj.bcp.2010.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Arhancet, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heasley, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerome, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baratta, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweifel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masferrer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez, M. L.</span><span> </span><span class="NLM_article-title">Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1114</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1016%2Fj.bmcl.2012.11.109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1114-1119&author=G.+B.+Arhancetauthor=D.+P.+Walkerauthor=S.+Metzauthor=Y.+M.+Fobianauthor=S.+E.+Heasleyauthor=J.+S.+Carterauthor=J.+R.+Springerauthor=D.+E.+Jonesauthor=M.+J.+Hayesauthor=A.+F.+Shafferauthor=G.+M.+Jeromeauthor=M.+T.+Barattaauthor=B.+Zweifelauthor=W.+M.+Mooreauthor=J.+L.+Masferrerauthor=M.+L.+Vazquez&title=Discovery+and+SAR+of+PF-4693627%2C+a+potent%2C+selective+and+orally+bioavailable+mPGES-1+inhibitor+for+the+potential+treatment+of+inflammation&doi=10.1016%2Fj.bmcl.2012.11.109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.109%26sid%3Dliteratum%253Aachs%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DMetz%26aufirst%3DS.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DHeasley%26aufirst%3DS.%2BE.%26aulast%3DCarter%26aufirst%3DJ.%2BS.%26aulast%3DSpringer%26aufirst%3DJ.%2BR.%26aulast%3DJones%26aufirst%3DD.%2BE.%26aulast%3DHayes%26aufirst%3DM.%2BJ.%26aulast%3DShaffer%26aufirst%3DA.%2BF.%26aulast%3DJerome%26aufirst%3DG.%2BM.%26aulast%3DBaratta%26aufirst%3DM.%2BT.%26aulast%3DZweifel%26aufirst%3DB.%26aulast%3DMoore%26aufirst%3DW.%2BM.%26aulast%3DMasferrer%26aufirst%3DJ.%2BL.%26aulast%3DVazquez%26aufirst%3DM.%2BL.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520PF-4693627%252C%2520a%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520mPGES-1%2520inhibitor%2520for%2520the%2520potential%2520treatment%2520of%2520inflammation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1114%26epage%3D1119%26doi%3D10.1016%2Fj.bmcl.2012.11.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span>To our knowledge, the structure of GRC27864 has not been disclosed. See: GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers. <a href="http://clinicaltrials.gov/ct2/show/NCT02179645" class="extLink">http://clinicaltrials.gov/ct2/show/NCT02179645</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=To+our+knowledge%2C+the+structure+of+GRC27864+has+not+been+disclosed.+See%3A+GRC+27864+First+in+Man%2C+Single+Ascending+Dose+Study+in+Healthy+Volunteers.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02179645."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.5b01249/suppl_file/jm5b01249_si_001.pdf" class="ext-link">Supporting Information</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Huntjens, D. R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danhof, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Pasqua, O. E.</span><span> </span><span class="NLM_article-title">Pharmacokinetic–pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors</span> <span class="citation_source-journal">Rheumatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">846</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span><span class="refDoi"> DOI: 10.1093/rheumatology/keh627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1093%2Frheumatology%2Fkeh627" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=846-859&author=D.+R.+H.+Huntjensauthor=M.+Danhofauthor=O.+E.+Della+Pasqua&title=Pharmacokinetic%E2%80%93pharmacodynamic+correlations+and+biomarkers+in+the+development+of+COX-2+inhibitors&doi=10.1093%2Frheumatology%2Fkeh627"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fkeh627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fkeh627%26sid%3Dliteratum%253Aachs%26aulast%3DHuntjens%26aufirst%3DD.%2BR.%2BH.%26aulast%3DDanhof%26aufirst%3DM.%26aulast%3DDella%2BPasqua%26aufirst%3DO.%2BE.%26atitle%3DPharmacokinetic%25E2%2580%2593pharmacodynamic%2520correlations%2520and%2520biomarkers%2520in%2520the%2520development%2520of%2520COX-2%2520inhibitors%26jtitle%3DRheumatology%26date%3D2005%26volume%3D44%26spage%3D846%26epage%3D859%26doi%3D10.1093%2Frheumatology%2Fkeh627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><div class="note"><p class="first last">Due to the short half-life of TXA<sub>2</sub>, TXB<sub>2</sub> is frequently used as a marker for TXA<sub>2</sub> production. See:</p></div><span class="NLM_contrib-group">Kyrle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichler, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jäger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, K.</span><span> </span><span class="NLM_article-title">Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span><span class="refDoi"> DOI: 10.1161/01.CIR.75.5.1025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1161%2F01.CIR.75.5.1025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1987&pages=1025-1029&author=P.+A.+Kyrleauthor=H.+G.+Eichlerauthor=U.+J%C3%A4gerauthor=K.+Lechner&title=Inhibition+of+prostacyclin+and+thromboxane+A2+generation+by+low-dose+aspirin+at+the+site+of+plug+formation+in+man+in+vivo&doi=10.1161%2F01.CIR.75.5.1025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.75.5.1025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.75.5.1025%26sid%3Dliteratum%253Aachs%26aulast%3DKyrle%26aufirst%3DP.%2BA.%26aulast%3DEichler%26aufirst%3DH.%2BG.%26aulast%3DJ%25C3%25A4ger%26aufirst%3DU.%26aulast%3DLechner%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520prostacyclin%2520and%2520thromboxane%2520A2%2520generation%2520by%2520low-dose%2520aspirin%2520at%2520the%2520site%2520of%2520plug%2520formation%2520in%2520man%2520in%2520vivo%26jtitle%3DCirculation%26date%3D1987%26volume%3D75%26spage%3D1025%26epage%3D1029%26doi%3D10.1161%2F01.CIR.75.5.1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Tacconelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capone, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciulli, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricciotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrignani, P.</span><span> </span><span class="NLM_article-title">The Biochemical Selectivity of Novel COX-2 Inhibitors in Whole Blood Assays of COX-isozyme Activity</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span><span class="refDoi"> DOI: 10.1185/030079902125001335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1185%2F030079902125001335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=12564662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1Wku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2002&pages=503-511&author=S.+Tacconelliauthor=M.+L.+Caponeauthor=M.+G.+Sciulliauthor=E.+Ricciottiauthor=P.+Patrignani&title=The+Biochemical+Selectivity+of+Novel+COX-2+Inhibitors+in+Whole+Blood+Assays+of+COX-isozyme+Activity&doi=10.1185%2F030079902125001335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity</span></div><div class="casAuthors">Tacconelli, Stefania; Capone, Marta L.; Sciulli, Maria G.; Ricciotti, Emanuela; Patrignani, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">503-511</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">LibraPharm Ltd.</span>)
        </div><div class="casAbstract">We have evaluated the biochem. selectivity of novel cyclo-oxygenase (COX)-2 inhibitors, etoricoxib, valdecoxib/, DFU and DFP, vs. rofecoxib and celecoxib, using the human whole blood assays of COX-isoenzyme activity, in vitro.  Compds. were incubated with human whole blood samples, allowed to clot for 1 h at 37°, or stimulated with lipopolysaccharide (10 μg/mL) for 24 h at 37°.  Serum thromboxane (TX) B2 and plasma prostaglandin (PG) E2 levels were measured by specific RIAs as indexes of platelet COX-1 and monocyte COX-2 activity, resp.  Valdecoxib, etoricoxib, DFU and DFP inhibited platelet COX-1 and monocyte COX-2 with the following COX-1/COX-2 IC50 ratios: 61.5, 344, 660 and 1918, resp.  The ref. compds., celecoxib and rofecoxib had corresponding values of 29.6 and 272.  In conclusion, a second wave of COX-2 inhibitors with higher biochem. selectivity than the existing coxibs has been developed.  Whether their administration will be assocd. with improved clin. efficacy and/or safety visa-vis celecoxib and rofecoxib remains to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXp52P5XevwrVg90H21EOLACvtfcHk0li7tvvksBmawA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1Wku7c%253D&md5=6adbff0cb04b5f79618387d63efef8d5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1185%2F030079902125001335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F030079902125001335%26sid%3Dliteratum%253Aachs%26aulast%3DTacconelli%26aufirst%3DS.%26aulast%3DCapone%26aufirst%3DM.%2BL.%26aulast%3DSciulli%26aufirst%3DM.%2BG.%26aulast%3DRicciotti%26aufirst%3DE.%26aulast%3DPatrignani%26aufirst%3DP.%26atitle%3DThe%2520Biochemical%2520Selectivity%2520of%2520Novel%2520COX-2%2520Inhibitors%2520in%2520Whole%2520Blood%2520Assays%2520of%2520COX-isozyme%2520Activity%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2002%26volume%3D18%26spage%3D503%26epage%3D511%26doi%3D10.1185%2F030079902125001335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">In our hands, the IC<sub>50</sub> of celecoxib for PGE<sub>2</sub> reduction in LPS-stimulated HWB was 425 nM ×/÷ 2.00 (<i>n</i> = 372). See <a href="/doi/suppl/10.1021/acs.jmedchem.5b01249/suppl_file/jm5b01249_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Paulson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughn, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessen, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawal, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gresk, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maziasz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karim, A.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of Celecoxib after Oral Administration in Dogs and Humans: Effect of Food and Site of Absorption</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=11303053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1Wlsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2001&pages=638-648&author=S.+K.+Paulsonauthor=M.+B.+Vaughnauthor=S.+M.+Jessenauthor=Y.+Lawalauthor=C.+J.+Greskauthor=B.+Yanauthor=T.+J.+Maziaszauthor=C.+S.+Cookauthor=A.+Karim&title=Pharmacokinetics+of+Celecoxib+after+Oral+Administration+in+Dogs+and+Humans%3A+Effect+of+Food+and+Site+of+Absorption"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption</span></div><div class="casAuthors">Paulson, Susan K.; Vaughn, Margaret B.; Jessen, Susan M.; Lawal, Yvette; Gresk, Christopher J.; Yan, Bo; Maziasz, Timothy J.; Cook, Chyung S.; Karim, Aziz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">638-645</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Celecoxib pharmacokinetics was evaluated after single and multiple oral dosing; after dosing in a soln. and as a solid; with and without food; and after administration into different sites of the GI tract using dog.  After oral dosing in a soln., celecoxib was rapidly absorbed and reached max. concns. by 1 h; absorption was delayed another 1 to 2 h when administered as a solid.  The abs. bioavailability of celecoxib was higher when given as a soln. (64-88%) compared with capsule (22-40%).  The absorption of celecoxib given in a capsule was delayed by food, although systemic exposure increased by 3- to 5-fold.  The systemic availability of celecoxib given intragastrically in soln. was similar to that obtained following direct instillation into the duodenum, jejunum, or colon through a chronic intestinal access port.  Collectively, these data suggest that celecoxib is a highly permeable drug that can be absorbed throughout the GI tract and that dissoln. may be a rate-limiting factor for absorption from solid dosage forms.  Unlike dogs, celecoxib given to humans with a high fat meal exhibits only a slight increase in AUCo-∞ (11%) that is not clin. significant with regard to safety of efficacy.  In humans, a lower dose and a longer GI residence time may promote the opportunity for absorption of a poorly sol. drug such as celecoxib that can be absorbed throughout the GI tract.  This would minimize the effect of food on absorption; as such, patients with arthritis can be given celecoxib with or without food.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEL8NF2Q6F4LVg90H21EOLACvtfcHk0ljRXDEdx1AgMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1Wlsbw%253D&md5=f5041ca44c2ec46273624ca712ea8c48</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaulson%26aufirst%3DS.%2BK.%26aulast%3DVaughn%26aufirst%3DM.%2BB.%26aulast%3DJessen%26aufirst%3DS.%2BM.%26aulast%3DLawal%26aufirst%3DY.%26aulast%3DGresk%26aufirst%3DC.%2BJ.%26aulast%3DYan%26aufirst%3DB.%26aulast%3DMaziasz%26aufirst%3DT.%2BJ.%26aulast%3DCook%26aufirst%3DC.%2BS.%26aulast%3DKarim%26aufirst%3DA.%26atitle%3DPharmacokinetics%2520of%2520Celecoxib%2520after%2520Oral%2520Administration%2520in%2520Dogs%2520and%2520Humans%253A%2520Effect%2520of%2520Food%2520and%2520Site%2520of%2520Absorption%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D297%26spage%3D638%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">All IC<sub>50</sub> and IC<sub>80</sub> values are reported as geometric means times or divided by geometric standard deviations.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Luz, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonysamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuklish, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. J.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-inflammatory Therapeutics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4727</span><span class="NLM_x">–</span> <span class="NLM_lpage">4737</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00330</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00330" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BC2MXot1Srsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4727-4737&author=J.+G.+Luzauthor=S.+Antonysamyauthor=S.+L.+Kuklishauthor=B.+Condonauthor=M.+Leeauthor=D.+Allisonauthor=X.-P.+Yuauthor=R.+Backerauthor=A.+Zhangauthor=M.+Russellauthor=S.+S.+Changauthor=A.+Harveyauthor=A.+V.+Sloanauthor=M.+J.+Fisher&title=Crystal+Structures+of+mPGES-1+Inhibitor+Complexes+Form+a+Basis+for+the+Rational+Design+of+Potent+Analgesic+and+Anti-inflammatory+Therapeutics&doi=10.1021%2Facs.jmedchem.5b00330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics</span></div><div class="casAuthors">Luz, John Gately; Antonysamy, Stephen; Kuklish, Steven L.; Condon, Bradley; Lee, Matthew R.; Allison, Dagart; Yu, Xiao-Peng; Chandrasekhar, Srinivasan; Backer, Ryan; Zhang, Aiping; Russell, Marijane; Chang, Shawn S.; Harvey, Anita; Sloan, Ashley V.; Fisher, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4727-4737</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Microsomal prostaglandin E synthase 1 (mPGES-1) is an α-helical homotrimeric integral membrane inducible enzyme that catalyzes the formation of prostaglandin E2 (PGE2) from prostaglandin H2 (PGH2).  Inhibition of mPGES-1 has been proposed as a therapeutic strategy for the treatment of pain, inflammation, and some cancers.  Interest in mPGES-1 inhibition can, in part, be attributed to the potential circumvention of cardiovascular risks assocd. with anti-inflammatory cyclooxygenase 2 inhibitors (coxibs) by targeting the prostaglandin pathway downstream of PGH2 synthesis and avoiding suppression of antithrombotic prostacyclin prodn.  We detd. the crystal structure of mPGES-1 bound to four potent inhibitors in order to understand their structure-activity relationships and provide a framework for the rational design of improved mols.  In addn., we developed a light-scattering-based thermal stability assay to identify mols. for crystallog. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovxJRoDSaZVbVg90H21EOLACvtfcHk0ljRXDEdx1AgMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXot1Srsrg%253D&md5=d02b757118396726c57657a8321bc289</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00330%26sid%3Dliteratum%253Aachs%26aulast%3DLuz%26aufirst%3DJ.%2BG.%26aulast%3DAntonysamy%26aufirst%3DS.%26aulast%3DKuklish%26aufirst%3DS.%2BL.%26aulast%3DCondon%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DAllison%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DX.-P.%26aulast%3DBacker%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DS.%2BS.%26aulast%3DHarvey%26aufirst%3DA.%26aulast%3DSloan%26aufirst%3DA.%2BV.%26aulast%3DFisher%26aufirst%3DM.%2BJ.%26atitle%3DCrystal%2520Structures%2520of%2520mPGES-1%2520Inhibitor%2520Complexes%2520Form%2520a%2520Basis%2520for%2520the%2520Rational%2520Design%2520of%2520Potent%2520Analgesic%2520and%2520Anti-inflammatory%2520Therapeutics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4727%26epage%3D4737%26doi%3D10.1021%2Facs.jmedchem.5b00330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="note"><p class="first last">For additional results from the A549 and HWB assays, see <a href="/doi/suppl/10.1021/acs.jmedchem.5b01249/suppl_file/jm5b01249_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="note"><p class="first last">COX inhibition was determined using assays essentially as described in ref <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">30</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Riley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grime, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, R.</span><span> </span><span class="NLM_article-title">Time-dependent CYP inhibition</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1517/17425255.3.1.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1517%2F17425255.3.1.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=17269894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=51-66&author=R.+J.+Rileyauthor=K.+Grimeauthor=R.+Weaver&title=Time-dependent+CYP+inhibition&doi=10.1517%2F17425255.3.1.51"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Time-dependent CYP inhibition</span></div><div class="casAuthors">Riley, Robert J.; Grime, Ken; Weaver, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-66</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Time-dependent inhibition (TDI) of CYP refers to a change in potency during an in vitro incubation or dosing period in vivo.  Potential mechanisms include the formation of inhibitory metabolites and mechanism-based inhibition (MBI).  In vitro expts. are configured to assess TDI and MBI is inferred, at least initially.  MBI is more profound after multiple-dosing and the recovery period is independent of continued drug exposure.  Advances in in vitro-in vivo extrapolations for competitive inhibition and the potential relationship between MBI and reactive metabolite-mediated toxicity, have redirected emphasis to CYP TDI.  In contrast, with reversible inhibition, strategies for projecting the risks from TDI are less developed and the traditional I/Ki model often yields a dramatic underprediction.  This review explores the contribution of TDI to drug-drug interactions and idiosyncratic drug toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8w1eAZ9QULVg90H21EOLACvtfcHk0liekwNhKq628g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGlurY%253D&md5=184636ac0768f51d65f407a0655233e4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1517%2F17425255.3.1.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.3.1.51%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DGrime%26aufirst%3DK.%26aulast%3DWeaver%26aufirst%3DR.%26atitle%3DTime-dependent%2520CYP%2520inhibition%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2007%26volume%3D3%26spage%3D51%26epage%3D66%26doi%3D10.1517%2F17425255.3.1.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">De Bruin, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyboom, R. H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoes, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leufkens, H. G. M.</span><span> </span><span class="NLM_article-title">Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">590</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span><span class="refDoi"> DOI: 10.1093/eurheartj/ehi092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1093%2Feurheartj%2Fehi092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=15637086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksFCns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=590-597&author=M.+L.+De+Bruinauthor=M.+Petterssonauthor=R.+H.+B.+Meyboomauthor=A.+W.+Hoesauthor=H.+G.+M.+Leufkens&title=Anti-HERG+activity+and+the+risk+of+drug-induced+arrhythmias+and+sudden+death&doi=10.1093%2Feurheartj%2Fehi092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death</span></div><div class="casAuthors">De Bruin, M. L.; Pettersson, M.; Meyboom, R. H. B.; Hoes, A. W.; Leufkens, H. G. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">590-597</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Drug-induced QTc-prolongation, resulting from inhibition of HERG potassium channels may lead to serious ventricular arrhythmias and sudden death.  We studied the quant. anti-HERG activity of pro-arrhythmic drugs as a risk factor for this outcome in day-to-day practice.  All 284 426 case reports of suspected adverse drug reactions of drugs with known anti-HERG activity received by the International Drug Monitoring Program of the World Health Organization (WHO-UMC) up to the first quarter of 2003, were used to calc. reporting odds ratios (RORs).  Cases were defined as reports of cardiac arrest, sudden death, torsade de pointes, ventricular fibrillation, and ventricular tachycardia (n = 5591), and compared with non-cases regarding the anti-HERG activity, defined as the effective therapeutic plasma concn. (ETCPunbound) divided by the HERG IC50 value, of suspected drugs.  We identified a significant assocn. of 1.93 (95% CI: 1.89-1.98) between the anti-HERG activity of drugs, measured as logo (ETCPunbound/IC50), and reporting of serious ventricular arrhythmias and sudden death to the WHO-UMC database.  Anti-HERG activity is assocd. with the risk of reports of serious ventricular arrhythmias and sudden death in the WHO-UMC database.  These findings are in support of the value of pre-clin. HERG testing to predict pro-arrhythmic effects of medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphZ75xPspJQrVg90H21EOLACvtfcHk0liekwNhKq628g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksFCns70%253D&md5=f998055d70fcd947341358cf4cd84481</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehi092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehi092%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBruin%26aufirst%3DM.%2BL.%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DMeyboom%26aufirst%3DR.%2BH.%2BB.%26aulast%3DHoes%26aufirst%3DA.%2BW.%26aulast%3DLeufkens%26aufirst%3DH.%2BG.%2BM.%26atitle%3DAnti-HERG%2520activity%2520and%2520the%2520risk%2520of%2520drug-induced%2520arrhythmias%2520and%2520sudden%2520death%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2005%26volume%3D26%26spage%3D590%26epage%3D597%26doi%3D10.1093%2Feurheartj%2Fehi092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.5b01249/suppl_file/jm5b01249_si_001.pdf" class="ext-link">Supporting Information</a> for further <i>in vitro</i> characterization of <b>8</b> and <b>26</b>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Leclerc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawelzik, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idborg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spahiu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korotkova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobsson, P.-J.</span><span> </span><span class="NLM_article-title">Characterization of a new mPGES-1 inhibitor in rat models of inflammation</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">102–103</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/j.prostaglandins.2013.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1016%2Fj.prostaglandins.2013.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=23528231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVGgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102%E2%80%93103&publication_year=2013&pages=1-12&author=P.+Leclercauthor=S.-C.+Pawelzikauthor=H.+Idborgauthor=L.+Spahiuauthor=C.+Larssonauthor=P.+Stenbergauthor=M.+Korotkovaauthor=P.-J.+Jakobsson&title=Characterization+of+a+new+mPGES-1+inhibitor+in+rat+models+of+inflammation&doi=10.1016%2Fj.prostaglandins.2013.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a new mPGES-1 inhibitor in rat models of inflammation</span></div><div class="casAuthors">Leclerc, Patrick; Pawelzik, Sven-Christian; Idborg, Helena; Spahiu, Linda; Larsson, Charlotte; Stenberg, Patric; Korotkova, Marina; Jakobsson, Per-Johan</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102-103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Microsomal prostaglandin E synthase (mPGES)-1 inhibition has been proposed as an alternative to cyclooxygenase (COX) inhibition in the treatment of pain and inflammation.  This novel approach could potentially mitigate the gastro-intestinal and cardiovascular side effects seen after long-term treatment with traditional non-steroidal anti-inflammatory drugs (NSAIDs) and Coxibs resp.  Several human mPGES-1 inhibitors have been developed in the recent years.  However, they were all shown to be considerably less active on rodent mPGES-1, precluding the study of mPGES-1 inhibition in rodent models of inflammation and pain.  The aim of this study was to characterize the new mPGES-1 inhibitor compd. II, a pyrazolone that has similar potency on rat and human recombinant mPGES-1, in exptl. models of inflammation.  In cell culture, compd. II inhibited PGE2 prodn. in synovial fibroblasts from patients with rheumatoid arthritis (RASF) and in rat peritoneal macrophages.  In vivo, compd. II was first characterized in the rat air pouch model of inflammation where treatment inhibited intra-pouch PGE2 prodn.  Compd. II was also investigated in a rat adjuvant-induced arthritis model where it attenuated both the acute and delayed inflammatory responses.  In conclusion, compd. II represents a valuable pharmacol. tool for the study of mPGES-1 inhibition in rat models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCqs3q8nycd7Vg90H21EOLACvtfcHk0liRN8QmzZodfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVGgt7w%253D&md5=e00007f3fe1312007db2979a37b8915f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2013.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2013.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DLeclerc%26aufirst%3DP.%26aulast%3DPawelzik%26aufirst%3DS.-C.%26aulast%3DIdborg%26aufirst%3DH.%26aulast%3DSpahiu%26aufirst%3DL.%26aulast%3DLarsson%26aufirst%3DC.%26aulast%3DStenberg%26aufirst%3DP.%26aulast%3DKorotkova%26aufirst%3DM.%26aulast%3DJakobsson%26aufirst%3DP.-J.%26atitle%3DCharacterization%2520of%2520a%2520new%2520mPGES-1%2520inhibitor%2520in%2520rat%2520models%2520of%2520inflammation%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2013%26volume%3D102%25E2%2580%2593103%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.prostaglandins.2013.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span>Due to the inability of <b>8</b> and <b>26</b> to inhibit rat or mouse <i>m</i>PGES-1, <i>in vivo</i> efficacy studies in those species were untenable. However, efficacy studies were performed in guinea pigs and will be reported in due course. See: <span class="NLM_contrib-group">Chandrasekhar, S.; Harvey, A. K.; Yu, X.-P.; Chambers, M. G.; Oskins, J. L.; Lin, C.; Seng, T. W.; Thibodeaux, S. J.; Norman, B. H.; Hughes, N. E.; Schiffler, M. A.; Fisher, M. J.</span> Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Due+to+the+inability+of+8+and+26+to+inhibit+rat+or+mouse+mPGES-1%2C+in+vivo+efficacy+studies+in+those+species+were+untenable.+However%2C+efficacy+studies+were+performed+in+guinea+pigs+and+will+be+reported+in+due+course.+See%3A+Chandrasekhar%2C+S.%3B+Harvey%2C+A.+K.%3B+Yu%2C+X.-P.%3B+Chambers%2C+M.+G.%3B+Oskins%2C+J.+L.%3B+Lin%2C+C.%3B+Seng%2C+T.+W.%3B+Thibodeaux%2C+S.+J.%3B+Norman%2C+B.+H.%3B+Hughes%2C+N.+E.%3B+Schiffler%2C+M.+A.%3B+Fisher%2C+M.+J.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DChandrasekhar%26aufirst%3DS." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Brouwers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewster, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustijns, P.</span><span> </span><span class="NLM_article-title">Supersaturating drug delivery systems: The answer to solubility-limited oral bioavailability?</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">2549</span><span class="NLM_x">–</span> <span class="NLM_lpage">2572</span><span class="refDoi"> DOI: 10.1002/jps.21650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1002%2Fjps.21650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=19373886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1eqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2009&pages=2549-2572&author=J.+Brouwersauthor=M.+E.+Brewsterauthor=P.+Augustijns&title=Supersaturating+drug+delivery+systems%3A+The+answer+to+solubility-limited+oral+bioavailability%3F&doi=10.1002%2Fjps.21650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Supersaturating drug delivery systems: The answer to solubility-limited oral bioavailability?</span></div><div class="casAuthors">Brouwers, Joachim; Brewster, Marcus E.; Augustijns, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2549-2572</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Contemporary pharmaceutical pipelines are often highly populated with poorly water-sol. drug candidates necessitating novel formulation technologies to provide dosage forms with appropriate biopharmaceutical properties.  The configuration of supersaturating drug delivery systems (SDDS) is a promising concept to obtain adequate oral bioavailability.  SDDS contain the drug in a high energy or otherwise rapidly dissolving form such that intraluminal concns. above the satn. soly. of the drug are generated.  For the strategy to be useful, the formed supersatd. soln. must then be stabilized to allow for significant absorption and eventually sufficient bioavailability.  The stabilization of a supersatd. soln. can be accomplished by adding pptn. inhibitors which may act through a variety of mechanisms.  The goal of this review is to assess methods and excipients assocd. with the development of SDDS and provide some context for their use.  In addn., the future directions and factors likely to contribute to or detract from optimal dosage form selection are assessed.  This includes a discussion on the potential effect of the gastrointestinal physiol. on the ability to attain and maintain supersatn. as this information is essential in designing useful formulations based on the supersaturating concept.  © 2009 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci 98:2549-2572, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjyLXZB5OgNLVg90H21EOLACvtfcHk0liRN8QmzZodfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1eqt7s%253D&md5=f5de4aee34adef042e124f061b36534e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fjps.21650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21650%26sid%3Dliteratum%253Aachs%26aulast%3DBrouwers%26aufirst%3DJ.%26aulast%3DBrewster%26aufirst%3DM.%2BE.%26aulast%3DAugustijns%26aufirst%3DP.%26atitle%3DSupersaturating%2520drug%2520delivery%2520systems%253A%2520The%2520answer%2520to%2520solubility-limited%2520oral%2520bioavailability%253F%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D98%26spage%3D2549%26epage%3D2572%26doi%3D10.1002%2Fjps.21650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Takano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aso, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, S.</span><span> </span><span class="NLM_article-title">Quantitative Analysis of the Effect of Supersaturation on in Vivo Drug Absorption</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1431</span><span class="NLM_x">–</span> <span class="NLM_lpage">1440</span><span class="refDoi"> DOI: 10.1021/mp100109a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp100109a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVSmsLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=1431-1440&author=R.+Takanoauthor=N.+Takataauthor=R.+Saitoauthor=K.+Furumotoauthor=S.+Higoauthor=Y.+Hayashiauthor=M.+Machidaauthor=Y.+Asoauthor=S.+Yamashita&title=Quantitative+Analysis+of+the+Effect+of+Supersaturation+on+in+Vivo+Drug+Absorption&doi=10.1021%2Fmp100109a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative Analysis of the Effect of Supersaturation on in Vivo Drug Absorption</span></div><div class="casAuthors">Takano, Ryusuke; Takata, Noriyuki; Saito, Ryoichi; Furumoto, Kentaro; Higo, Shoichi; Hayashi, Yoshiki; Machida, Minoru; Aso, Yoshinori; Yamashita, Shinji</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1431-1440</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The purpose of this study is to clarify the effects of intestinal drug supersatn. on soly.-limited nonlinear absorption.  Oral absorption of a novel farnesyltransferase inhibitor (FTI-2600) from its cryst. free base and its HCl salt was detd. in dogs.  To clarify the contribution of supersatn. on improving drug absorption, in vivo intraluminal concn. of FTI-2600 after oral administration was estd. from the pharmacokinetics data using a physiol. based model.  Dissoln. and pptn. characteristics of FTI-2600 in a biorelevant media were investigated in vitro using a miniscale dissoln. test and powder X-ray diffraction anal.  In the in vitro study, the HCl salt immediately dissolved but pptd. rapidly.  The metastable amorphous free base precipitant, which did not convert into the stable cryst. free base in the simulated intestinal fluids for several hours, generated a 5-fold increase in dissolved concn. compared to the equil. soly. of the cryst. free base.  By computer simulation, the intraluminal drug concn. after administration of the free base was estd. to reach the satd. soly., indicating soly.-limited absorption.  On the other hand, administration of the HCl salt resulted in an increased intraluminal concn. and the plasma concn. was 400% greater than that after administration of the free base.  This in vivo/in vitro correlation of the increased drug concns. in the small intestine provide clear evidence that not only the increase in the dissoln. rate, but also the supersatn. phenomenon, improved the soly.-limited absorption of FTI-2600.  These results indicate that formulation technologies that can induce supersatn. may be of great assistance to the successful development of poorly water-sol. drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruX0KFuq6W67Vg90H21EOLACvtfcHk0ljkxOx-r42Qxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVSmsLjM&md5=f77bb6b9ed56b857b85a1866bc539eaa</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fmp100109a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp100109a%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DR.%26aulast%3DTakata%26aufirst%3DN.%26aulast%3DSaito%26aufirst%3DR.%26aulast%3DFurumoto%26aufirst%3DK.%26aulast%3DHigo%26aufirst%3DS.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DMachida%26aufirst%3DM.%26aulast%3DAso%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DS.%26atitle%3DQuantitative%2520Analysis%2520of%2520the%2520Effect%2520of%2520Supersaturation%2520on%2520in%2520Vivo%2520Drug%2520Absorption%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2010%26volume%3D7%26spage%3D1431%26epage%3D1440%26doi%3D10.1021%2Fmp100109a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><div class="note"><p class="first last">Performed per the procedure described in:</p></div><span class="NLM_contrib-group">Bhattachar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, L. J.</span><span> </span><span class="NLM_article-title">Effect of gastric pH on the pharmacokinetics of a bcs class II compound in dogs: Utilization of an artificial stomach and duodenum dissolution model and gastroplus, simulations to predict absorption</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4756</span><span class="NLM_x">–</span> <span class="NLM_lpage">4765</span><span class="refDoi"> DOI: 10.1002/jps.22669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1002%2Fjps.22669" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4756-4765&author=S.+Bhattacharauthor=E.+J.+Perkinsauthor=J.+S.+Tanauthor=L.+J.+Burns&title=Effect+of+gastric+pH+on+the+pharmacokinetics+of+a+bcs+class+II+compound+in+dogs%3A+Utilization+of+an+artificial+stomach+and+duodenum+dissolution+model+and+gastroplus%2C+simulations+to+predict+absorption&doi=10.1002%2Fjps.22669"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fjps.22669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22669%26sid%3Dliteratum%253Aachs%26aulast%3DBhattachar%26aufirst%3DS.%26aulast%3DPerkins%26aufirst%3DE.%2BJ.%26aulast%3DTan%26aufirst%3DJ.%2BS.%26aulast%3DBurns%26aufirst%3DL.%2BJ.%26atitle%3DEffect%2520of%2520gastric%2520pH%2520on%2520the%2520pharmacokinetics%2520of%2520a%2520bcs%2520class%2520II%2520compound%2520in%2520dogs%253A%2520Utilization%2520of%2520an%2520artificial%2520stomach%2520and%2520duodenum%2520dissolution%2520model%2520and%2520gastroplus%252C%2520simulations%2520to%2520predict%2520absorption%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4756%26epage%3D4765%26doi%3D10.1002%2Fjps.22669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Bartroli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turmo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alguero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boncompte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vericat, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Rafanell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forn, J.</span><span> </span><span class="NLM_article-title">Synthesis and Antifungal Activity of New Azole Derivatives Containing an <i>N</i>-Acylmorpholine Ring</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3918</span><span class="NLM_x">–</span> <span class="NLM_lpage">3932</span><span class="refDoi"> DOI: 10.1021/jm00020a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00020a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaK2MXnvFSqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3918-3932&author=J.+Bartroliauthor=E.+Turmoauthor=M.+Algueroauthor=E.+Boncompteauthor=M.+L.+Vericatauthor=J.+Garcia-Rafanellauthor=J.+Forn&title=Synthesis+and+Antifungal+Activity+of+New+Azole+Derivatives+Containing+an+N-Acylmorpholine+Ring&doi=10.1021%2Fjm00020a005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antifungal Activity of New Azole Derivatives Containing an N-Acylmorpholine Ring</span></div><div class="casAuthors">Bartroli, Javier; Turmo, Enric; Alguero, Monica; Boncompte, Eulalia; Vericat, Maria L.; Garcia-Rafanell, Julian; Forn, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3918-32</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of azole derivs. carrying an N-acylmorpholine ring are described.  The compds. were chem. designed to simulate the lanosterol D ring, taking advantage of the conformational preferences of 2-alkyl-1-acylmorpholines.  Three structural variables, the nature of the N-benzoyl group, the Ph substituents, and the degree of oxidn. at carbon 2 of the morpholine, were optimized for max. activity.  Only the (5R,6R) isomers showed antifungal activity.  Cyclic hemiacetal (-)-6-(2,4-difluorophenyl)-5-methyl-6-[(2H-1,2,4-triazol-2-yl)methyl]-4-[4-(trifluoromethyl)benzoyl]-2-morpholinol (UR-9746) (I) and cyclic ether (-)-2-(2,4-difluorophenyl)-3-methyl-2-[(2H-1,2,4-triazol-2-yl)methyl]-4-[4-(trifluoromethyl)benzoyl]morpholine (UR-9751) (II) were selected for further development.  In vitro, II was clearly more active than (-)-39 and somewhat less active than the acyclic counterpart (-)-N-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-(trifluoromethyl)benzamide.  In vivo activity was assessed by a systemic (mouse) and a vaginal (rat) candidiasis model.  In the former, I, II, and (-)-N-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-(trifluoromethyl)benzamide at 1 mg/kg given 1, 4, and 24 h postinfection displayed 90-100% protection from mortality on day 9.  Compd. I was slightly more potent than II and similar in potency to (-)-N-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-(trifluoromethyl)benzamide.  The three compds. were superior in potency to fluconazole and similar in potency to SCH-42427 in this test.  In the vaginal model, I and II given daily during 3 days after infection at 0.5 mg/kg showed high levels of protection on days 10 and 15.  At 0.25 mg/kg, I was slightly more potent than SCH-42427 and (-)-N-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-(trifluoromethyl)benzamide and superior in potency to II and fluconazole in this model.  Preliminary 28-day toxicity tests at 100 mg/kg/day po in rats indicated no or very mild adverse effects for the two UR compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFsd4wq91fsLVg90H21EOLACvtfcHk0ljkxOx-r42Qxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvFSqs7k%253D&md5=102892e57052be2334ac20f2f3776965</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm00020a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00020a005%26sid%3Dliteratum%253Aachs%26aulast%3DBartroli%26aufirst%3DJ.%26aulast%3DTurmo%26aufirst%3DE.%26aulast%3DAlguero%26aufirst%3DM.%26aulast%3DBoncompte%26aufirst%3DE.%26aulast%3DVericat%26aufirst%3DM.%2BL.%26aulast%3DGarcia-Rafanell%26aufirst%3DJ.%26aulast%3DForn%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Antifungal%2520Activity%2520of%2520New%2520Azole%2520Derivatives%2520Containing%2520an%2520N-Acylmorpholine%2520Ring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3918%26epage%3D3932%26doi%3D10.1021%2Fjm00020a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Fajgelj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanovnik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tišler, M.</span><span> </span><span class="NLM_article-title">Transformations of <i>N</i>-Heteroarylformamidines. A Novel Synthesis of Imidazo/2,1-b/thiazole and Imidazo/2,1-b//1,3,4/thiadiazole Derivatives</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span><span class="refDoi"> DOI: 10.3987/R-1986-02-0379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.3987%2FR-1986-02-0379" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1986&pages=379-386&author=S.+Fajgeljauthor=B.+Stanovnikauthor=M.+Ti%C5%A1ler&title=Transformations+of+N-Heteroarylformamidines.+A+Novel+Synthesis+of+Imidazo%2F2%2C1-b%2Fthiazole+and+Imidazo%2F2%2C1-b%2F%2F1%2C3%2C4%2Fthiadiazole+Derivatives&doi=10.3987%2FR-1986-02-0379"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3987%2FR-1986-02-0379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FR-1986-02-0379%26sid%3Dliteratum%253Aachs%26aulast%3DFajgelj%26aufirst%3DS.%26aulast%3DStanovnik%26aufirst%3DB.%26aulast%3DTi%25C5%25A1ler%26aufirst%3DM.%26atitle%3DTransformations%2520of%2520N-Heteroarylformamidines.%2520A%2520Novel%2520Synthesis%2520of%2520Imidazo%252F2%252C1-b%252Fthiazole%2520and%2520Imidazo%252F2%252C1-b%252F%252F1%252C3%252C4%252Fthiadiazole%2520Derivatives%26jtitle%3DHeterocycles%26date%3D1986%26volume%3D24%26spage%3D379%26epage%3D386%26doi%3D10.3987%2FR-1986-02-0379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Desirant, Y.</span><span> </span><span class="NLM_article-title">Ethyl difluoroacetylacetate</span> <span class="citation_source-journal">Bull. Soc. Chim. Belg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1930</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaA3cXjslalug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1930&pages=143-156&author=Y.+Desirant&title=Ethyl+difluoroacetylacetate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Ethyl difluoroacetylacetate</span></div><div class="casAuthors">Desirant, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin des Societes Chimiques Belges</span>
        (<span class="NLM_cas:date">1930</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">143-56</span>CODEN:
                <span class="NLM_cas:coden">BSCBAG</span>;
        ISSN:<span class="NLM_cas:issn">0037-9646</span>.
    </div><div class="casAbstract">See C. A. 24, 3493.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDaNhIW19K-7Vg90H21EOLACvtfcHk0lgld9W0iHZuJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA3cXjslalug%253D%253D&md5=509fed338703e77bb46e157c4d9e2b54</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDesirant%26aufirst%3DY.%26atitle%3DEthyl%2520difluoroacetylacetate%26jtitle%3DBull.%2520Soc.%2520Chim.%2520Belg.%26date%3D1930%26volume%3D39%26spage%3D143%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Vorbrueggen, H.</span><span> </span><span class="NLM_article-title">Esterification of Carboxylic Acids and Etherification of Phenols with Amide Acetals</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">1603</span><span class="NLM_x">–</span> <span class="NLM_lpage">1617</span><span class="refDoi"> DOI: 10.1055/s-2008-1077882</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1055%2Fs-2008-1077882" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2008&publication_year=2008&pages=1603-1617&author=H.+Vorbrueggen&title=Esterification+of+Carboxylic+Acids+and+Etherification+of+Phenols+with+Amide+Acetals&doi=10.1055%2Fs-2008-1077882"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1055%2Fs-2008-1077882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2008-1077882%26sid%3Dliteratum%253Aachs%26aulast%3DVorbrueggen%26aufirst%3DH.%26atitle%3DEsterification%2520of%2520Carboxylic%2520Acids%2520and%2520Etherification%2520of%2520Phenols%2520with%2520Amide%2520Acetals%26jtitle%3DSynlett%26date%3D2008%26volume%3D2008%26spage%3D1603%26epage%3D1617%26doi%3D10.1055%2Fs-2008-1077882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgld9W0iHZuJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damu, G. L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, R.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, C.-H.</span><span> </span><span class="NLM_article-title">Comprehensive Review in Current Developments of Imid-azole-Based Medicinal Chemistry</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span><span class="refDoi"> DOI: 10.1002/med.21290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1002%2Fmed.21290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=23740514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVaqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=340-437&author=L.+Zhangauthor=X.-M.+Pengauthor=G.+L.+V.+Damuauthor=R.-X.+Gengauthor=C.-H.+Zhou&title=Comprehensive+Review+in+Current+Developments+of+Imid-azole-Based+Medicinal+Chemistry&doi=10.1002%2Fmed.21290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive Review in Current Developments of Imidazole-Based Medicinal Chemistry</span></div><div class="casAuthors">Zhang, Ling; Peng, Xin-Mei; Damu, Guri L. V.; Geng, Rong-Xia; Zhou, Cheng-He</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">340-437</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Imidazole ring is an important five-membered arom. heterocycle widely present in natural products and synthetic mols.  The unique structural feature of imidazole ring with desirable electron-rich characteristic is beneficial for imidazole derivs. to readily bind with a variety of enzymes and receptors in biol. systems through diverse weak interactions, thereby exhibiting broad bioactivities.  The related research and developments of imidazole-based medicinal chem. have become a rapidly developing and increasingly active topic.  Particularly, numerous imidazole-based compds. as clin. drugs have been extensively used in the clinic to treat various types of diseases with high therapeutic potency, which have shown the enormous development value.  This work systematically gives a comprehensive review in current developments of imidazole-based compds. in the whole range of medicinal chem. as anticancer, antifungal, antibacterial, antitubercular, anti-inflammatory, antineuropathic, antihypertensive, antihistaminic, antiparasitic, antiobesity, antiviral, and other medicinal agents, together with their potential applications in diagnostics and pathol.  It is hoped that this review will be helpful for new thoughts in the quest for rational designs of more active and less toxic imidazole-based medicinal drugs, as well as more effective diagnostic agents and pathol. probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb3kIrWVjpNbVg90H21EOLACvtfcHk0lgld9W0iHZuJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVaqtrw%253D&md5=459b5fc9e1789d5880a7396512844b51</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fmed.21290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21290%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DX.-M.%26aulast%3DDamu%26aufirst%3DG.%2BL.%2BV.%26aulast%3DGeng%26aufirst%3DR.-X.%26aulast%3DZhou%26aufirst%3DC.-H.%26atitle%3DComprehensive%2520Review%2520in%2520Current%2520Developments%2520of%2520Imid-azole-Based%2520Medicinal%2520Chemistry%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2014%26volume%3D34%26spage%3D340%26epage%3D437%26doi%3D10.1002%2Fmed.21290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Ritchie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, S. D.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span><span class="refDoi"> DOI: 10.1016/j.drudis.2010.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1016%2Fj.drudis.2010.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=21129497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&author=T.+J.+Ritchieauthor=S.+J.+F.+Macdonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insights+by+examining+carbo-+and+hetero-aromatic+and+-aliphatic+ring+types&doi=10.1016%2Fj.drudis.2010.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.; Young, Robert J.; Pickett, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">164-171</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of carboarom., heteroarom., carboaliph. and heteroaliph. ring counts and fused arom. ring count on several developability measures (soly., lipophilicity, protein binding, P 450 inhibition and hERG binding) is the topic for this review article.  Recent results indicate that increasing ring counts have detrimental effects on developability in the order carboaroms. » heteroaroms. > carboaliphatics > heteroaliphatics, with heteroaliphatics exerting a beneficial effect in many cases.  Increasing arom. ring count exerts effects on several developability parameters that are lipophilicity- and size-independent, and fused arom. systems have a beneficial effect relative to their nonfused counterparts.  Increasing arom. ring count has a detrimental effect on human bioavailability parameters, and heteroarom. ring count (but not other ring counts) has increased over time in marketed oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYPC7hkoyv7Vg90H21EOLACvtfcHk0liIRjVj7EDP8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D&md5=8e2d0e4e499d2f07d66ca2f385defb2d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insights%2520by%2520examining%2520carbo-%2520and%2520hetero-aromatic%2520and%2520-aliphatic%2520ring%2520types%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D164%26epage%3D171%26doi%3D10.1016%2Fj.drudis.2010.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Einhorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischkopff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szelinski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schupp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spröngerts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladisch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauermayer, T.</span><span> </span><span class="NLM_article-title">Über die N-Methylolverbindungen der Säureamide [Erste Abhandlung]</span> <span class="citation_source-journal">Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1905</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span><span class="refDoi"> DOI: 10.1002/jlac.19053430207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1002%2Fjlac.19053430207" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=1905&pages=207-305&author=A.+Einhornauthor=E.+Bischkopffauthor=B.+Szelinskiauthor=G.+Schuppauthor=E.+Spr%C3%B6ngertsauthor=C.+Ladischauthor=T.+Mauermayer&title=%C3%9Cber+die+N-Methylolverbindungen+der+S%C3%A4ureamide+%5BErste+Abhandlung%5D&doi=10.1002%2Fjlac.19053430207"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fjlac.19053430207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlac.19053430207%26sid%3Dliteratum%253Aachs%26aulast%3DEinhorn%26aufirst%3DA.%26aulast%3DBischkopff%26aufirst%3DE.%26aulast%3DSzelinski%26aufirst%3DB.%26aulast%3DSchupp%26aufirst%3DG.%26aulast%3DSpr%25C3%25B6ngerts%26aufirst%3DE.%26aulast%3DLadisch%26aufirst%3DC.%26aulast%3DMauermayer%26aufirst%3DT.%26atitle%3D%25C3%259Cber%2520die%2520N-Methylolverbindungen%2520der%2520S%25C3%25A4ureamide%2520%255BErste%2520Abhandlung%255D%26jtitle%3DLiebigs%2520Ann.%2520Chem.%26date%3D1905%26volume%3D343%26spage%3D207%26epage%3D305%26doi%3D10.1002%2Fjlac.19053430207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Tscherniac, J.</span><span> </span><span class="NLM_article-title">Verfahren zur Darstellung von Benzylphtalimiden</span>. German Patent 134,979, Jun 2,<span class="NLM_x"> </span><span class="NLM_year">1901</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1901&author=J.+Tscherniac&title=Verfahren+zur+Darstellung+von+Benzylphtalimiden"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTscherniac%26aufirst%3DJ.%26atitle%3DVerfahren%2520zur%2520Darstellung%2520von%2520Benzylphtalimiden%26date%3D1901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="note"><p class="first last">As of September 2015, available from AstaTech, Inc. (catalog no. CL9222) and Zylexa Pharma (catalog no. ZP-DC002387), among other suppliers.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':[],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':[],'ref30':['cit30'],'ref31':[],'ref32':['cit32'],'ref33':[],'ref34':[],'ref35':['cit35'],'ref36':['cit36'],'ref37':[],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 38 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Maria G. Chini, Assunta Giordano, Marianna Potenza, Stefania Terracciano, Katrin Fischer, Maria C. Vaccaro, Ester Colarusso, Ines Bruno, Raffaele Riccio, Andreas Koeberle, Oliver Werz, <span class="NLM_string-name hlFld-ContribAuthor">Giuseppe Bifulco</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting mPGES-1 by a Combinatorial Approach: Identification of the Aminobenzothiazole Scaffold to Suppress PGE2 Levels. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 783-789. <a href="https://doi.org/10.1021/acsmedchemlett.9b00618" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTargeting%252BmPGES-1%252Bby%252Ba%252BCombinatorial%252BApproach%25253A%252BIdentification%252Bof%252Bthe%252BAminobenzothiazole%252BScaffold%252Bto%252BSuppress%252BPGE2%252BLevels%26aulast%3DChini%26aufirst%3DMaria%2BG.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18122019%26date%3D05032020%26date%3D10032020%26date%3D05032020%26volume%3D11%26issue%3D5%26spage%3D783%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">David K. Miyamoto, Hope A. Flaxman, Hung-Yi Wu, Jinxu Gao, <span class="NLM_string-name hlFld-ContribAuthor">Christina M. Woo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Celecoxib Binding Site on Prostaglandin E Synthase (PTGES) with a Cleavable Chelation-Assisted Biotin Probe. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2019,</strong> <em>14 </em>
                                    (12)
                                     , 2527-2532. <a href="https://doi.org/10.1021/acschembio.9b00511" title="DOI URL">https://doi.org/10.1021/acschembio.9b00511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.9b00511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.9b00511%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DDiscovery%252Bof%252Ba%252BCelecoxib%252BBinding%252BSite%252Bon%252BProstaglandin%252BE%252BSynthase%252B%252528PTGES%252529%252Bwith%252Ba%252BCleavable%252BChelation-Assisted%252BBiotin%252BProbe%26aulast%3DMiyamoto%26aufirst%3DDavid%2BK.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D25062019%26date%3D22102019%26date%3D25102019%26volume%3D14%26issue%3D12%26spage%3D2527%26epage%3D2532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shuo Zhou, Ziyuan Zhou, Kai Ding, Yaxia Yuan, Fang Zheng, <span class="NLM_string-name hlFld-ContribAuthor">Chang-Guo Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">In Silico Observation of the Conformational Opening of the Glutathione-Binding Site of Microsomal Prostaglandin E2 Synthase-1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (9)
                                     , 3839-3845. <a href="https://doi.org/10.1021/acs.jcim.9b00289" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00289%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DIn%252BSilico%252BObservation%252Bof%252Bthe%252BConformational%252BOpening%252Bof%252Bthe%252BGlutathione-Binding%252BSite%252Bof%252BMicrosomal%252BProstaglandin%252BE2%252BSynthase-1%26aulast%3DZhou%26aufirst%3DShuo%26date%3D2019%26date%3D2019%26date%3D2019%26volume%3D59%26issue%3D9%26spage%3D3839%26epage%3D3845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bryan H. Norman, Matthew J. Fisher, Matthew A. Schiffler, Steven L. Kuklish, Norman E. Hughes, Boris A. Czeskis, Kenneth C. Cassidy, Trent L. Abraham, Jeffrey J. Alberts, <span class="NLM_string-name hlFld-ContribAuthor">Debra Luffer-Atlas</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Mitigation of Reactive Metabolites of 2-Aminoimidazole-Containing Microsomal Prostaglandin E Synthase-1 Inhibitors Terminated Due to Clinical Drug-Induced Liver Injury. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 2041-2051. <a href="https://doi.org/10.1021/acs.jmedchem.7b01806" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01806</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01806%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252BMitigation%252Bof%252BReactive%252BMetabolites%252Bof%252B2-Aminoimidazole-Containing%252BMicrosomal%252BProstaglandin%252BE%252BSynthase-1%252BInhibitors%252BTerminated%252BDue%252Bto%252BClinical%252BDrug-Induced%252BLiver%252BInjury%26aulast%3DNorman%26aufirst%3DBryan%2BH.%26date%3D2018%26date%3D2018%26date%3D2017%26volume%3D61%26issue%3D5%26spage%3D2041%26epage%3D2051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuo  Zhou</span>, <span class="hlFld-ContribAuthor ">Fang  Zheng</span>, <span class="hlFld-ContribAuthor ">Chang-Guo  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical data mining reveals analgesic effects of lapatinib in cancer patients. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-82318-w" title="DOI URL">https://doi.org/10.1038/s41598-021-82318-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-82318-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-82318-w%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DClinical%252Bdata%252Bmining%252Breveals%252Banalgesic%252Beffects%252Bof%252Blapatinib%252Bin%252Bcancer%252Bpatients%26aulast%3DZhou%26aufirst%3DShuo%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marianna  Potenza</span>, <span class="hlFld-ContribAuthor ">Martina  Sciarretta</span>, <span class="hlFld-ContribAuthor ">Maria Giovanna  Chini</span>, <span class="hlFld-ContribAuthor ">Anella  Saviano</span>, <span class="hlFld-ContribAuthor ">Francesco  Maione</span>, <span class="hlFld-ContribAuthor ">Maria Valeria  D'Auria</span>, <span class="hlFld-ContribAuthor ">Simona  De Marino</span>, <span class="hlFld-ContribAuthor ">Assunta  Giordano</span>, <span class="hlFld-ContribAuthor ">Robert Klaus  Hofstetter</span>, <span class="hlFld-ContribAuthor ">Carmen  Festa</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Bifulco</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based screening for the discovery of 1,2,4-oxadiazoles as promising hits for the development of new anti-inflammatory agents interfering with eicosanoid biosynthesis pathways. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113693. <a href="https://doi.org/10.1016/j.ejmech.2021.113693" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113693</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113693%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bscreening%252Bfor%252Bthe%252Bdiscovery%252Bof%252B1%25252C2%25252C4-oxadiazoles%252Bas%252Bpromising%252Bhits%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bnew%252Banti-inflammatory%252Bagents%252Binterfering%252Bwith%252Beicosanoid%252Bbiosynthesis%252Bpathways%26aulast%3DPotenza%26aufirst%3DMarianna%26date%3D2021%26volume%3D224%26spage%3D113693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan‐Ying  Zhu</span>, <span class="hlFld-ContribAuthor ">Hui‐Bei  Xu</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi  Luo</span>, <span class="hlFld-ContribAuthor ">Lin  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Ru(II)‐Catalyzed Difluoromethylations of 7‐Azaindoles: Access to Novel Fluoro‐7‐Azaindole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>10 </em>
                                    (6)
                                     , 1410-1413. <a href="https://doi.org/10.1002/ajoc.202100159" title="DOI URL">https://doi.org/10.1002/ajoc.202100159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202100159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202100159%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRu%252528II%252529%2525E2%252580%252590Catalyzed%252BDifluoromethylations%252Bof%252B7%2525E2%252580%252590Azaindoles%25253A%252BAccess%252Bto%252BNovel%252BFluoro%2525E2%252580%2525907%2525E2%252580%252590Azaindole%252BDerivatives%26aulast%3DZhu%26aufirst%3DYan%25E2%2580%2590Ying%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D6%26spage%3D1410%26epage%3D1413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simone  Di Micco</span>, <span class="hlFld-ContribAuthor ">Stefania  Terracciano</span>, <span class="hlFld-ContribAuthor ">Dafne  Ruggiero</span>, <span class="hlFld-ContribAuthor ">Marianna  Potenza</span>, <span class="hlFld-ContribAuthor ">Maria C.  Vaccaro</span>, <span class="hlFld-ContribAuthor ">Katrin  Fischer</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Ines  Bruno</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Bifulco</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fchem.2021.676631" title="DOI URL">https://doi.org/10.3389/fchem.2021.676631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2021.676631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2021.676631%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DIdentification%252Bof%252B2-%252528thiophen-2-yl%252529acetic%252BAcid-Based%252BLead%252BCompound%252Bfor%252BmPGES-1%252BInhibition%26aulast%3DDi%2BMicco%26aufirst%3DSimone%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liudmila L.  Mazaleuskaya</span>, <span class="hlFld-ContribAuthor ">Emanuela  Ricciotti</span>. </span><span class="cited-content_cbyCitation_article-title">Eicosanoid Pathway Modulators: Prostaglandins, Prostacyclin, and Thromboxane. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-54. <a href="https://doi.org/10.1002/0471266949.bmc284" title="DOI URL">https://doi.org/10.1002/0471266949.bmc284</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc284%26sid%3Dliteratum%253Aachs%26atitle%3DEicosanoid%252BPathway%252BModulators%25253A%252BProstaglandins%25252C%252BProstacyclin%25252C%252Band%252BThromboxane%26aulast%3DMazaleuskaya%26aufirst%3DLiudmila%2BL.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D54%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph D.  Ho</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Charles T.  Rauch</span>, <span class="hlFld-ContribAuthor ">Kristen  Aznavour</span>, <span class="hlFld-ContribAuthor ">Jonathan S.  Park</span>, <span class="hlFld-ContribAuthor ">John G.  Luz</span>, <span class="hlFld-ContribAuthor ">Stephen  Antonysamy</span>, <span class="hlFld-ContribAuthor ">Bradley  Condon</span>, <span class="hlFld-ContribAuthor ">Milan  Maletic</span>, <span class="hlFld-ContribAuthor ">Aiping  Zhang</span>, <span class="hlFld-ContribAuthor ">Michael J.  Hickey</span>, <span class="hlFld-ContribAuthor ">Norman E.  Hughes</span>, <span class="hlFld-ContribAuthor ">Srinivasan  Chandrasekhar</span>, <span class="hlFld-ContribAuthor ">Ashley V.  Sloan</span>, <span class="hlFld-ContribAuthor ">Karen  Gooding</span>, <span class="hlFld-ContribAuthor ">Anita  Harvey</span>, <span class="hlFld-ContribAuthor ">Xiao-Peng  Yu</span>, <span class="hlFld-ContribAuthor ">Steven D.  Kahl</span>, <span class="hlFld-ContribAuthor ">Bryan H.  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP). </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - General Subjects</span><span> <strong>2021,</strong> <em>1865 </em>
                                    (2)
                                     , 129800. <a href="https://doi.org/10.1016/j.bbagen.2020.129800" title="DOI URL">https://doi.org/10.1016/j.bbagen.2020.129800</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbagen.2020.129800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbagen.2020.129800%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520General%2520Subjects%26atitle%3DStructure-based%25252C%252Bmulti-targeted%252Bdrug%252Bdiscovery%252Bapproach%252Bto%252Beicosanoid%252Binhibition%25253A%252BDual%252Binhibitors%252Bof%252BmPGES-1%252Band%252B5-lipoxygenase%252Bactivating%252Bprotein%252B%252528FLAP%252529%26aulast%3DHo%26aufirst%3DJoseph%2BD.%26date%3D2021%26volume%3D1865%26issue%3D2%26spage%3D129800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zsófia  Makra</span>, <span class="hlFld-ContribAuthor ">Attila  Bényei</span>, <span class="hlFld-ContribAuthor ">László G.  Puskás</span>, <span class="hlFld-ContribAuthor ">Iván  Kanizsai</span>. </span><span class="cited-content_cbyCitation_article-title">One‐Pot Access towards 4,5‐Disubstituted 2‐Amino‐1
              H
              ‐imidazoles Starting from Mannich Substrates and their Transformation Utilities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (46)
                                     , 7184-7196. <a href="https://doi.org/10.1002/ejoc.202001253" title="DOI URL">https://doi.org/10.1002/ejoc.202001253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202001253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202001253%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOne%2525E2%252580%252590Pot%252BAccess%252Btowards%252B4%25252C5%2525E2%252580%252590Disubstituted%252B2%2525E2%252580%252590Amino%2525E2%252580%2525901%252BH%252B%2525E2%252580%252590imidazoles%252BStarting%252Bfrom%252BMannich%252BSubstrates%252Band%252Btheir%252BTransformation%252BUtilities%26aulast%3DMakra%26aufirst%3DZs%25C3%25B3fia%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D46%26spage%3D7184%26epage%3D7196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuo  Zhou</span>, <span class="hlFld-ContribAuthor ">Ziyuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Kai  Ding</span>, <span class="hlFld-ContribAuthor ">Yaxia  Yuan</span>, <span class="hlFld-ContribAuthor ">Charles  Loftin</span>, <span class="hlFld-ContribAuthor ">Fang  Zheng</span>, <span class="hlFld-ContribAuthor ">Chang-Guo  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">DREAM-in-CDM Approach and Identification of a New Generation of Anti-inflammatory Drugs Targeting mPGES-1. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-67283-0" title="DOI URL">https://doi.org/10.1038/s41598-020-67283-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-67283-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-67283-0%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDREAM-in-CDM%252BApproach%252Band%252BIdentification%252Bof%252Ba%252BNew%252BGeneration%252Bof%252BAnti-inflammatory%252BDrugs%252BTargeting%252BmPGES-1%26aulast%3DZhou%26aufirst%3DShuo%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Afsaneh  Zonouzi</span>, <span class="hlFld-ContribAuthor ">Ali  Kakeshpour</span>, <span class="hlFld-ContribAuthor ">Parviz Rashidi  Ranjbar</span>, <span class="hlFld-ContribAuthor ">Ashraf  Moradi</span>. </span><span class="cited-content_cbyCitation_article-title">Computational studies on the conformational preference of
              N
              ‐(Thiazol‐2‐yl) benzamide. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Chinese Chemical Society</span><span> <strong>2020,</strong> <em>67 </em>
                                    (10)
                                     , 1800-1806. <a href="https://doi.org/10.1002/jccs.201900277" title="DOI URL">https://doi.org/10.1002/jccs.201900277</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jccs.201900277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjccs.201900277%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Chinese%2520Chemical%2520Society%26atitle%3DComputational%252Bstudies%252Bon%252Bthe%252Bconformational%252Bpreference%252Bof%252BN%252B%2525E2%252580%252590%252528Thiazol%2525E2%252580%2525902%2525E2%252580%252590yl%252529%252Bbenzamide%26aulast%3DZonouzi%26aufirst%3DAfsaneh%26date%3D2020%26date%3D2020%26volume%3D67%26issue%3D10%26spage%3D1800%26epage%3D1806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nazahiyah A.  Rodzli</span>, <span class="hlFld-ContribAuthor ">Michael P.  Lockhart-Cairns</span>, <span class="hlFld-ContribAuthor ">Colin W.  Levy</span>, <span class="hlFld-ContribAuthor ">John  Chipperfield</span>, <span class="hlFld-ContribAuthor ">Louise  Bird</span>, <span class="hlFld-ContribAuthor ">Clair  Baldock</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Prince</span>. </span><span class="cited-content_cbyCitation_article-title">The Dual PDZ Domain from Postsynaptic Density Protein 95 Forms a Scaffold with Peptide Ligand. </span><span class="cited-content_cbyCitation_journal-name">Biophysical Journal</span><span> <strong>2020,</strong> <em>119 </em>
                                    (3)
                                     , 667-689. <a href="https://doi.org/10.1016/j.bpj.2020.06.018" title="DOI URL">https://doi.org/10.1016/j.bpj.2020.06.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bpj.2020.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bpj.2020.06.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBiophysical%2520Journal%26atitle%3DThe%252BDual%252BPDZ%252BDomain%252Bfrom%252BPostsynaptic%252BDensity%252BProtein%252B95%252BForms%252Ba%252BScaffold%252Bwith%252BPeptide%252BLigand%26aulast%3DRodzli%26aufirst%3DNazahiyah%2BA.%26date%3D2020%26volume%3D119%26issue%3D3%26spage%3D667%26epage%3D689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Filip  Bergqvist</span>, <span class="hlFld-ContribAuthor ">Ralf  Morgenstern</span>, <span class="hlFld-ContribAuthor ">Per-Johan  Jakobsson</span>. </span><span class="cited-content_cbyCitation_article-title">A review on mPGES-1 inhibitors: From preclinical studies to clinical applications. </span><span class="cited-content_cbyCitation_journal-name">Prostaglandins & Other Lipid Mediators</span><span> <strong>2020,</strong> <em>147 </em>, 106383. <a href="https://doi.org/10.1016/j.prostaglandins.2019.106383" title="DOI URL">https://doi.org/10.1016/j.prostaglandins.2019.106383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.prostaglandins.2019.106383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.prostaglandins.2019.106383%26sid%3Dliteratum%253Aachs%26jtitle%3DProstaglandins%2520%2526%2520Other%2520Lipid%2520Mediators%26atitle%3DA%252Breview%252Bon%252BmPGES-1%252Binhibitors%25253A%252BFrom%252Bpreclinical%252Bstudies%252Bto%252Bclinical%252Bapplications%26aulast%3DBergqvist%26aufirst%3DFilip%26date%3D2020%26volume%3D147%26spage%3D106383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianluigi  Lauro</span>, <span class="hlFld-ContribAuthor ">Stefania  Terracciano</span>, <span class="hlFld-ContribAuthor ">Vincenza  Cantone</span>, <span class="hlFld-ContribAuthor ">Dafne  Ruggiero</span>, <span class="hlFld-ContribAuthor ">Katrin  Fischer</span>, <span class="hlFld-ContribAuthor ">Simona  Pace</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Ines  Bruno</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Bifulco</span>. </span><span class="cited-content_cbyCitation_article-title">A Combinatorial Virtual Screening Approach Driving the Synthesis of 2,4‐Thiazolidinedione‐Based Molecules as New Dual mPGES‐1/5‐LO Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (6)
                                     , 481-489. <a href="https://doi.org/10.1002/cmdc.201900694" title="DOI URL">https://doi.org/10.1002/cmdc.201900694</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900694%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DA%252BCombinatorial%252BVirtual%252BScreening%252BApproach%252BDriving%252Bthe%252BSynthesis%252Bof%252B2%25252C4%2525E2%252580%252590Thiazolidinedione%2525E2%252580%252590Based%252BMolecules%252Bas%252BNew%252BDual%252BmPGES%2525E2%252580%2525901%25252F5%2525E2%252580%252590LO%252BInhibitors%26aulast%3DLauro%26aufirst%3DGianluigi%26date%3D2020%26volume%3D15%26issue%3D6%26spage%3D481%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liudmila L.  Mazaleuskaya</span>, <span class="hlFld-ContribAuthor ">Emanuela  Ricciotti</span>. </span><span class="cited-content_cbyCitation_article-title">Druggable Prostanoid Pathway. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 29-54. <a href="https://doi.org/10.1007/978-3-030-50621-6_3" title="DOI URL">https://doi.org/10.1007/978-3-030-50621-6_3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-50621-6_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-50621-6_3%26sid%3Dliteratum%253Aachs%26atitle%3DDruggable%252BProstanoid%252BPathway%26aulast%3DMazaleuskaya%26aufirst%3DLiudmila%2BL.%26date%3D2020%26date%3D2020%26spage%3D29%26epage%3D54%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DDruggable%252BLipid%252BSignaling%252BPathways%26aulast%3DKihara%26aufirst%3DYasuyuki%26date%3D2020%26volume%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcus  Koppitz</span>, <span class="hlFld-ContribAuthor ">Nico  Bräuer</span>, <span class="hlFld-ContribAuthor ">Antonius  Ter Laak</span>, <span class="hlFld-ContribAuthor ">Horst  Irlbacher</span>, <span class="hlFld-ContribAuthor ">Andrea  Rotgeri</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Coelho</span>, <span class="hlFld-ContribAuthor ">Daryl  Walter</span>, <span class="hlFld-ContribAuthor ">Andreas  Steinmeyer</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Zollner</span>, <span class="hlFld-ContribAuthor ">Michaele  Peters</span>, <span class="hlFld-ContribAuthor ">Jens  Nagel</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of pyridyl-cycloalkyl-carboxylic acids as inhibitors of microsomal prostaglandin E synthase-1 for the treatment of endometriosis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (18)
                                     , 2700-2705. <a href="https://doi.org/10.1016/j.bmcl.2019.07.007" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252Bpyridyl-cycloalkyl-carboxylic%252Bacids%252Bas%252Binhibitors%252Bof%252Bmicrosomal%252Bprostaglandin%252BE%252Bsynthase-1%252Bfor%252Bthe%252Btreatment%252Bof%252Bendometriosis%26aulast%3DKoppitz%26aufirst%3DMarcus%26date%3D2019%26volume%3D29%26issue%3D18%26spage%3D2700%26epage%3D2705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianluigi  Lauro</span>, <span class="hlFld-ContribAuthor ">Vincenza  Cantone</span>, <span class="hlFld-ContribAuthor ">Marianna  Potenza</span>, <span class="hlFld-ContribAuthor ">Katrin  Fischer</span>, <span class="hlFld-ContribAuthor ">Andreas  Koeberle</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Raffaele  Riccio</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Bifulco</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-hydroxy-3-pyrrolin-2-one-based mPGES-1 inhibitors using a multi-step virtual screening protocol. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (12)
                                     , 2028-2036. <a href="https://doi.org/10.1039/C8MD00497H" title="DOI URL">https://doi.org/10.1039/C8MD00497H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00497H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00497H%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252B3-hydroxy-3-pyrrolin-2-one-based%252BmPGES-1%252Binhibitors%252Busing%252Ba%252Bmulti-step%252Bvirtual%252Bscreening%252Bprotocol%26aulast%3DLauro%26aufirst%3DGianluigi%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D12%26spage%3D2028%26epage%3D2036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Ding</span>, <span class="hlFld-ContribAuthor ">Ziyuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Shurong  Hou</span>, <span class="hlFld-ContribAuthor ">Yaxia  Yuan</span>, <span class="hlFld-ContribAuthor ">Shuo  Zhou</span>, <span class="hlFld-ContribAuthor ">Xirong  Zheng</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Chen</span>, <span class="hlFld-ContribAuthor ">Charles  Loftin</span>, <span class="hlFld-ContribAuthor ">Fang  Zheng</span>, <span class="hlFld-ContribAuthor ">Chang-Guo  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based discovery of mPGES-1 inhibitors suitable for preclinical testing in wild-type mice as a new generation of anti-inflammatory drugs. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-23482-4" title="DOI URL">https://doi.org/10.1038/s41598-018-23482-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-23482-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-23482-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DStructure-based%252Bdiscovery%252Bof%252BmPGES-1%252Binhibitors%252Bsuitable%252Bfor%252Bpreclinical%252Btesting%252Bin%252Bwild-type%252Bmice%252Bas%252Ba%252Bnew%252Bgeneration%252Bof%252Banti-inflammatory%252Bdrugs%26aulast%3DDing%26aufirst%3DKai%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagarajan  Muthukaman</span>, <span class="hlFld-ContribAuthor ">Sanjay  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Macchindra  Tambe</span>, <span class="hlFld-ContribAuthor ">Dnyandeo  Pisal</span>, <span class="hlFld-ContribAuthor ">Shital  Tondlekar</span>, <span class="hlFld-ContribAuthor ">Mahamadhanif  Shaikh</span>, <span class="hlFld-ContribAuthor ">Neelam  Sarode</span>, <span class="hlFld-ContribAuthor ">Vidya G.  Kattige</span>, <span class="hlFld-ContribAuthor ">Pooja  Sawant</span>, <span class="hlFld-ContribAuthor ">Monali  Pisat</span>, <span class="hlFld-ContribAuthor ">Vikas  Karande</span>, <span class="hlFld-ContribAuthor ">Srinivasa  Honnegowda</span>, <span class="hlFld-ContribAuthor ">Abhay  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Dayanidhi  Behera</span>, <span class="hlFld-ContribAuthor ">Satyawan B.  Jadhav</span>, <span class="hlFld-ContribAuthor ">Ramchandra R.  Sangana</span>, <span class="hlFld-ContribAuthor ">Girish S.  Gudi</span>, <span class="hlFld-ContribAuthor ">Neelima  Khairatkar-Joshi</span>, <span class="hlFld-ContribAuthor ">Laxmikant A.  Gharat</span>. </span><span class="cited-content_cbyCitation_article-title">Alleviating CYP and hERG liabilities by structure optimization of dihydrofuran-fused tricyclic benzo[ d ]imidazole series – Potent, selective and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (7)
                                     , 1211-1218. <a href="https://doi.org/10.1016/j.bmcl.2018.02.048" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.02.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.02.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.02.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAlleviating%252BCYP%252Band%252BhERG%252Bliabilities%252Bby%252Bstructure%252Boptimization%252Bof%252Bdihydrofuran-fused%252Btricyclic%252Bbenzo%25255B%252Bd%252B%25255Dimidazole%252Bseries%252B%2525E2%252580%252593%252BPotent%25252C%252Bselective%252Band%252Borally%252Befficacious%252Bmicrosomal%252Bprostaglandin%252BE%252Bsynthase-1%252B%252528mPGES-1%252529%252Binhibitors%25253A%252BPart-2%26aulast%3DMuthukaman%26aufirst%3DNagarajan%26date%3D2018%26volume%3D28%26issue%3D7%26spage%3D1211%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simone  Di Micco</span>, <span class="hlFld-ContribAuthor ">Stefania  Terracciano</span>, <span class="hlFld-ContribAuthor ">Vincenza  Cantone</span>, <span class="hlFld-ContribAuthor ">Katrin  Fischer</span>, <span class="hlFld-ContribAuthor ">Andreas  Koeberle</span>, <span class="hlFld-ContribAuthor ">Antonio  Foglia</span>, <span class="hlFld-ContribAuthor ">Raffaele  Riccio</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Ines  Bruno</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Bifulco</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new potent molecular entities able to inhibit mPGES-1. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 1419-1427. <a href="https://doi.org/10.1016/j.ejmech.2017.10.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.10.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.10.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnew%252Bpotent%252Bmolecular%252Bentities%252Bable%252Bto%252Binhibit%252BmPGES-1%26aulast%3DDi%2BMicco%26aufirst%3DSimone%26date%3D2018%26volume%3D143%26spage%3D1419%26epage%3D1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagarajan  Muthukaman</span>, <span class="hlFld-ContribAuthor ">Macchindra  Tambe</span>, <span class="hlFld-ContribAuthor ">Sanjay  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Dnyandeo  Pisal</span>, <span class="hlFld-ContribAuthor ">Shital  Tondlekar</span>, <span class="hlFld-ContribAuthor ">Mahamadhanif  Shaikh</span>, <span class="hlFld-ContribAuthor ">Neelam  Sarode</span>, <span class="hlFld-ContribAuthor ">Vidya G.  Kattige</span>, <span class="hlFld-ContribAuthor ">Monali  Pisat</span>, <span class="hlFld-ContribAuthor ">Pooja  Sawant</span>, <span class="hlFld-ContribAuthor ">Srinivasa  Honnegowda</span>, <span class="hlFld-ContribAuthor ">Vikas  Karande</span>, <span class="hlFld-ContribAuthor ">Abhay  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Dayanidhi  Behera</span>, <span class="hlFld-ContribAuthor ">Satyawan B.  Jadhav</span>, <span class="hlFld-ContribAuthor ">Ramchandra R.  Sangana</span>, <span class="hlFld-ContribAuthor ">Girish S.  Gudi</span>, <span class="hlFld-ContribAuthor ">Neelima  Khairatkar-Joshi</span>, <span class="hlFld-ContribAuthor ">Laxmikant A.  Gharat</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of furan and dihydrofuran-fused tricyclic benzo[ d ]imidazole derivatives as potent and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (23)
                                     , 5131-5138. <a href="https://doi.org/10.1016/j.bmcl.2017.10.062" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.10.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.10.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.10.062%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bfuran%252Band%252Bdihydrofuran-fused%252Btricyclic%252Bbenzo%25255B%252Bd%252B%25255Dimidazole%252Bderivatives%252Bas%252Bpotent%252Band%252Borally%252Befficacious%252Bmicrosomal%252Bprostaglandin%252BE%252Bsynthase-1%252B%252528mPGES-1%252529%252Binhibitors%25253A%252BPart-1%26aulast%3DMuthukaman%26aufirst%3DNagarajan%26date%3D2017%26volume%3D27%26issue%3D23%26spage%3D5131%26epage%3D5138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anastasia  Psarra</span>, <span class="hlFld-ContribAuthor ">Aikaterini  Nikolaou</span>, <span class="hlFld-ContribAuthor ">Maroula G  Kokotou</span>, <span class="hlFld-ContribAuthor ">Dimitris  Limnios</span>, <span class="hlFld-ContribAuthor ">George  Kokotos</span>. </span><span class="cited-content_cbyCitation_article-title">Microsomal prostaglandin E
              2
              synthase-1 inhibitors: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (9)
                                     , 1047-1059. <a href="https://doi.org/10.1080/13543776.2017.1344218" title="DOI URL">https://doi.org/10.1080/13543776.2017.1344218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1344218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1344218%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DMicrosomal%252Bprostaglandin%252BE%252B2%252Bsynthase-1%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%26aulast%3DPsarra%26aufirst%3DAnastasia%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D9%26spage%3D1047%26epage%3D1059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhonghua  Xia</span>, <span class="hlFld-ContribAuthor ">Aixia  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2017,</strong> <em>21 </em>
                                    (3)
                                     , 661-675. <a href="https://doi.org/10.1007/s11030-017-9743-x" title="DOI URL">https://doi.org/10.1007/s11030-017-9743-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-017-9743-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-017-9743-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DComputational%252Bmodels%252Bfor%252Bthe%252Bclassification%252Bof%252BmPGES-1%252Binhibitors%252Bwith%252Bfingerprint%252Bdescriptors%26aulast%3DXia%26aufirst%3DZhonghua%26date%3D2017%26date%3D2017%26volume%3D21%26issue%3D3%26spage%3D661%26epage%3D675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ziyuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Yaxia  Yuan</span>, <span class="hlFld-ContribAuthor ">Shuo  Zhou</span>, <span class="hlFld-ContribAuthor ">Kai  Ding</span>, <span class="hlFld-ContribAuthor ">Fang  Zheng</span>, <span class="hlFld-ContribAuthor ">Chang-Guo  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Selective inhibitors of human mPGES-1 from structure-based computational screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (16)
                                     , 3739-3743. <a href="https://doi.org/10.1016/j.bmcl.2017.06.075" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.06.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.06.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.06.075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSelective%252Binhibitors%252Bof%252Bhuman%252BmPGES-1%252Bfrom%252Bstructure-based%252Bcomputational%252Bscreening%26aulast%3DZhou%26aufirst%3DZiyuan%26date%3D2017%26volume%3D27%26issue%3D16%26spage%3D3739%26epage%3D3743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victor I.  Saloutin</span>, <span class="hlFld-ContribAuthor ">Yulia S.  Kudyakova</span>, <span class="hlFld-ContribAuthor ">Marina V.  Goryaeva</span>, <span class="hlFld-ContribAuthor ">Yanina V.  Burgart</span>, <span class="hlFld-ContribAuthor ">Oleg N.  Chupakhin</span>. </span><span class="cited-content_cbyCitation_article-title">Polyfluoroalkylated 2-ethoxymethylene- 3-oxo esters: synthesis and chemical properties overview. </span><span class="cited-content_cbyCitation_journal-name">Pure and Applied Chemistry</span><span> <strong>2017,</strong> <em>89 </em>
                                    (8)
                                     , 1209-1222. <a href="https://doi.org/10.1515/pac-2016-1015" title="DOI URL">https://doi.org/10.1515/pac-2016-1015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/pac-2016-1015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fpac-2016-1015%26sid%3Dliteratum%253Aachs%26jtitle%3DPure%2520and%2520Applied%2520Chemistry%26atitle%3DPolyfluoroalkylated%252B2-ethoxymethylene-%252B3-oxo%252Besters%25253A%252Bsynthesis%252Band%252Bchemical%252Bproperties%252Boverview%26aulast%3DSaloutin%26aufirst%3DVictor%2BI.%26date%3D2017%26volume%3D89%26issue%3D8%26spage%3D1209%26epage%3D1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catarina  Pereira-Leite</span>, <span class="hlFld-ContribAuthor ">Cláudia  Nunes</span>, <span class="hlFld-ContribAuthor ">Sarah K.  Jamal</span>, <span class="hlFld-ContribAuthor ">Iolanda M.  Cuccovia</span>, <span class="hlFld-ContribAuthor ">Salette  Reis</span>. </span><span class="cited-content_cbyCitation_article-title">Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2017,</strong> <em>37 </em>
                                    (4)
                                     , 802-859. <a href="https://doi.org/10.1002/med.21424" title="DOI URL">https://doi.org/10.1002/med.21424</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21424%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DNonsteroidal%252BAnti-Inflammatory%252BTherapy%25253A%252BA%252BJourney%252BToward%252BSafety%26aulast%3DPereira-Leite%26aufirst%3DCatarina%26date%3D2017%26date%3D2016%26volume%3D37%26issue%3D4%26spage%3D802%26epage%3D859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagarajan  Muthukaman</span>, <span class="hlFld-ContribAuthor ">Macchindra  Tambe</span>, <span class="hlFld-ContribAuthor ">Mahamadhanif  Shaikh</span>, <span class="hlFld-ContribAuthor ">Dnyandeo  Pisal</span>, <span class="hlFld-ContribAuthor ">Sanjay  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Shital  Tondlekar</span>, <span class="hlFld-ContribAuthor ">Neelam  Sarode</span>, <span class="hlFld-ContribAuthor ">Lakshminarayana  Narayana</span>, <span class="hlFld-ContribAuthor ">Jitendra M.  Gajera</span>, <span class="hlFld-ContribAuthor ">Vidya G.  Kattige</span>, <span class="hlFld-ContribAuthor ">Srinivasa  Honnegowda</span>, <span class="hlFld-ContribAuthor ">Vikas  Karande</span>, <span class="hlFld-ContribAuthor ">Abhay  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Dayanidhi  Behera</span>, <span class="hlFld-ContribAuthor ">Satyawan B.  Jadhav</span>, <span class="hlFld-ContribAuthor ">Girish S.  Gudi</span>, <span class="hlFld-ContribAuthor ">Neelima  Khairatkar-Joshi</span>, <span class="hlFld-ContribAuthor ">Laxmikant A.  Gharat</span>. </span><span class="cited-content_cbyCitation_article-title">Tricyclic 4,4-dimethyl-3,4-dihydrochromeno[3,4- d ]imidazole derivatives as microsomal prostaglandin E 2 synthase-1 (mPGES-1) inhibitors: SAR and in vivo efficacy in hyperalgesia pain model. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 2594-2601. <a href="https://doi.org/10.1016/j.bmcl.2017.03.068" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.068%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTricyclic%252B4%25252C4-dimethyl-3%25252C4-dihydrochromeno%25255B3%25252C4-%252Bd%252B%25255Dimidazole%252Bderivatives%252Bas%252Bmicrosomal%252Bprostaglandin%252BE%252B2%252Bsynthase-1%252B%252528mPGES-1%252529%252Binhibitors%25253A%252BSAR%252Band%252Bin%252Bvivo%252Befficacy%252Bin%252Bhyperalgesia%252Bpain%252Bmodel%26aulast%3DMuthukaman%26aufirst%3DNagarajan%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D2594%26epage%3D2601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhong-Yuan  Li</span>, <span class="hlFld-ContribAuthor ">Liang  Li</span>, <span class="hlFld-ContribAuthor ">Qi-Li  Li</span>, <span class="hlFld-ContribAuthor ">Kun  Jing</span>, <span class="hlFld-ContribAuthor ">Hui  Xu</span>, <span class="hlFld-ContribAuthor ">Guan-Wu  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium-Catalyzed
              meta
              -Selective C−H Mono- and Difluoromethylation of Arenes through
              ortho
              -Metalation Strategy. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2017,</strong> <em>23 </em>
                                    (14)
                                     , 3285-3290. <a href="https://doi.org/10.1002/chem.201700354" title="DOI URL">https://doi.org/10.1002/chem.201700354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201700354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201700354%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DRuthenium-Catalyzed%252Bmeta%252B-Selective%252BC%2525E2%252588%252592H%252BMono-%252Band%252BDifluoromethylation%252Bof%252BArenes%252Bthrough%252Bortho%252B-Metalation%252BStrategy%26aulast%3DLi%26aufirst%3DZhong-Yuan%26date%3D2017%26date%3D2017%26volume%3D23%26issue%3D14%26spage%3D3285%26epage%3D3290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katherine M.  Partridge</span>, <span class="hlFld-ContribAuthor ">Stephen  Antonysamy</span>, <span class="hlFld-ContribAuthor ">Shobha N.  Bhattachar</span>, <span class="hlFld-ContribAuthor ">Srinivasan  Chandrasekhar</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Fisher</span>, <span class="hlFld-ContribAuthor ">Adrian  Fretland</span>, <span class="hlFld-ContribAuthor ">Karen  Gooding</span>, <span class="hlFld-ContribAuthor ">Anita  Harvey</span>, <span class="hlFld-ContribAuthor ">Norman E.  Hughes</span>, <span class="hlFld-ContribAuthor ">Steven L.  Kuklish</span>, <span class="hlFld-ContribAuthor ">John G.  Luz</span>, <span class="hlFld-ContribAuthor ">Peter R.  Manninen</span>, <span class="hlFld-ContribAuthor ">James E.  McGee</span>, <span class="hlFld-ContribAuthor ">Daniel R.  Mudra</span>, <span class="hlFld-ContribAuthor ">Antonio  Navarro</span>, <span class="hlFld-ContribAuthor ">Bryan H.  Norman</span>, <span class="hlFld-ContribAuthor ">Steven J.  Quimby</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Schiffler</span>, <span class="hlFld-ContribAuthor ">Ashley V.  Sloan</span>, <span class="hlFld-ContribAuthor ">Alan M.  Warshawsky</span>, <span class="hlFld-ContribAuthor ">Jennifer M.  Weller</span>, <span class="hlFld-ContribAuthor ">Jeremy S.  York</span>, <span class="hlFld-ContribAuthor ">Xiao-Peng  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (6)
                                     , 1478-1483. <a href="https://doi.org/10.1016/j.bmcl.2016.11.011" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.11.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.11.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Bcharacterization%252Bof%252B%25255B%252528cyclopentyl%252529ethyl%25255Dbenzoic%252Bacid%252Binhibitors%252Bof%252Bmicrosomal%252Bprostaglandin%252BE%252Bsynthase-1%26aulast%3DPartridge%26aufirst%3DKatherine%2BM.%26date%3D2017%26volume%3D27%26issue%3D6%26spage%3D1478%26epage%3D1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yulia S.  Kudyakova</span>, <span class="hlFld-ContribAuthor ">Denis N.  Bazhin</span>, <span class="hlFld-ContribAuthor ">Pavel A.  Slepukhin</span>, <span class="hlFld-ContribAuthor ">Yanina V.  Burgart</span>, <span class="hlFld-ContribAuthor ">Victor I.  Saloutin</span>, <span class="hlFld-ContribAuthor ">Valery N.  Charushin</span>. </span><span class="cited-content_cbyCitation_article-title">Unexpected formation of diethyl 2-ethoxy-6-CF 3 -2 H -pyran-3,5-dicarboxylate from the condensation of ethyl 4,4,4-trifluoroacetoacetate with CH(OEt) 3. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (8)
                                     , 744-747. <a href="https://doi.org/10.1016/j.tetlet.2017.01.026" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.01.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.01.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.01.026%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DUnexpected%252Bformation%252Bof%252Bdiethyl%252B2-ethoxy-6-CF%252B3%252B-2%252BH%252B-pyran-3%25252C5-dicarboxylate%252Bfrom%252Bthe%252Bcondensation%252Bof%252Bethyl%252B4%25252C4%25252C4-trifluoroacetoacetate%252Bwith%252BCH%252528OEt%252529%252B3%26aulast%3DKudyakova%26aufirst%3DYulia%2BS.%26date%3D2017%26volume%3D58%26issue%3D8%26spage%3D744%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianluigi  Lauro</span>, <span class="hlFld-ContribAuthor ">Michele  Manfra</span>, <span class="hlFld-ContribAuthor ">Silvana  Pedatella</span>, <span class="hlFld-ContribAuthor ">Katrin  Fischer</span>, <span class="hlFld-ContribAuthor ">Vincenza  Cantone</span>, <span class="hlFld-ContribAuthor ">Stefania  Terracciano</span>, <span class="hlFld-ContribAuthor ">Alessia  Bertamino</span>, <span class="hlFld-ContribAuthor ">Carmine  Ostacolo</span>, <span class="hlFld-ContribAuthor ">Isabel  Gomez-Monterrey</span>, <span class="hlFld-ContribAuthor ">Mauro  De Nisco</span>, <span class="hlFld-ContribAuthor ">Raffaele  Riccio</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Pietro  Campiglia</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Bifulco</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel microsomal prostaglandin E2 synthase-1 (mPGES-1) lead inhibitors from Fragment Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>125 </em>, 278-287. <a href="https://doi.org/10.1016/j.ejmech.2016.09.042" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.09.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.09.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.09.042%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bnovel%252Bmicrosomal%252Bprostaglandin%252BE2%252Bsynthase-1%252B%252528mPGES-1%252529%252Blead%252Binhibitors%252Bfrom%252BFragment%252BVirtual%252BScreening%26aulast%3DLauro%26aufirst%3DGianluigi%26date%3D2017%26volume%3D125%26spage%3D278%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagarajan  Muthukaman</span>, <span class="hlFld-ContribAuthor ">Sanjay  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Neelam  Sarode</span>, <span class="hlFld-ContribAuthor ">Shital  Tondlekar</span>, <span class="hlFld-ContribAuthor ">Macchindra  Tambe</span>, <span class="hlFld-ContribAuthor ">Dnyandeo  Pisal</span>, <span class="hlFld-ContribAuthor ">Mahamadhanif  Shaikh</span>, <span class="hlFld-ContribAuthor ">Vidya G.  Kattige</span>, <span class="hlFld-ContribAuthor ">Srinivasa  Honnegowda</span>, <span class="hlFld-ContribAuthor ">Vikas  Karande</span>, <span class="hlFld-ContribAuthor ">Abhay  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Satyawan B.  Jadhav</span>, <span class="hlFld-ContribAuthor ">Mahamad Yunnus A.  Mahat</span>, <span class="hlFld-ContribAuthor ">Girish S.  Gudi</span>, <span class="hlFld-ContribAuthor ">Neelima  Khairatkar-Joshi</span>, <span class="hlFld-ContribAuthor ">Laxmikant A.  Gharat</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-((2-chloro-6-fluorophenyl)amino)- N -(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1 H -[1,4]dioxino[2′,3′:3,4]benzo[1,2- d ]imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E 2 synthase-1 (mPGES-1) inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (24)
                                     , 5977-5984. <a href="https://doi.org/10.1016/j.bmcl.2016.10.079" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.10.079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.10.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.10.079%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B2-%252528%2525282-chloro-6-fluorophenyl%252529amino%252529-%252BN%252B-%2525283-fluoro-5-%252528trifluoromethyl%252529phenyl%252529-1-methyl-7%25252C8-dihydro-1%252BH%252B-%25255B1%25252C4%25255Ddioxino%25255B2%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2%25253A3%25252C4%25255Dbenzo%25255B1%25252C2-%252Bd%252B%25255Dimidazole-5-carboxamide%252Bas%252Bpotent%25252C%252Bselective%252Band%252Befficacious%252Bmicrosomal%252Bprostaglandin%252BE%252B2%252Bsynthase-1%252B%252528mPGES-1%252529%252Binhibitor%26aulast%3DMuthukaman%26aufirst%3DNagarajan%26date%3D2016%26volume%3D26%26issue%3D24%26spage%3D5977%26epage%3D5984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eun Beul  Park</span>, <span class="hlFld-ContribAuthor ">Kwang Jong  Kim</span>, <span class="hlFld-ContribAuthor ">Hui Rak  Jeong</span>, <span class="hlFld-ContribAuthor ">Jae Kyun  Lee</span>, <span class="hlFld-ContribAuthor ">Hyoung Ja  Kim</span>, <span class="hlFld-ContribAuthor ">Hwi Ho  Lee</span>, <span class="hlFld-ContribAuthor ">Ji Woong  Lim</span>, <span class="hlFld-ContribAuthor ">Ji-Sun  Shin</span>, <span class="hlFld-ContribAuthor ">Andreas  Koeberle</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Kyung-Tae  Lee</span>, <span class="hlFld-ContribAuthor ">Jae Yeol  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, structure determination, and biological evaluation of phenylsulfonyl hydrazide derivatives as potential anti-inflammatory agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (21)
                                     , 5193-5197. <a href="https://doi.org/10.1016/j.bmcl.2016.09.070" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.09.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.09.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.09.070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%25252C%252Bstructure%252Bdetermination%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bphenylsulfonyl%252Bhydrazide%252Bderivatives%252Bas%252Bpotential%252Banti-inflammatory%252Bagents%26aulast%3DPark%26aufirst%3DEun%2BBeul%26date%3D2016%26volume%3D26%26issue%3D21%26spage%3D5193%26epage%3D5197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven L.  Kuklish</span>, <span class="hlFld-ContribAuthor ">Stephen  Antonysamy</span>, <span class="hlFld-ContribAuthor ">Shobha N.  Bhattachar</span>, <span class="hlFld-ContribAuthor ">Srinivasan  Chandrasekhar</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Fisher</span>, <span class="hlFld-ContribAuthor ">Adrian J.  Fretland</span>, <span class="hlFld-ContribAuthor ">Karen  Gooding</span>, <span class="hlFld-ContribAuthor ">Anita  Harvey</span>, <span class="hlFld-ContribAuthor ">Norman E.  Hughes</span>, <span class="hlFld-ContribAuthor ">John G.  Luz</span>, <span class="hlFld-ContribAuthor ">Peter R.  Manninen</span>, <span class="hlFld-ContribAuthor ">James E.  McGee</span>, <span class="hlFld-ContribAuthor ">Antonio  Navarro</span>, <span class="hlFld-ContribAuthor ">Bryan H.  Norman</span>, <span class="hlFld-ContribAuthor ">Katherine M.  Partridge</span>, <span class="hlFld-ContribAuthor ">Steven J.  Quimby</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Schiffler</span>, <span class="hlFld-ContribAuthor ">Ashley V.  Sloan</span>, <span class="hlFld-ContribAuthor ">Alan M.  Warshawsky</span>, <span class="hlFld-ContribAuthor ">Jeremy S.  York</span>, <span class="hlFld-ContribAuthor ">Xiao-Peng  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (19)
                                     , 4824-4828. <a href="https://doi.org/10.1016/j.bmcl.2016.08.023" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.08.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.08.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCharacterization%252Bof%252B3%25252C3-dimethyl%252Bsubstituted%252BN-aryl%252Bpiperidines%252Bas%252Bpotent%252Bmicrosomal%252Bprostaglandin%252BE%252Bsynthase-1%252Binhibitors%26aulast%3DKuklish%26aufirst%3DSteven%2BL.%26date%3D2016%26volume%3D26%26issue%3D19%26spage%3D4824%26epage%3D4828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianluigi  Lauro</span>, <span class="hlFld-ContribAuthor ">Paolo  Tortorella</span>, <span class="hlFld-ContribAuthor ">Alessia  Bertamino</span>, <span class="hlFld-ContribAuthor ">Carmine  Ostacolo</span>, <span class="hlFld-ContribAuthor ">Andreas  Koeberle</span>, <span class="hlFld-ContribAuthor ">Katrin  Fischer</span>, <span class="hlFld-ContribAuthor ">Ines  Bruno</span>, <span class="hlFld-ContribAuthor ">Stefania  Terracciano</span>, <span class="hlFld-ContribAuthor ">Isabel Maria  Gomez-Monterrey</span>, <span class="hlFld-ContribAuthor ">Marilena  Tauro</span>, <span class="hlFld-ContribAuthor ">Fulvio  Loiodice</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Raffaele  Riccio</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Pietro  Campiglia</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Bifulco</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Microsomal Prostaglandin E
              2
              Synthase-1 (mPGES-1) Inhibitors using a Virtual Fragment Growing Optimization Scheme. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (6)
                                     , 612-619. <a href="https://doi.org/10.1002/cmdc.201500598" title="DOI URL">https://doi.org/10.1002/cmdc.201500598</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500598%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructure-Based%252BDesign%252Bof%252BMicrosomal%252BProstaglandin%2525E2%252580%252585E%252B2%252BSynthase-1%252B%252528mPGES-1%252529%252BInhibitors%252Busing%252Ba%252BVirtual%252BFragment%252BGrowing%252BOptimization%252BScheme%26aulast%3DLauro%26aufirst%3DGianluigi%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D6%26spage%3D612%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Chandrasekhar</span>, <span class="hlFld-ContribAuthor ">A. K.  Harvey</span>, <span class="hlFld-ContribAuthor ">X.-P.  Yu</span>, <span class="hlFld-ContribAuthor ">M. G.  Chambers</span>, <span class="hlFld-ContribAuthor ">J. L.  Oskins</span>, <span class="hlFld-ContribAuthor ">C.  Lin</span>, <span class="hlFld-ContribAuthor ">T. W.  Seng</span>, <span class="hlFld-ContribAuthor ">S. J.  Thibodeaux</span>, <span class="hlFld-ContribAuthor ">B. H.  Norman</span>, <span class="hlFld-ContribAuthor ">N. E.  Hughes</span>, <span class="hlFld-ContribAuthor ">M. A.  Schiffler</span>, <span class="hlFld-ContribAuthor ">M. J.  Fisher</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Characterization of Novel Microsomal Prostaglandin E Synthase-1 Inhibitors for Analgesia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2016,</strong> <em>356 </em>
                                    (3)
                                     , 635-644. <a href="https://doi.org/10.1124/jpet.115.228932" title="DOI URL">https://doi.org/10.1124/jpet.115.228932</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.115.228932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.115.228932%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DIdentification%252Band%252BCharacterization%252Bof%252BNovel%252BMicrosomal%252BProstaglandin%252BE%252BSynthase-1%252BInhibitors%252Bfor%252BAnalgesia%26aulast%3DChandrasekhar%26aufirst%3DS.%26date%3D2016%26date%3D2016%26volume%3D356%26issue%3D3%26spage%3D635%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Prostaglandin synthesis pathway.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Examples of Known <i>m</i>PGES-1 Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Initial Screening Hit</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal structures of <i>m</i>PGES-1 with <b>4</b> (A) and <b>5</b> (B). Ligands, key side chains, and glutathione cofactors are highlighted with thick bonds. Some atoms are omitted for clarity. H-bond distances are given in Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0015.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. PK of <b>8</b> in dog after 2 mg/kg po dosing (solid diamonds, <i>n</i> = 3) and 0.5 mg/kg iv dosing (hollow diamonds, <i>n</i> = 3). Diamonds indicate geometric means, and error bars represent geometric standard deviations of measured values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0016.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Time-dependent exposure profile of <b>8</b> and <b>8·H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub> in a dynamic dissolution test in artificial stomach (A) and artificial duodenum (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0001.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. PK of <b>8</b> (solid diamonds, <i>n</i> = 6) and <b>8·H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub> (hollow diamonds, <i>n</i> = 6) in dog after 60 mg/kg po dosing. Diamonds indicate geometric means, and error bars represent geometric standard deviations of measured values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>8·H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Br<sub>2</sub>, AcOH, 92%; (b) 2-aminopyrimidine, NaHCO<sub>3</sub>, <i>i</i>-PrOH, 80 °C, 22%; (c) NH<sub>2</sub>OH, EtOH, 82 °C, 95%; (d) (EtO)<sub>3</sub>CH, Ac<sub>2</sub>O, 90–100 °C, 86%; (e) (CH<sub>3</sub>)<sub>2</sub>NCH═CHCN, 60–65 °C, then NH<sub>4</sub>OAc, 60–65 °C, 85%; (f) H<sub>2</sub>, Pd/C, Boc<sub>2</sub>O, EtOH, Et<sub>3</sub>N, then HCl, 1,4-dioxane, MTBE, 66%; (g) <i>i</i>-PrCOCl, Et<sub>3</sub>N, toluene, then LiOH(aq), 70%; (h) T3P, NMM, EtOAc, 65–75 °C, 64%; (i) H<sub>3</sub>PO<sub>4</sub>, CH<sub>3</sub>CN, H<sub>2</sub>O, 79%.</p></p></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0002.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray cocrystal structure of mPGES-1 with <b>8</b>. Ligand, key side chains, and glutathione cofactor are highlighted with thick bonds. Some atoms are omitted for clarity. H-bond distances are given in Å.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>t</i>-BuCONHCH<sub>2</sub>OH, H<sub>2</sub>SO<sub>4</sub>, rt, then chromatographic separation, 27% of <b>32</b> and 28% of <b>33</b>; (b) 2-aminoimidazole monosulfate, BOP, Et<sub>3</sub>N, DMF, 60 °C, 87%.</p></p></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0003.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. PK of <b>26</b> in dog (A) after 0.5 mg/kg po dosing (solid diamonds, <i>n</i> = 3) and 0.5 mg/kg iv dosing (hollow diamonds, <i>n</i> = 3) and (B) after 2 mg/kg po dosing (<i>n</i> = 3). Diamonds indicate geometric means, and error bars represent geometric standard deviations of measured values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/medium/jm-2015-01249p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-1/acs.jmedchem.5b01249/20160113/images/large/jm-2015-01249p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01249&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>t</i>-BuCOCl, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (b) LiOH, H<sub>2</sub>O, 1,4-dioxane, rt, 1 h, then HCl<sub>(aq)</sub>, 97% (2 steps); (c) 2-aminoimidazole monosulfate, TBTU, DIEA, DMF, 80 °C, 18 h, 83%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Stone, E.</span><span> </span><span class="NLM_article-title">An Account of the Success of the Bark of the Willow in the Cure of Agues</span> <span class="citation_source-journal">Philos. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1763</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">200</span><span class="refDoi"> DOI: 10.1098/rstl.1763.0033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1098%2Frstl.1763.0033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1763&pages=195-200&author=E.+Stone&title=An+Account+of+the+Success+of+the+Bark+of+the+Willow+in+the+Cure+of+Agues&doi=10.1098%2Frstl.1763.0033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1098%2Frstl.1763.0033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstl.1763.0033%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DE.%26atitle%3DAn%2520Account%2520of%2520the%2520Success%2520of%2520the%2520Bark%2520of%2520the%2520Willow%2520in%2520the%2520Cure%2520of%2520Agues%26jtitle%3DPhilos.%2520Trans.%26date%3D1763%26volume%3D53%26spage%3D195%26epage%3D200%26doi%3D10.1098%2Frstl.1763.0033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Norn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Permin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, E.</span><span> </span><span class="NLM_article-title">From willow bark to acetylsalicylic acid</span> <span class="citation_source-journal">Dansk Medicinhistorisk Årbog</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=79-98&author=S.+Nornauthor=H.+Perminauthor=P.+R.+Kruseauthor=E.+Kruse&title=From+willow+bark+to+acetylsalicylic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNorn%26aufirst%3DS.%26aulast%3DPermin%26aufirst%3DH.%26aulast%3DKruse%26aufirst%3DP.%2BR.%26aulast%3DKruse%26aufirst%3DE.%26atitle%3DFrom%2520willow%2520bark%2520to%2520acetylsalicylic%2520acid%26jtitle%3DDansk%2520Medicinhistorisk%2520%25C3%2585rbog%26date%3D2009%26volume%3D37%26spage%3D79%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Piria, R.</span><span> </span><span class="NLM_article-title">Untersuchungen über das Salicin und die daraus entstehenden Producte</span> <span class="citation_source-journal">Ann. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1839</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1002/jlac.18390300203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1002%2Fjlac.18390300203" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1839&pages=151-185&author=R.+Piria&title=Untersuchungen+%C3%BCber+das+Salicin+und+die+daraus+entstehenden+Producte&doi=10.1002%2Fjlac.18390300203"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fjlac.18390300203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlac.18390300203%26sid%3Dliteratum%253Aachs%26aulast%3DPiria%26aufirst%3DR.%26atitle%3DUntersuchungen%2520%25C3%25BCber%2520das%2520Salicin%2520und%2520die%2520daraus%2520entstehenden%2520Producte%26jtitle%3DAnn.%2520Pharm.%26date%3D1839%26volume%3D30%26spage%3D151%26epage%3D185%26doi%3D10.1002%2Fjlac.18390300203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Vane, J. R.</span><span> </span><span class="NLM_article-title">Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs</span> <span class="citation_source-journal">Nature New Biology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span><span class="refDoi"> DOI: 10.1038/newbio231232a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1038%2Fnewbio231232a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=5284360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaE3MXltVyjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1971&pages=232-235&author=J.+R.+Vane&title=Inhibition+of+Prostaglandin+Synthesis+as+a+Mechanism+of+Action+for+Aspirin-like+Drugs&doi=10.1038%2Fnewbio231232a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs</span></div><div class="casAuthors">Vane, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London), New Biology</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">232-5</span>CODEN:
                <span class="NLM_cas:coden">NNBYA7</span>;
        ISSN:<span class="NLM_cas:issn">0369-4887</span>.
    </div><div class="casAbstract">Indomethacin (I) aspirin (II), and Na salicylate inhibited the generation of prostaglandin F2α (PGF2α)-like activity by guinea pig lung prepns.  Thus, on a wt. basis, I was 23-times more potent than II as an inhibitor of PGF2α, and on a molar basis 47-times more potent.  Na salicylate was less potent than II as an inhibitor of PGF2α-like activity and there was much more variation in the results.  Similar results were obtained when the activity of the samples were assayed on rat stomach strips in terms of prostaglandin E2 (PGE2).  Hydrocortisone (50 μg/ml) inhibited PGF2α and PGE2-like activity <20%; morphine (50 μg/ml) or mepyramine (50 μg/ml) had no effect.  Some of the therapeutic effects of Na salicylate and II-like drugs may be due to inhibition of the synthesis of prostaglandins.  Incubation of lung homogenates with arachidonic acid for 30 min increased PGF2α-like activity by 220-520 ng/ml and PGE2-like activity by 100-500 ng/ml.  The ID50 values for I was 0.27 μg/ml, whereas that for II was 6.3 μg/ml.  None of the drugs tested decreased the contractions of the assay tissues (rat stomach strips and colons) induced by the prostaglandins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSuOCB-VIpVrVg90H21EOLACvtfcHk0libwyXQHI-Ygg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXltVyjur4%253D&md5=20de9e860c4f6bb6fb8b46530dd8aaa6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnewbio231232a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnewbio231232a0%26sid%3Dliteratum%253Aachs%26aulast%3DVane%26aufirst%3DJ.%2BR.%26atitle%3DInhibition%2520of%2520Prostaglandin%2520Synthesis%2520as%2520a%2520Mechanism%2520of%2520Action%2520for%2520Aspirin-like%2520Drugs%26jtitle%3DNature%2520New%2520Biology%26date%3D1971%26volume%3D231%26spage%3D232%26epage%3D235%26doi%3D10.1038%2Fnewbio231232a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Smith, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, A. L.</span><span> </span><span class="NLM_article-title">Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets</span> <span class="citation_source-journal">Nature New Biology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span><span class="refDoi"> DOI: 10.1038/newbio231235a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1038%2Fnewbio231235a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=5284361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaE3MXkvFOhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1971&pages=235-237&author=J.+B.+Smithauthor=A.+L.+Willis&title=Aspirin+Selectively+Inhibits+Prostaglandin+Production+in+Human+Platelets&doi=10.1038%2Fnewbio231235a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Aspirin selectively inhibits prostaglandin production in human platelets</span></div><div class="casAuthors">Smith, J. B.; Willis, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London), New Biology</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">235-7</span>CODEN:
                <span class="NLM_cas:coden">NNBYA7</span>;
        ISSN:<span class="NLM_cas:issn">0369-4887</span>.
    </div><div class="casAbstract">Aspirin (I) (0.01-10.0 μg/ml) markedly decreased the production of prostaglandins F2α and E2 by 3-14C-labeled 5-hydroxytryptamine creatinine sulfate (5-HT) treated human platelets although it had no effect on the release of 5-HT, β-N-acetyl glucosamidase, or phospholipase A1.  I (0.3 μg/ml) inhibited the production of prostaglandin by 50%.  Indomethacin (II) was ∼10-times more potent than I, whereas Na salicylate was ∼10-times less potent.  Hydrocortisone (100 μg/ml) had no effect.  I (600 mg) inhibited the production of prostaglandins in the platelet in a system in which "the release reaction" induced by thrombin (5 units/ml) was impaired.  II (50 mg) taken by 2 volunteers, and II (100 mg) taken by 1 volunteer inhibited the production of prostaglandins by 51, 64, and 83%, resp., without affecting the release of lysosomal enzymes.  No change in the production of prostaglandins was found in platelets of 1 individual given 60 mg codeine or 2 untreated controls.  The finding that the production of prostaglandins is inhibited by I, while the release of phospholipase A is unaffected, strongly suggests that one action of I on platelets is inhibition of the conversion of arachidonic acid into prostaglandins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreUmLyWeiTCLVg90H21EOLACvtfcHk0libwyXQHI-Ygg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXkvFOhsr0%253D&md5=5aaae4920427d85d276c84d38ccaa3fa</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnewbio231235a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnewbio231235a0%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BB.%26aulast%3DWillis%26aufirst%3DA.%2BL.%26atitle%3DAspirin%2520Selectively%2520Inhibits%2520Prostaglandin%2520Production%2520in%2520Human%2520Platelets%26jtitle%3DNature%2520New%2520Biology%26date%3D1971%26volume%3D231%26spage%3D235%26epage%3D237%26doi%3D10.1038%2Fnewbio231235a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ferreira, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vane, J. R.</span><span> </span><span class="NLM_article-title">Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen</span> <span class="citation_source-journal">Nature New Biology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span><span class="refDoi"> DOI: 10.1038/newbio231237a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1038%2Fnewbio231237a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=5284362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaE3MXkvFOjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1971&pages=237-240&author=S.+H.+Ferreiraauthor=S.+Moncadaauthor=J.+R.+Vane&title=Indomethacin+and+Aspirin+abolish+Prostaglandin+Release+from+the+Spleen&doi=10.1038%2Fnewbio231237a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Indomethacin and aspirin abolish prostaglandin release from the spleen</span></div><div class="casAuthors">Ferreira, S. H.; Moncada, S.; Vane, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London), New Biology</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">237-9</span>CODEN:
                <span class="NLM_cas:coden">NNBYA7</span>;
        ISSN:<span class="NLM_cas:issn">0369-4887</span>.
    </div><div class="casAbstract">Adrenaline bitartrate (I) (200 ng/min or 6-10 mg/ml during 3 min) infusion into the perfusion dog spleen increased splenic perfusion pressures, contracted the spleen, and increased prostaglandin output, chiefly prostaglandin E2.  Indomethacin (II) (0.37 μg/ml) infusions into the spleen did not decrease splenic wt. or change the splenic perfusion pressure.  The increase in prostaglandin output induced by I infusion, however, was abolished.  In sep. expts., II (4 μg/ml for 15 min and 750 ng/ml for 15 min) completely abolished prostaglandin output.  In these expts., after the II infusion was stopped, there was a gradual return of prostaglandin output induced by I infusion, which reached at least 60% of the initial output within 1-3 hr and sometimes 100%.  Aspirin was much less effective as an inhibitor of prostaglandin release, i.e., at 15 μg/ml, there was 60% inhibition and at 40 μg/ml (2 expts.), there was 75 and 100% inhibition.  Na salicylate (20 and 40 μg/ml) (2 expts.) and hydrocortisone dihydrogen succinate (2 or 25 μg/ml) did not change the prostaglandin output induced by I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNurGG3-yqlLVg90H21EOLACvtfcHk0lho23SVIehYFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXkvFOjur4%253D&md5=1651bcb0653f9d27358a46b2f96ec76a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnewbio231237a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnewbio231237a0%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DS.%2BH.%26aulast%3DMoncada%26aufirst%3DS.%26aulast%3DVane%26aufirst%3DJ.%2BR.%26atitle%3DIndomethacin%2520and%2520Aspirin%2520abolish%2520Prostaglandin%2520Release%2520from%2520the%2520Spleen%26jtitle%3DNature%2520New%2520Biology%26date%3D1971%26volume%3D231%26spage%3D237%26epage%3D240%26doi%3D10.1038%2Fnewbio231237a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Burch, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanford, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majerus, P. W.</span><span> </span><span class="NLM_article-title">Inhibition of platelet prostaglandin synthetase by oral aspirin</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span><span class="refDoi"> DOI: 10.1172/JCI108941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1172%2FJCI108941" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1978&pages=314-319&author=J.+W.+Burchauthor=N.+Stanfordauthor=P.+W.+Majerus&title=Inhibition+of+platelet+prostaglandin+synthetase+by+oral+aspirin&doi=10.1172%2FJCI108941"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1172%2FJCI108941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI108941%26sid%3Dliteratum%253Aachs%26aulast%3DBurch%26aufirst%3DJ.%2BW.%26aulast%3DStanford%26aufirst%3DN.%26aulast%3DMajerus%26aufirst%3DP.%2BW.%26atitle%3DInhibition%2520of%2520platelet%2520prostaglandin%2520synthetase%2520by%2520oral%2520aspirin%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1978%26volume%3D61%26spage%3D314%26epage%3D319%26doi%3D10.1172%2FJCI108941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Laneuville, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuer, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeWitt, D. L.</span><span> </span><span class="NLM_article-title">Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs</span> <span class="citation_source-journal">J. Pharmacol Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=7965814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaK2MXisVyjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1994&pages=927-934&author=O.+Laneuvilleauthor=D.+K.+Breuerauthor=D.+L.+DeWitt&title=Differential+inhibition+of+human+prostaglandin+endoperoxide+H+synthases-1+and+-2+by+nonsteroidal+anti-inflammatory+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs</span></div><div class="casAuthors">Laneuville, Odette; Breuer, Debra K.; Dewitt, David L.; Hla, Tim; Funk, Colin D.; Smith, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">927-34</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">We developed an in vitro expression system for accurate kinetic analyses of the inhibition of the human prostaglandin H synthase isoenzymes (hPGHS-1 and -2) by nonsteroidal anti-inflammatory drugs (NSAIDs).  Assays of instantaneous inhibition in which enzyme, 10 μM arachidonate, and an NSAID were mixed simultaneously were used to det. apparent affinities of 14 common NSAIDs for hPGHS-1 and hPGHS-2.  All NSAIDs except salicylate had appreciable apparent affinities (IC50 ≤ 100 μM) for hPGHS-1.  Most NSAIDs also exhibited appreciable affinities toward hPGHS-2, but three prominent exceptions were indomethacin, piroxicam and phenylbutazone.  We subsequently performed measurements of time-dependent inhibition in which either (a) enzyme and an NSAID were preincubated before substrate was added to initiate the reactions or (b) recovery of activity after time-dependent inhibition was measured using intact cells preincubated with various NSAIDs.  Indomethacin, flurbiprofen, meclofenamate and diclofenac, but not ibuprofen, piroxicam or phenylbutazone, caused time-dependent inhibition of both hPGHS-1 and -2 in vitro.  For cells pretreated with flurbiprofen or meclofenamate, hPGHS-2 activities, but not hPGHS-1 activities, were recovered relatively rapidly; with indomethacin, recoveries of hPGHS-1 and hPGHS-2 activities were both slow.  HPGHS-2 is thought to be the target of NSAIDs acting as anti-inflammatory agents.  However, our results indicate that neither measurements of affinities of NSAIDs for hPGHS-2 conducted in vitro with 10 μM arachidonate nor measurements of time-dependent inhibition of hPGH-2 always predict whether a compd. (e.g., piroxicam or phenylbutazone) has anti-inflammatory activity in vivo.  We propose that the most inclusive approach for screening for hPGH-2-selective NSAIDs is to preincubate intact cells that express hPGHS-2 with potential inhibitors and then measure prostanoid prodn. from arachidonate mobilized from endogenous lipids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoItue73glLlbVg90H21EOLACvtfcHk0lho23SVIehYFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXisVyjs74%253D&md5=4212b87a0a395263dab9fe38e7062dc4</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaneuville%26aufirst%3DO.%26aulast%3DBreuer%26aufirst%3DD.%2BK.%26aulast%3DDeWitt%26aufirst%3DD.%2BL.%26atitle%3DDifferential%2520inhibition%2520of%2520human%2520prostaglandin%2520endoperoxide%2520H%2520synthases-1%2520and%2520-2%2520by%2520nonsteroidal%2520anti-inflammatory%2520drugs%26jtitle%3DJ.%2520Pharmacol%2520Exp.%2520Ther.%26date%3D1994%26volume%3D271%26spage%3D927%26epage%3D934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Seibert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masferrer, J. L.</span><span> </span><span class="NLM_article-title">Role of inducible cyclooxygenase (COX-2) in inflammation</span> <span class="citation_source-journal">Receptor</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=8038702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaK2cXksl2lsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=17-23&author=K.+Seibertauthor=J.+L.+Masferrer&title=Role+of+inducible+cyclooxygenase+%28COX-2%29+in+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Role of inducible cyclooxygenase (COX-2) in inflammation</span></div><div class="casAuthors">Seibert, Karen; Masferrer, Jaime L.</div><div class="citationInfo"><span class="NLM_cas:title">Receptor</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-23</span>CODEN:
                <span class="NLM_cas:coden">RECEE5</span>;
        ISSN:<span class="NLM_cas:issn">1052-8040</span>.
    </div><div class="casAbstract">A review, with 26 refs.  Nonsteroidal anti-inflammatory drugs (NSAIDs) are potent anti-inflammatory agents that act through the inhibition of the cyclooxygenase (COX) enzyme and the subsequent inhibition of prostaglandins at the site of inflammation.  Unfortunately, inhibition of gastrointestinal or renal prostaglandins is assocd. with mechanism-based toxicities that limit the usefulness of these otherwise potent and efficacious drugs.  Recently two forms of the COX enzyme have been identified: COX-1, which is constitutively expressed in many cells and tissues, and COX-2, which is selectively induced by proinflammatory cytokines at the site of inflammation.  The discovery of a second COX enzyme led to the hypothesis that toxicity assocd. with the clin. useful NSAIDs is caused by the inhibition of COX-1, whereas the anti-inflammatory properties were caused by the inhibition of inducible COX-2.  In support of this hypothesis, expression of the inducible COX-2 enzyme is selectively blocked by the potent anti-inflammatory drug dexamethasone.  Selective inhibition of COX-2 may produce superior anti-inflammatory drugs with substantial safety over existing NSAIDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFIZ3CemiSK7Vg90H21EOLACvtfcHk0lho23SVIehYFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksl2lsb4%253D&md5=f01419c191dbbfb76522eb60e910634b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeibert%26aufirst%3DK.%26aulast%3DMasferrer%26aufirst%3DJ.%2BL.%26atitle%3DRole%2520of%2520inducible%2520cyclooxygenase%2520%2528COX-2%2529%2520in%2520inflammation%26jtitle%3DReceptor%26date%3D1994%26volume%3D4%26spage%3D17%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Hawkey, C. J.</span><span> </span><span class="NLM_article-title">Cox-2 Inhibitors</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">353</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span><span class="refDoi"> DOI: 10.1016/S0140-6736(98)12154-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1016%2FS0140-6736%2898%2912154-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=9929039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaK1MXhsF2lsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=1999&pages=307-314&author=C.+J.+Hawkey&title=Cox-2+Inhibitors&doi=10.1016%2FS0140-6736%2898%2912154-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">COX-2 inhibitors</span></div><div class="casAuthors">Hawkey, C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">9149</span>),
    <span class="NLM_cas:pages">307-314</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Ltd.</span>)
        </div><div class="casAbstract">A review with 75 refs.  In the past 100 yr aspirin has demonstrated its value as an analgesic, anti-inflammatory, and antithrombotic agent.  However, by 1938, it was clear that aspirin was gastrotoxic.  Non-steroidal anti-inflammatory drugs (NSAIDs), developed since the 1960s, failed to achieve the goal of "a safer aspirin".  The demonstration that inhibition of prostaglandin synthesis via a cyclo-oxygenase (COX) enzyme was central to both the therapeutic and toxic effects of aspirin and non-aspirin NSAIDs appeared to establish the principle of no gain without pain.  This link may have been broken by drugs that selectively inhibit the inducible COX-2 enzyme.  The COX enzyme is now a target of drug interventions against the inflammatory process.  Might the "safe aspirin" be here at last.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEghq0hjl727Vg90H21EOLACvtfcHk0lhHzH5JmJg6Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhsF2lsrw%253D&md5=8f1066e83b41674fbde81632c8fb0d79</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2898%2912154-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252898%252912154-2%26sid%3Dliteratum%253Aachs%26aulast%3DHawkey%26aufirst%3DC.%2BJ.%26atitle%3DCox-2%2520Inhibitors%26jtitle%3DLancet%26date%3D1999%26volume%3D353%26spage%3D307%26epage%3D314%26doi%3D10.1016%2FS0140-6736%2898%2912154-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Chen, Y.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jobanputra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry-Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. S.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation</span> <span class="citation_source-journal">Health Technology Assessment</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span><span class="refDoi"> DOI: 10.3310/hta12110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.3310%2Fhta12110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=1-278&author=Y.-F.+Chenauthor=P.+Jobanputraauthor=P.+Bartonauthor=S.+Bryanauthor=A.+Fry-Smithauthor=G.+Harrisauthor=R.+S.+Taylor&title=Cyclooxygenase-2+selective+non-steroidal+anti-inflammatory+drugs+%28etodolac%2C+meloxicam%2C+celecoxib%2C+rofecoxib%2C+etoricoxib%2C+valdecoxib+and+lumiracoxib%29+for+osteoarthritis+and+rheumatoid+arthritis%3A+a+systematic+review+and+economic+evaluation&doi=10.3310%2Fhta12110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3310%2Fhta12110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3310%252Fhta12110%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.-F.%26aulast%3DJobanputra%26aufirst%3DP.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DBryan%26aufirst%3DS.%26aulast%3DFry-Smith%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DG.%26aulast%3DTaylor%26aufirst%3DR.%2BS.%26atitle%3DCyclooxygenase-2%2520selective%2520non-steroidal%2520anti-inflammatory%2520drugs%2520%2528etodolac%252C%2520meloxicam%252C%2520celecoxib%252C%2520rofecoxib%252C%2520etoricoxib%252C%2520valdecoxib%2520and%2520lumiracoxib%2529%2520for%2520osteoarthritis%2520and%2520rheumatoid%2520arthritis%253A%2520a%2520systematic%2520review%2520and%2520economic%2520evaluation%26jtitle%3DHealth%2520Technology%2520Assessment%26date%3D2008%26volume%3D12%26spage%3D1%26epage%3D278%26doi%3D10.3310%2Fhta12110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Moncada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vane, J. R.</span><span> </span><span class="NLM_article-title">Interrelationships between prostacyclin and thromboxane A2</span> <span class="citation_source-journal">Ciba Found. Symp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1002/9780470720615.ch9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1002%2F9780470720615.ch9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2008&pages=165-183&author=S.+Moncadaauthor=J.+R.+Vane&title=Interrelationships+between+prostacyclin+and+thromboxane+A2&doi=10.1002%2F9780470720615.ch9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2F9780470720615.ch9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470720615.ch9%26sid%3Dliteratum%253Aachs%26aulast%3DMoncada%26aufirst%3DS.%26aulast%3DVane%26aufirst%3DJ.%2BR.%26atitle%3DInterrelationships%2520between%2520prostacyclin%2520and%2520thromboxane%2520A2%26jtitle%3DCiba%2520Found.%2520Symp.%26date%3D2008%26volume%3D78%26spage%3D165%26epage%3D183%26doi%3D10.1002%2F9780470720615.ch9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Sun, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, J. L.</span><span> </span><span class="NLM_article-title">Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1859</span><span class="NLM_x">–</span> <span class="NLM_lpage">1866</span><span class="refDoi"> DOI: 10.1185/030079907X210561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1185%2F030079907X210561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=17605893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFejtrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2007&pages=1859-1866&author=S.+X.+Sunauthor=K.+Y.+Leeauthor=C.+T.+Bertramauthor=J.+L.+Goldstein&title=Withdrawal+of+COX-2+selective+inhibitors+rofecoxib+and+valdecoxib%3A+impact+on+NSAID+and+gastroprotective+drug+prescribing+and+utilization&doi=10.1185%2F030079907X210561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization</span></div><div class="casAuthors">Sun, Shawn X.; Lee, Kwan Y.; Bertram, Carl T.; Goldstein, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1859-1866</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Objective: Cyclo-oxygenase-2 (COX-2) inhibitors rofecoxib and valdecoxib were withdrawn from the market because of their assocn. with cardiovascular problems.  There is a lack of information on the impact of the COX-2 inhibitors withdrawal on the prescribing and utilization of related drugs.  The main objective of this study was to evaluate to what extent prescriptions of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) and gastroprotective drugs changed after the removal of the two COX-2 inhibitors.  Research design and methods: A segmented regression of interrupted time series approach was used to analyze prescription data from July 1, 2003 through Dec. 31, 2005 from a pharmacy claims database maintained by a large pharmacy benefit manager (PBM).  Patients continuously eligible for the pharmacy benefit but not enrolled in COX-2 or proton pump inhibitor (PPI) Step Care programs during the study period were included.  The no. of prescriptions per thousand patients per mo for targeted drugs were analyzed and compared.  Results: A total of 175193 patients were included in the anal.  After the withdrawal of the COX-2 inhibitor, the av. monthly non-selective NSAID and PPI prescriptions per thousand patients increased from 13.96 to 19.63 (a change of 40.62%, p < 0.0001) and from 38.67 to 43.33 (a change of 12.05%, p<0.0001) resp., whereas COX-2 prescriptions decreased by 54.51% (from 23.61 to 10.74, p<0.0001).  Among non-selective NSAIDs, the five drugs with highest percentage increase were meloxicam (167.12%, from 1.46 to 3.90, p<0.0001), etodolac (72.06%, from 0.68 to 1.17, p<0.0001), piroxicam (58.33%, from 0.36 to 0.57, p<0.0001), nabumetone (52.38%, from 1.26 to 1.92, p<0.0001), and diclofenac (37.89%, from 1.61 to 2.22, p<0.0001).  Limitations: This study was restricted to patients with employer-sponsored drug coverage which might not be representative of the national population.  Since over-the-counter (OTC) PPI, non-selective NSAID and H2RA were not captured in our claims data, we were unable to examine whether and to what extent the utilization of these drugs has changed.  Addnl., the direct impact of these changes on population based outcomes is unknown.  Conclusions: After the withdrawal of COX-2 inhibitors rofecoxib and valdecoxib, there were significant increases in non-selective NSAID and PPI prescriptions but not H2RA and misoprostol.  Given the safety concerns with the NSAIDs, further studies are warranted regarding the clin. outcomes assocd. with the increased use of non-selective NSAIDs with or without gastroprotective agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLU1QxLNxUO7Vg90H21EOLACvtfcHk0lgAqtAtz2TIbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFejtrvF&md5=46096744585c471611e7e5de2bc0ed28</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1185%2F030079907X210561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F030079907X210561%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BX.%26aulast%3DLee%26aufirst%3DK.%2BY.%26aulast%3DBertram%26aufirst%3DC.%2BT.%26aulast%3DGoldstein%26aufirst%3DJ.%2BL.%26atitle%3DWithdrawal%2520of%2520COX-2%2520selective%2520inhibitors%2520rofecoxib%2520and%2520valdecoxib%253A%2520impact%2520on%2520NSAID%2520and%2520gastroprotective%2520drug%2520prescribing%2520and%2520utilization%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2007%26volume%3D23%26spage%3D1859%26epage%3D1866%26doi%3D10.1185%2F030079907X210561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobsson, P. J.</span><span> </span><span class="NLM_article-title">Membrane prostaglandin E synthase-1: a novel therapeutic target</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1124/pr.59.3.1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1124%2Fpr.59.3.1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=17878511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ahsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2007&pages=207-224&author=B.+Samuelssonauthor=R.+Morgensternauthor=P.+J.+Jakobsson&title=Membrane+prostaglandin+E+synthase-1%3A+a+novel+therapeutic+target&doi=10.1124%2Fpr.59.3.1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane prostaglandin E synthase-1: a novel therapeutic target</span></div><div class="casAuthors">Samuelsson, Bengt; Morgenstern, Ralf; Jakobsson, Per-Johan</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-224</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Prostaglandin E2 (PGE2) is the most abundant prostaglandin in the human body.  It has a large no. of biol. actions that it exerts via four types of receptors, EP1-4.  PGE2 is formed from arachidonic acid by cyclooxygenase (COX-1 and COX-2)-catalyzed formation of prostaglandin H2 (PGH2) and further transformation by PGE synthases.  The isomerization of the endoperoxide PGH2 to PGE2 is catalyzed by three different PGE synthases, viz. cytosolic PGE synthase (cPGES) and two membrane-bound PGE synthases, mPGES-1 and mPGES-2.  Of these isomerases, cPGES and mPGES-2 are constitutive enzymes, whereas mPGES-1 is mainly an induced isomerase.  CPGES uses PGH2 produced by COX-1 whereas mPGES-1 uses COX-2-derived endoperoxide.  MPGES-2 can use both sources of PGH2.  MPGES-1 is a member of the membrane assocd. proteins involved in eicosanoid and glutathione metab. (MAPEG) superfamily.  It requires glutathione as an essential cofactor for its activity.  MPGES-1 is up-regulated in response to various proinflammatory stimuli with a concomitant increased expression of COX-2.  The coordinate increased expression of COX-2 and mPGES-1 is reversed by glucocorticoids.  Differences in the kinetics of the expression of the two enzymes suggest distinct regulatory mechanisms for their expression.  Studies, mainly from disruption of the mPGES-1 gene in mice, indicate key roles of mPGES-1-generated PGE2 in female reprodn. and in pathol. conditions such as inflammation, pain, fever, anorexia, atherosclerosis, stroke, and tumorigenesis.  These findings indicate that mPGES-1 is a potential target for the development of therapeutic agents for treatment of several diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquliKs3pT-37Vg90H21EOLACvtfcHk0lgAqtAtz2TIbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ahsr3P&md5=700ba869963fd456d18eb68965e673c7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fpr.59.3.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.59.3.1%26sid%3Dliteratum%253Aachs%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DMorgenstern%26aufirst%3DR.%26aulast%3DJakobsson%26aufirst%3DP.%2BJ.%26atitle%3DMembrane%2520prostaglandin%2520E%2520synthase-1%253A%2520a%2520novel%2520therapeutic%2520target%26jtitle%3DPharmacol.%2520Rev.%26date%3D2007%26volume%3D59%26spage%3D207%26epage%3D224%26doi%3D10.1124%2Fpr.59.3.1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Jakobsson, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorén, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span> </span><span class="NLM_article-title">Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">7220</span><span class="NLM_x">–</span> <span class="NLM_lpage">7225</span><span class="refDoi"> DOI: 10.1073/pnas.96.13.7220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1073%2Fpnas.96.13.7220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10377395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaK1MXltVOrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=7220-7225&author=P.-J.+Jakobssonauthor=S.+Thor%C3%A9nauthor=R.+Morgensternauthor=B.+Samuelsson&title=Identification+of+human+prostaglandin+E+synthase%3A+A+microsomal%2C+glutathione-dependent%2C+inducible+enzyme%2C+constituting+a+potential+novel+drug+target&doi=10.1073%2Fpnas.96.13.7220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target</span></div><div class="casAuthors">Jakobsson, Per-Johan; Thoren, Staffan; Morgenstern, Ralf; Samuelsson, Bengt</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">7220-7225</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Human prostaglandin (PG) E synthase (EC 5.3.99.3) is a member of a recently recognized protein superfamily consisting of membrane assocd. proteins involved in eicosanoid and glutathione metab. (the MAPEG family).  Previous designations of the protein are PIG12 and MGST1-L1.  PGE synthase was expressed in Escherichia coli, and both cytosolic and membrane fractions were prepd.  Western blot anal. specifically detected a 15- to 16-kDa protein in the membrane fraction.  Both fractions were incubated with prostaglandin H2 in the presence or absence of reduced glutathione.  The membrane but not the cytosolic fraction was found to possess high glutathione-dependent PGE synthase activity (0.25 μmol/min/mg).  The human tissue distribution was analyzed by Northern blot anal.  High expression of PGE synthase mRNA was detected in A549 and HeLa cancer cell lines.  Intermediate level of expression was demonstrated in placenta, prostate, testis, mammary gland, and bladder whereas low mRNA expression was obsd. in several other tissues.  A549 cells have been used as a model system to study cyclooxygenase-2 induction by IL-1β.  If A549 cells were grown in the presence of IL-1β, a significant induction of the PGE synthase was obsd. by Western blot anal.  Also, Western blot anal. specifically detected a 16-kDa protein in sheep seminal vesicles.  In summary, we have identified a human membrane bound PGE synthase.  The enzyme activity is glutathione-dependent, and the protein expression is induced by the proinflammatory cytokine IL-1β.  PGE synthase is a potential novel target for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZGo96GT36n7Vg90H21EOLACvtfcHk0lgAqtAtz2TIbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltVOrtb0%253D&md5=72e7b564853d3d9f13d2c2a113c5323c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.13.7220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.13.7220%26sid%3Dliteratum%253Aachs%26aulast%3DJakobsson%26aufirst%3DP.-J.%26aulast%3DThor%25C3%25A9n%26aufirst%3DS.%26aulast%3DMorgenstern%26aufirst%3DR.%26aulast%3DSamuelsson%26aufirst%3DB.%26atitle%3DIdentification%2520of%2520human%2520prostaglandin%2520E%2520synthase%253A%2520A%2520microsomal%252C%2520glutathione-dependent%252C%2520inducible%2520enzyme%252C%2520constituting%2520a%2520potential%2520novel%2520drug%2520target%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D7220%26epage%3D7225%26doi%3D10.1073%2Fpnas.96.13.7220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Chang, H.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meuillet, E. J.</span><span> </span><span class="NLM_article-title">Identification and development of mPGES-1 inhibitors: where we are at?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1909</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span><span class="refDoi"> DOI: 10.4155/fmc.11.136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.4155%2Ffmc.11.136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=22023034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGku77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=1909-1934&author=H.-H.+Changauthor=E.+J.+Meuillet&title=Identification+and+development+of+mPGES-1+inhibitors%3A+where+we+are+at%3F&doi=10.4155%2Ffmc.11.136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and development of mPGES-1 inhibitors: where we are at?</span></div><div class="casAuthors">Chang, Hui-Hua; Meuillet, Emmanuelle J.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1909-1934</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Microsomal prostaglandin E synthase-1 (mPGES-1) is the terminal synthase responsible for the synthesis of the pro-tumorigenic prostaglandin E2 (PGE2). mPGES-1 is overexpressed in a wide variety of cancers.  Since its discovery in 1997 by Bengt Samuelsson and collaborators, the enzyme has been the object of over 200 peer-reviewed articles.  Although today mPGES-1 is considered a validated and promising therapeutic target for anticancer drug discovery, challenges in inhibitor design and selectivity are such that up to this date there are only a few published records of small-mol. inhibitors targeting the enzyme and exhibiting some in vivo anticancer activity.  This review summarizes the structures, and the in vitro and in vivo activities of these novel mPGES-1 inhibitors.  Challenges that have been encountered are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK1gwT4lhJiLVg90H21EOLACvtfcHk0lgoJ2yK6PCZMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGku77I&md5=cf98f2d5951c19b4941abf36038fb915</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.4155%2Ffmc.11.136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.11.136%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DH.-H.%26aulast%3DMeuillet%26aufirst%3DE.%2BJ.%26atitle%3DIdentification%2520and%2520development%2520of%2520mPGES-1%2520inhibitors%253A%2520where%2520we%2520are%2520at%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D1909%26epage%3D1934%26doi%3D10.4155%2Ffmc.11.136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><div class="note"><p class="first last">See</p></div><span class="NLM_contrib-group">Takusagawa, F.</span><span> </span><span class="NLM_article-title">Microsomal prostaglandin E synthase type 2 (mPGES2) is a glutathione-dependent heme protein, and dithiothreitol dissociates the bound heme to produce active prostaglandin E2 synthase in vitro</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">10166</span><span class="NLM_x">–</span> <span class="NLM_lpage">10175</span><div class="note"><p class="first last">and references therein.</p></div><span class="refDoi"> DOI: 10.1074/jbc.M112.418475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1074%2Fjbc.M112.418475" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=10166-10175&author=F.+Takusagawa&title=Microsomal+prostaglandin+E+synthase+type+2+%28mPGES2%29+is+a+glutathione-dependent+heme+protein%2C+and+dithiothreitol+dissociates+the+bound+heme+to+produce+active+prostaglandin+E2+synthase+in+vitro&doi=10.1074%2Fjbc.M112.418475"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.418475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.418475%26sid%3Dliteratum%253Aachs%26aulast%3DTakusagawa%26aufirst%3DF.%26atitle%3DMicrosomal%2520prostaglandin%2520E%2520synthase%2520type%25202%2520%2528mPGES2%2529%2520is%2520a%2520glutathione-dependent%2520heme%2520protein%252C%2520and%2520dithiothreitol%2520dissociates%2520the%2520bound%2520heme%2520to%2520produce%2520active%2520prostaglandin%2520E2%2520synthase%2520in%2520vitro%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D10166%26epage%3D10175%26doi%3D10.1074%2Fjbc.M112.418475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Singh Bahia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar Katare, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silakari, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silakari, P.</span><span> </span><span class="NLM_article-title">Inhibitors of Microsomal Prostaglandin E2 Synthase-1 Enzyme as Emerging Anti-Inflammatory Candidates</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1002/med.21306</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1002%2Fmed.21306" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=25019142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVagurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=825-855&author=M.+Singh+Bahiaauthor=Y.+Kumar+Katareauthor=O.+Silakariauthor=B.+Vyasauthor=P.+Silakari&title=Inhibitors+of+Microsomal+Prostaglandin+E2+Synthase-1+Enzyme+as+Emerging+Anti-Inflammatory+Candidates&doi=10.1002%2Fmed.21306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Microsomal Prostaglandin E2 Synthase-1 Enzyme as Emerging Anti-Inflammatory Candidates</span></div><div class="casAuthors">Singh Bahia, Malkeet; Kumar Katare, Yogesh; Silakari, Om; Vyas, Bhawna; Silakari, Pragati</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">825-855</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Cyclooxygenases (COX-1 and COX-2) catalyze the conversion of arachidonic acid (AA) into PGH2 that is further metabolized by terminal prostaglandin (PG) synthases into biol. active PGs, for example, prostaglandin E2 (PGE2), prostacyclin I2 (PGI2), thromboxane A2 (TXA2), prostaglandin D2 (PGD2), and prostaglandin F2 alpha (PGF2α).  Among them, PGE2 is a widely distributed PG in the human body, and an important mediator of inflammatory processes.  The successful modulation of this PG provides a beneficial strategy for the potential anti-inflammatory therapy.  For instance, nonsteroidal anti-inflammatory agents (NSAIDs), both classical nonselective (cNSAIDs) and the selective COX-2 inhibitors (coxibs) attenuate the generation of PGH2 from AA that in turn reduces the synthesis of PGE2 and modifies the inflammatory conditions.  However, the long-term use of these agents causes severe side effects due to the nonselective inhibition of other PGs, such as PGI2 and TXA2, etc.  Microsomal prostaglandin E2 synthase-1 (mPGES-1), a downstream PG synthase, specifically catalyzes the biosynthesis of COX-2-derived PGE2 from PGH2, and describes itself as a valuable therapeutic target for the treatment of acute and chronic inflammatory disease conditions.  Therefore, the small mol. inhibitors of mPGES-1 would serve as a beneficial anti-inflammatory therapy, with reduced side effects that are usually assocd. with the nonselective inhibition of PG biosynthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU4wyO_mJTBrVg90H21EOLACvtfcHk0lgoJ2yK6PCZMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVagurk%253D&md5=d130be77b4ae504b144df0ceda613e0c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fmed.21306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21306%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%2BBahia%26aufirst%3DM.%26aulast%3DKumar%2BKatare%26aufirst%3DY.%26aulast%3DSilakari%26aufirst%3DO.%26aulast%3DVyas%26aufirst%3DB.%26aulast%3DSilakari%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520Microsomal%2520Prostaglandin%2520E2%2520Synthase-1%2520Enzyme%2520as%2520Emerging%2520Anti-Inflammatory%2520Candidates%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2014%26volume%3D34%26spage%3D825%26epage%3D855%26doi%3D10.1002%2Fmed.21306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Abdul-Malik, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akasaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, K. H.</span><span> </span><span class="NLM_article-title">Current Advances of Microsomal Prostaglandin E Synthase-1 as a Target in Inflammation and Cancer</span> <span class="citation_source-journal">Am. J. Integrative Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=2-11&author=H.+M.+Abdul-Malikauthor=H.+Akasakaauthor=K.+H.+Ruan&title=Current+Advances+of+Microsomal+Prostaglandin+E+Synthase-1+as+a+Target+in+Inflammation+and+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbdul-Malik%26aufirst%3DH.%2BM.%26aulast%3DAkasaka%26aufirst%3DH.%26aulast%3DRuan%26aufirst%3DK.%2BH.%26atitle%3DCurrent%2520Advances%2520of%2520Microsomal%2520Prostaglandin%2520E%2520Synthase-1%2520as%2520a%2520Target%2520in%2520Inflammation%2520and%2520Cancer%26jtitle%3DAm.%2520J.%2520Integrative%2520Med.%26date%3D2013%26volume%3D3%26spage%3D2%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Xu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giroux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiral, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducharme, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesen, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méthot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audoly, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span> </span><span class="NLM_article-title">MF63 [2-(6-chloro-1H-phenanthro [9,10-d] imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">754</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1124/jpet.108.138776</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1124%2Fjpet.108.138776" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=18524979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVGqurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2008&pages=754-763&author=D.+Xuauthor=S.+E.+Rowlandauthor=P.+Clarkauthor=A.+Girouxauthor=B.+C%C3%B4t%C3%A9author=S.+Guiralauthor=M.+Salemauthor=Y.+Ducharmeauthor=R.+W.+Friesenauthor=N.+M%C3%A9thotauthor=J.+Manciniauthor=L.+Audolyauthor=D.+Riendeau&title=MF63+%5B2-%286-chloro-1H-phenanthro+%5B9%2C10-d%5D+imidazol-2-yl%29-isophthalonitrile%5D%2C+a+selective+microsomal+prostaglandin+E+synthase-1+inhibitor%2C+relieves+pyresis+and+pain+in+preclinical+models+of+inflammation&doi=10.1124%2Fjpet.108.138776"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation</span></div><div class="casAuthors">Xu, Daigen; Rowland, Steven E.; Clark, Patsy; Giroux, Andre; Cote, Bernard; Guiral, Sebastien; Salem, Myriam; Ducharme, Yves; Friesen, Richard W.; Methot, Nathalie; Mancini, Joseph; Audoly, Laurent; Riendeau, Denis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">754-763</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Microsomal prostaglandin E synthase-1 (mPGES-1) is a terminal prostaglandin E2 (PGE2) synthase in the cyclooxygenase pathway.  Inhibitors of mPGES-1 may block PGE2 prodn. and relieve inflammatory symptoms.  To test the hypothesis, we evaluated the antipyretic and analgesic properties of a novel and selective mPGES-1 inhibitor, MF63 [2-(6-chloro-1H-phenanthro-[9,10-d]imidazol-2-yl)isophthalonitrile], in animal models of inflammation.  MF63 potently inhibited the human mPGES-1 enzyme (IC50 = 1.3 nM), with a high degree (>1000-fold) of selectivity over other prostanoid synthases.  In rodent species, MF63 strongly inhibited guinea pig mPGES-1 (IC50 = 0.9 nM) but not the mouse or rat enzyme.  When tested in the guinea pig and a knock-in (KI) mouse expressing human mPGES-1, the compd. selectively suppressed the synthesis of PGE2, but not other prostaglandins inhibitable by nonsteroidal anti-inflammatory drugs (NSAIDs), yet retained NSAID-like efficacy at inhibiting lipopolysaccharide-induced pyresis, hyperalgesia, and iodoacetate-induced osteoarthritic pain.  In addn., MF63 did not cause NSAID-like gastrointestinal toxic effects, such as mucosal erosions or leakage in the KI mice or nonhuman primates, although it markedly inhibited PGE2 synthesis in the KI mouse stomach.  Our data demonstrate that mPGES-1 inhibition leads to effective relief of both pyresis and inflammatory pain in preclin. models of inflammation and may be a useful approach for treating inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiuE_hD_RJhbVg90H21EOLACvtfcHk0liKCnCOYmi81Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVGqurnK&md5=3f13b177e1cd540833be0fe2abce290c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.138776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.138776%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DRowland%26aufirst%3DS.%2BE.%26aulast%3DClark%26aufirst%3DP.%26aulast%3DGiroux%26aufirst%3DA.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DB.%26aulast%3DGuiral%26aufirst%3DS.%26aulast%3DSalem%26aufirst%3DM.%26aulast%3DDucharme%26aufirst%3DY.%26aulast%3DFriesen%26aufirst%3DR.%2BW.%26aulast%3DM%25C3%25A9thot%26aufirst%3DN.%26aulast%3DMancini%26aufirst%3DJ.%26aulast%3DAudoly%26aufirst%3DL.%26aulast%3DRiendeau%26aufirst%3DD.%26atitle%3DMF63%2520%255B2-%25286-chloro-1H-phenanthro%2520%255B9%252C10-d%255D%2520imidazol-2-yl%2529-isophthalonitrile%255D%252C%2520a%2520selective%2520microsomal%2520prostaglandin%2520E%2520synthase-1%2520inhibitor%252C%2520relieves%2520pyresis%2520and%2520pain%2520in%2520preclinical%2520models%2520of%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D326%26spage%3D754%26epage%3D763%26doi%3D10.1124%2Fjpet.108.138776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aspiotis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gareau, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiral, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juteau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méthot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesen, R. W.</span><span> </span><span class="NLM_article-title">Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3352</span><span class="NLM_x">–</span> <span class="NLM_lpage">3355</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2005.05.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1016%2Fj.bmcl.2005.05.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=15953724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVCmurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3352-3355&author=D.+Riendeauauthor=R.+Aspiotisauthor=D.+Ethierauthor=Y.+Gareauauthor=E.+L.+Grimmauthor=J.+Guayauthor=S.+Guiralauthor=H.+Juteauauthor=J.+A.+Manciniauthor=N.+M%C3%A9thotauthor=J.+Rubinauthor=R.+W.+Friesen&title=Inhibitors+of+the+inducible+microsomal+prostaglandin+E2+synthase+%28mPGES-1%29+derived+from+MK-886&doi=10.1016%2Fj.bmcl.2005.05.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886</span></div><div class="casAuthors">Riendeau, Denis; Aspiotis, Renee; Ethier, Diane; Gareau, Yves; Grimm, Erich L.; Guay, Jocelyne; Guiral, Sebastien; Juteau, Helene; Mancini, Joseph A.; Methot, Nathalie; Rubin, Joel; Friesen, Richard W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3352-3355</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of potent and selective inhibitors of the inducible microsomal PGE2 synthase (mPGES-1) has been developed based on the indole FLAP inhibitor MK-886.  Compds. 23 and 30 inhibit mPGES-1 with potencies in the low nanomolar range and with selectivities of at least 100-fold compared to their inhibition of mPGES-2, thromboxane synthase and binding affinity to FLAP.  They also block the prodn. of PGE2 in cell based assays but with a decreased potency and more limited selectivity compared to the enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHu0Wz8iNsdbVg90H21EOLACvtfcHk0liKCnCOYmi81Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVCmurc%253D&md5=5da7bd8d4f5f725dd6624f5867ca7853</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.05.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.05.027%26sid%3Dliteratum%253Aachs%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DAspiotis%26aufirst%3DR.%26aulast%3DEthier%26aufirst%3DD.%26aulast%3DGareau%26aufirst%3DY.%26aulast%3DGrimm%26aufirst%3DE.%2BL.%26aulast%3DGuay%26aufirst%3DJ.%26aulast%3DGuiral%26aufirst%3DS.%26aulast%3DJuteau%26aufirst%3DH.%26aulast%3DMancini%26aufirst%3DJ.%2BA.%26aulast%3DM%25C3%25A9thot%26aufirst%3DN.%26aulast%3DRubin%26aufirst%3DJ.%26aulast%3DFriesen%26aufirst%3DR.%2BW.%26atitle%3DInhibitors%2520of%2520the%2520inducible%2520microsomal%2520prostaglandin%2520E2%2520synthase%2520%2528mPGES-1%2529%2520derived%2520from%2520MK-886%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3352%26epage%3D3355%26doi%3D10.1016%2Fj.bmcl.2005.05.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Mbalaviele, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweifel, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathialagan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mnich, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemirovskiy, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gierse, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masferrer, J. L.</span><span> </span><span class="NLM_article-title">Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1445</span><span class="NLM_x">–</span> <span class="NLM_lpage">1454</span><span class="refDoi"> DOI: 10.1016/j.bcp.2010.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1016%2Fj.bcp.2010.01.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=1445-1454&author=G.+Mbalavieleauthor=A.+M.+Pauleyauthor=A.+F.+Shafferauthor=B.+S.+Zweifelauthor=S.+Mathialaganauthor=S.+J.+Mnichauthor=O.+V.+Nemirovskiyauthor=J.+Carterauthor=J.+K.+Gierseauthor=J.+L.+Wangauthor=M.+L.+Vazquezauthor=W.+M.+Mooreauthor=J.+L.+Masferrer&title=Distinction+of+microsomal+prostaglandin+E+synthase-1+%28mPGES-1%29+inhibition+from+cyclooxygenase-2+inhibition+in+cells+using+a+novel%2C+selective+mPGES-1+inhibitor&doi=10.1016%2Fj.bcp.2010.01.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DMbalaviele%26aufirst%3DG.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DShaffer%26aufirst%3DA.%2BF.%26aulast%3DZweifel%26aufirst%3DB.%2BS.%26aulast%3DMathialagan%26aufirst%3DS.%26aulast%3DMnich%26aufirst%3DS.%2BJ.%26aulast%3DNemirovskiy%26aufirst%3DO.%2BV.%26aulast%3DCarter%26aufirst%3DJ.%26aulast%3DGierse%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DJ.%2BL.%26aulast%3DVazquez%26aufirst%3DM.%2BL.%26aulast%3DMoore%26aufirst%3DW.%2BM.%26aulast%3DMasferrer%26aufirst%3DJ.%2BL.%26atitle%3DDistinction%2520of%2520microsomal%2520prostaglandin%2520E%2520synthase-1%2520%2528mPGES-1%2529%2520inhibition%2520from%2520cyclooxygenase-2%2520inhibition%2520in%2520cells%2520using%2520a%2520novel%252C%2520selective%2520mPGES-1%2520inhibitor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D1445%26epage%3D1454%26doi%3D10.1016%2Fj.bcp.2010.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Arhancet, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heasley, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerome, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baratta, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweifel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masferrer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez, M. L.</span><span> </span><span class="NLM_article-title">Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1114</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1016%2Fj.bmcl.2012.11.109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1114-1119&author=G.+B.+Arhancetauthor=D.+P.+Walkerauthor=S.+Metzauthor=Y.+M.+Fobianauthor=S.+E.+Heasleyauthor=J.+S.+Carterauthor=J.+R.+Springerauthor=D.+E.+Jonesauthor=M.+J.+Hayesauthor=A.+F.+Shafferauthor=G.+M.+Jeromeauthor=M.+T.+Barattaauthor=B.+Zweifelauthor=W.+M.+Mooreauthor=J.+L.+Masferrerauthor=M.+L.+Vazquez&title=Discovery+and+SAR+of+PF-4693627%2C+a+potent%2C+selective+and+orally+bioavailable+mPGES-1+inhibitor+for+the+potential+treatment+of+inflammation&doi=10.1016%2Fj.bmcl.2012.11.109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.109%26sid%3Dliteratum%253Aachs%26aulast%3DArhancet%26aufirst%3DG.%2BB.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DMetz%26aufirst%3DS.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DHeasley%26aufirst%3DS.%2BE.%26aulast%3DCarter%26aufirst%3DJ.%2BS.%26aulast%3DSpringer%26aufirst%3DJ.%2BR.%26aulast%3DJones%26aufirst%3DD.%2BE.%26aulast%3DHayes%26aufirst%3DM.%2BJ.%26aulast%3DShaffer%26aufirst%3DA.%2BF.%26aulast%3DJerome%26aufirst%3DG.%2BM.%26aulast%3DBaratta%26aufirst%3DM.%2BT.%26aulast%3DZweifel%26aufirst%3DB.%26aulast%3DMoore%26aufirst%3DW.%2BM.%26aulast%3DMasferrer%26aufirst%3DJ.%2BL.%26aulast%3DVazquez%26aufirst%3DM.%2BL.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520PF-4693627%252C%2520a%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520mPGES-1%2520inhibitor%2520for%2520the%2520potential%2520treatment%2520of%2520inflammation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1114%26epage%3D1119%26doi%3D10.1016%2Fj.bmcl.2012.11.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span>To our knowledge, the structure of GRC27864 has not been disclosed. See: GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers. <a href="http://clinicaltrials.gov/ct2/show/NCT02179645" class="extLink">http://clinicaltrials.gov/ct2/show/NCT02179645</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=To+our+knowledge%2C+the+structure+of+GRC27864+has+not+been+disclosed.+See%3A+GRC+27864+First+in+Man%2C+Single+Ascending+Dose+Study+in+Healthy+Volunteers.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02179645."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.5b01249/suppl_file/jm5b01249_si_001.pdf" class="ext-link">Supporting Information</a> for details.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Huntjens, D. R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danhof, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Pasqua, O. E.</span><span> </span><span class="NLM_article-title">Pharmacokinetic–pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors</span> <span class="citation_source-journal">Rheumatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">846</span><span class="NLM_x">–</span> <span class="NLM_lpage">859</span><span class="refDoi"> DOI: 10.1093/rheumatology/keh627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1093%2Frheumatology%2Fkeh627" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=846-859&author=D.+R.+H.+Huntjensauthor=M.+Danhofauthor=O.+E.+Della+Pasqua&title=Pharmacokinetic%E2%80%93pharmacodynamic+correlations+and+biomarkers+in+the+development+of+COX-2+inhibitors&doi=10.1093%2Frheumatology%2Fkeh627"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2Fkeh627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252Fkeh627%26sid%3Dliteratum%253Aachs%26aulast%3DHuntjens%26aufirst%3DD.%2BR.%2BH.%26aulast%3DDanhof%26aufirst%3DM.%26aulast%3DDella%2BPasqua%26aufirst%3DO.%2BE.%26atitle%3DPharmacokinetic%25E2%2580%2593pharmacodynamic%2520correlations%2520and%2520biomarkers%2520in%2520the%2520development%2520of%2520COX-2%2520inhibitors%26jtitle%3DRheumatology%26date%3D2005%26volume%3D44%26spage%3D846%26epage%3D859%26doi%3D10.1093%2Frheumatology%2Fkeh627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><div class="note"><p class="first last">Due to the short half-life of TXA<sub>2</sub>, TXB<sub>2</sub> is frequently used as a marker for TXA<sub>2</sub> production. See:</p></div><span class="NLM_contrib-group">Kyrle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichler, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jäger, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, K.</span><span> </span><span class="NLM_article-title">Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span><span class="refDoi"> DOI: 10.1161/01.CIR.75.5.1025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1161%2F01.CIR.75.5.1025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1987&pages=1025-1029&author=P.+A.+Kyrleauthor=H.+G.+Eichlerauthor=U.+J%C3%A4gerauthor=K.+Lechner&title=Inhibition+of+prostacyclin+and+thromboxane+A2+generation+by+low-dose+aspirin+at+the+site+of+plug+formation+in+man+in+vivo&doi=10.1161%2F01.CIR.75.5.1025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1161%2F01.CIR.75.5.1025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.CIR.75.5.1025%26sid%3Dliteratum%253Aachs%26aulast%3DKyrle%26aufirst%3DP.%2BA.%26aulast%3DEichler%26aufirst%3DH.%2BG.%26aulast%3DJ%25C3%25A4ger%26aufirst%3DU.%26aulast%3DLechner%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520prostacyclin%2520and%2520thromboxane%2520A2%2520generation%2520by%2520low-dose%2520aspirin%2520at%2520the%2520site%2520of%2520plug%2520formation%2520in%2520man%2520in%2520vivo%26jtitle%3DCirculation%26date%3D1987%26volume%3D75%26spage%3D1025%26epage%3D1029%26doi%3D10.1161%2F01.CIR.75.5.1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Tacconelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capone, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciulli, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricciotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrignani, P.</span><span> </span><span class="NLM_article-title">The Biochemical Selectivity of Novel COX-2 Inhibitors in Whole Blood Assays of COX-isozyme Activity</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span><span class="refDoi"> DOI: 10.1185/030079902125001335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1185%2F030079902125001335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=12564662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhs1Wku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2002&pages=503-511&author=S.+Tacconelliauthor=M.+L.+Caponeauthor=M.+G.+Sciulliauthor=E.+Ricciottiauthor=P.+Patrignani&title=The+Biochemical+Selectivity+of+Novel+COX-2+Inhibitors+in+Whole+Blood+Assays+of+COX-isozyme+Activity&doi=10.1185%2F030079902125001335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity</span></div><div class="casAuthors">Tacconelli, Stefania; Capone, Marta L.; Sciulli, Maria G.; Ricciotti, Emanuela; Patrignani, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">503-511</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">LibraPharm Ltd.</span>)
        </div><div class="casAbstract">We have evaluated the biochem. selectivity of novel cyclo-oxygenase (COX)-2 inhibitors, etoricoxib, valdecoxib/, DFU and DFP, vs. rofecoxib and celecoxib, using the human whole blood assays of COX-isoenzyme activity, in vitro.  Compds. were incubated with human whole blood samples, allowed to clot for 1 h at 37°, or stimulated with lipopolysaccharide (10 μg/mL) for 24 h at 37°.  Serum thromboxane (TX) B2 and plasma prostaglandin (PG) E2 levels were measured by specific RIAs as indexes of platelet COX-1 and monocyte COX-2 activity, resp.  Valdecoxib, etoricoxib, DFU and DFP inhibited platelet COX-1 and monocyte COX-2 with the following COX-1/COX-2 IC50 ratios: 61.5, 344, 660 and 1918, resp.  The ref. compds., celecoxib and rofecoxib had corresponding values of 29.6 and 272.  In conclusion, a second wave of COX-2 inhibitors with higher biochem. selectivity than the existing coxibs has been developed.  Whether their administration will be assocd. with improved clin. efficacy and/or safety visa-vis celecoxib and rofecoxib remains to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXp52P5XevwrVg90H21EOLACvtfcHk0li02HRE-jZFJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhs1Wku7c%253D&md5=6adbff0cb04b5f79618387d63efef8d5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1185%2F030079902125001335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F030079902125001335%26sid%3Dliteratum%253Aachs%26aulast%3DTacconelli%26aufirst%3DS.%26aulast%3DCapone%26aufirst%3DM.%2BL.%26aulast%3DSciulli%26aufirst%3DM.%2BG.%26aulast%3DRicciotti%26aufirst%3DE.%26aulast%3DPatrignani%26aufirst%3DP.%26atitle%3DThe%2520Biochemical%2520Selectivity%2520of%2520Novel%2520COX-2%2520Inhibitors%2520in%2520Whole%2520Blood%2520Assays%2520of%2520COX-isozyme%2520Activity%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2002%26volume%3D18%26spage%3D503%26epage%3D511%26doi%3D10.1185%2F030079902125001335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">In our hands, the IC<sub>50</sub> of celecoxib for PGE<sub>2</sub> reduction in LPS-stimulated HWB was 425 nM ×/÷ 2.00 (<i>n</i> = 372). See <a href="/doi/suppl/10.1021/acs.jmedchem.5b01249/suppl_file/jm5b01249_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Paulson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughn, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessen, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawal, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gresk, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maziasz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karim, A.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of Celecoxib after Oral Administration in Dogs and Humans: Effect of Food and Site of Absorption</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=11303053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1Wlsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2001&pages=638-648&author=S.+K.+Paulsonauthor=M.+B.+Vaughnauthor=S.+M.+Jessenauthor=Y.+Lawalauthor=C.+J.+Greskauthor=B.+Yanauthor=T.+J.+Maziaszauthor=C.+S.+Cookauthor=A.+Karim&title=Pharmacokinetics+of+Celecoxib+after+Oral+Administration+in+Dogs+and+Humans%3A+Effect+of+Food+and+Site+of+Absorption"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption</span></div><div class="casAuthors">Paulson, Susan K.; Vaughn, Margaret B.; Jessen, Susan M.; Lawal, Yvette; Gresk, Christopher J.; Yan, Bo; Maziasz, Timothy J.; Cook, Chyung S.; Karim, Aziz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">638-645</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Celecoxib pharmacokinetics was evaluated after single and multiple oral dosing; after dosing in a soln. and as a solid; with and without food; and after administration into different sites of the GI tract using dog.  After oral dosing in a soln., celecoxib was rapidly absorbed and reached max. concns. by 1 h; absorption was delayed another 1 to 2 h when administered as a solid.  The abs. bioavailability of celecoxib was higher when given as a soln. (64-88%) compared with capsule (22-40%).  The absorption of celecoxib given in a capsule was delayed by food, although systemic exposure increased by 3- to 5-fold.  The systemic availability of celecoxib given intragastrically in soln. was similar to that obtained following direct instillation into the duodenum, jejunum, or colon through a chronic intestinal access port.  Collectively, these data suggest that celecoxib is a highly permeable drug that can be absorbed throughout the GI tract and that dissoln. may be a rate-limiting factor for absorption from solid dosage forms.  Unlike dogs, celecoxib given to humans with a high fat meal exhibits only a slight increase in AUCo-∞ (11%) that is not clin. significant with regard to safety of efficacy.  In humans, a lower dose and a longer GI residence time may promote the opportunity for absorption of a poorly sol. drug such as celecoxib that can be absorbed throughout the GI tract.  This would minimize the effect of food on absorption; as such, patients with arthritis can be given celecoxib with or without food.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEL8NF2Q6F4LVg90H21EOLACvtfcHk0li02HRE-jZFJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1Wlsbw%253D&md5=f5041ca44c2ec46273624ca712ea8c48</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaulson%26aufirst%3DS.%2BK.%26aulast%3DVaughn%26aufirst%3DM.%2BB.%26aulast%3DJessen%26aufirst%3DS.%2BM.%26aulast%3DLawal%26aufirst%3DY.%26aulast%3DGresk%26aufirst%3DC.%2BJ.%26aulast%3DYan%26aufirst%3DB.%26aulast%3DMaziasz%26aufirst%3DT.%2BJ.%26aulast%3DCook%26aufirst%3DC.%2BS.%26aulast%3DKarim%26aufirst%3DA.%26atitle%3DPharmacokinetics%2520of%2520Celecoxib%2520after%2520Oral%2520Administration%2520in%2520Dogs%2520and%2520Humans%253A%2520Effect%2520of%2520Food%2520and%2520Site%2520of%2520Absorption%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D297%26spage%3D638%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">All IC<sub>50</sub> and IC<sub>80</sub> values are reported as geometric means times or divided by geometric standard deviations.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Luz, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonysamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuklish, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. J.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-inflammatory Therapeutics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4727</span><span class="NLM_x">–</span> <span class="NLM_lpage">4737</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00330</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00330" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BC2MXot1Srsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4727-4737&author=J.+G.+Luzauthor=S.+Antonysamyauthor=S.+L.+Kuklishauthor=B.+Condonauthor=M.+Leeauthor=D.+Allisonauthor=X.-P.+Yuauthor=R.+Backerauthor=A.+Zhangauthor=M.+Russellauthor=S.+S.+Changauthor=A.+Harveyauthor=A.+V.+Sloanauthor=M.+J.+Fisher&title=Crystal+Structures+of+mPGES-1+Inhibitor+Complexes+Form+a+Basis+for+the+Rational+Design+of+Potent+Analgesic+and+Anti-inflammatory+Therapeutics&doi=10.1021%2Facs.jmedchem.5b00330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics</span></div><div class="casAuthors">Luz, John Gately; Antonysamy, Stephen; Kuklish, Steven L.; Condon, Bradley; Lee, Matthew R.; Allison, Dagart; Yu, Xiao-Peng; Chandrasekhar, Srinivasan; Backer, Ryan; Zhang, Aiping; Russell, Marijane; Chang, Shawn S.; Harvey, Anita; Sloan, Ashley V.; Fisher, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4727-4737</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Microsomal prostaglandin E synthase 1 (mPGES-1) is an α-helical homotrimeric integral membrane inducible enzyme that catalyzes the formation of prostaglandin E2 (PGE2) from prostaglandin H2 (PGH2).  Inhibition of mPGES-1 has been proposed as a therapeutic strategy for the treatment of pain, inflammation, and some cancers.  Interest in mPGES-1 inhibition can, in part, be attributed to the potential circumvention of cardiovascular risks assocd. with anti-inflammatory cyclooxygenase 2 inhibitors (coxibs) by targeting the prostaglandin pathway downstream of PGH2 synthesis and avoiding suppression of antithrombotic prostacyclin prodn.  We detd. the crystal structure of mPGES-1 bound to four potent inhibitors in order to understand their structure-activity relationships and provide a framework for the rational design of improved mols.  In addn., we developed a light-scattering-based thermal stability assay to identify mols. for crystallog. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovxJRoDSaZVbVg90H21EOLACvtfcHk0lhlUOotgSnUWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXot1Srsrg%253D&md5=d02b757118396726c57657a8321bc289</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00330%26sid%3Dliteratum%253Aachs%26aulast%3DLuz%26aufirst%3DJ.%2BG.%26aulast%3DAntonysamy%26aufirst%3DS.%26aulast%3DKuklish%26aufirst%3DS.%2BL.%26aulast%3DCondon%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DAllison%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DX.-P.%26aulast%3DBacker%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DS.%2BS.%26aulast%3DHarvey%26aufirst%3DA.%26aulast%3DSloan%26aufirst%3DA.%2BV.%26aulast%3DFisher%26aufirst%3DM.%2BJ.%26atitle%3DCrystal%2520Structures%2520of%2520mPGES-1%2520Inhibitor%2520Complexes%2520Form%2520a%2520Basis%2520for%2520the%2520Rational%2520Design%2520of%2520Potent%2520Analgesic%2520and%2520Anti-inflammatory%2520Therapeutics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4727%26epage%3D4737%26doi%3D10.1021%2Facs.jmedchem.5b00330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="note"><p class="first last">For additional results from the A549 and HWB assays, see <a href="/doi/suppl/10.1021/acs.jmedchem.5b01249/suppl_file/jm5b01249_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="note"><p class="first last">COX inhibition was determined using assays essentially as described in ref <a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">30</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Riley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grime, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, R.</span><span> </span><span class="NLM_article-title">Time-dependent CYP inhibition</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><span class="refDoi"> DOI: 10.1517/17425255.3.1.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1517%2F17425255.3.1.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=17269894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=51-66&author=R.+J.+Rileyauthor=K.+Grimeauthor=R.+Weaver&title=Time-dependent+CYP+inhibition&doi=10.1517%2F17425255.3.1.51"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Time-dependent CYP inhibition</span></div><div class="casAuthors">Riley, Robert J.; Grime, Ken; Weaver, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-66</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Time-dependent inhibition (TDI) of CYP refers to a change in potency during an in vitro incubation or dosing period in vivo.  Potential mechanisms include the formation of inhibitory metabolites and mechanism-based inhibition (MBI).  In vitro expts. are configured to assess TDI and MBI is inferred, at least initially.  MBI is more profound after multiple-dosing and the recovery period is independent of continued drug exposure.  Advances in in vitro-in vivo extrapolations for competitive inhibition and the potential relationship between MBI and reactive metabolite-mediated toxicity, have redirected emphasis to CYP TDI.  In contrast, with reversible inhibition, strategies for projecting the risks from TDI are less developed and the traditional I/Ki model often yields a dramatic underprediction.  This review explores the contribution of TDI to drug-drug interactions and idiosyncratic drug toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8w1eAZ9QULVg90H21EOLACvtfcHk0lhlUOotgSnUWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGlurY%253D&md5=184636ac0768f51d65f407a0655233e4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1517%2F17425255.3.1.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.3.1.51%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DGrime%26aufirst%3DK.%26aulast%3DWeaver%26aufirst%3DR.%26atitle%3DTime-dependent%2520CYP%2520inhibition%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2007%26volume%3D3%26spage%3D51%26epage%3D66%26doi%3D10.1517%2F17425255.3.1.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">De Bruin, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyboom, R. H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoes, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leufkens, H. G. M.</span><span> </span><span class="NLM_article-title">Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">590</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span><span class="refDoi"> DOI: 10.1093/eurheartj/ehi092</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1093%2Feurheartj%2Fehi092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=15637086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksFCns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=590-597&author=M.+L.+De+Bruinauthor=M.+Petterssonauthor=R.+H.+B.+Meyboomauthor=A.+W.+Hoesauthor=H.+G.+M.+Leufkens&title=Anti-HERG+activity+and+the+risk+of+drug-induced+arrhythmias+and+sudden+death&doi=10.1093%2Feurheartj%2Fehi092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death</span></div><div class="casAuthors">De Bruin, M. L.; Pettersson, M.; Meyboom, R. H. B.; Hoes, A. W.; Leufkens, H. G. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Heart Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">590-597</span>CODEN:
                <span class="NLM_cas:coden">EHJODF</span>;
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Drug-induced QTc-prolongation, resulting from inhibition of HERG potassium channels may lead to serious ventricular arrhythmias and sudden death.  We studied the quant. anti-HERG activity of pro-arrhythmic drugs as a risk factor for this outcome in day-to-day practice.  All 284 426 case reports of suspected adverse drug reactions of drugs with known anti-HERG activity received by the International Drug Monitoring Program of the World Health Organization (WHO-UMC) up to the first quarter of 2003, were used to calc. reporting odds ratios (RORs).  Cases were defined as reports of cardiac arrest, sudden death, torsade de pointes, ventricular fibrillation, and ventricular tachycardia (n = 5591), and compared with non-cases regarding the anti-HERG activity, defined as the effective therapeutic plasma concn. (ETCPunbound) divided by the HERG IC50 value, of suspected drugs.  We identified a significant assocn. of 1.93 (95% CI: 1.89-1.98) between the anti-HERG activity of drugs, measured as logo (ETCPunbound/IC50), and reporting of serious ventricular arrhythmias and sudden death to the WHO-UMC database.  Anti-HERG activity is assocd. with the risk of reports of serious ventricular arrhythmias and sudden death in the WHO-UMC database.  These findings are in support of the value of pre-clin. HERG testing to predict pro-arrhythmic effects of medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphZ75xPspJQrVg90H21EOLACvtfcHk0lhlUOotgSnUWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksFCns70%253D&md5=f998055d70fcd947341358cf4cd84481</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1093%2Feurheartj%2Fehi092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Feurheartj%252Fehi092%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBruin%26aufirst%3DM.%2BL.%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DMeyboom%26aufirst%3DR.%2BH.%2BB.%26aulast%3DHoes%26aufirst%3DA.%2BW.%26aulast%3DLeufkens%26aufirst%3DH.%2BG.%2BM.%26atitle%3DAnti-HERG%2520activity%2520and%2520the%2520risk%2520of%2520drug-induced%2520arrhythmias%2520and%2520sudden%2520death%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2005%26volume%3D26%26spage%3D590%26epage%3D597%26doi%3D10.1093%2Feurheartj%2Fehi092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.5b01249/suppl_file/jm5b01249_si_001.pdf" class="ext-link">Supporting Information</a> for further <i>in vitro</i> characterization of <b>8</b> and <b>26</b>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Leclerc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawelzik, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idborg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spahiu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korotkova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobsson, P.-J.</span><span> </span><span class="NLM_article-title">Characterization of a new mPGES-1 inhibitor in rat models of inflammation</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">102–103</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/j.prostaglandins.2013.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1016%2Fj.prostaglandins.2013.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=23528231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVGgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102%E2%80%93103&publication_year=2013&pages=1-12&author=P.+Leclercauthor=S.-C.+Pawelzikauthor=H.+Idborgauthor=L.+Spahiuauthor=C.+Larssonauthor=P.+Stenbergauthor=M.+Korotkovaauthor=P.-J.+Jakobsson&title=Characterization+of+a+new+mPGES-1+inhibitor+in+rat+models+of+inflammation&doi=10.1016%2Fj.prostaglandins.2013.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a new mPGES-1 inhibitor in rat models of inflammation</span></div><div class="casAuthors">Leclerc, Patrick; Pawelzik, Sven-Christian; Idborg, Helena; Spahiu, Linda; Larsson, Charlotte; Stenberg, Patric; Korotkova, Marina; Jakobsson, Per-Johan</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins and Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102-103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Microsomal prostaglandin E synthase (mPGES)-1 inhibition has been proposed as an alternative to cyclooxygenase (COX) inhibition in the treatment of pain and inflammation.  This novel approach could potentially mitigate the gastro-intestinal and cardiovascular side effects seen after long-term treatment with traditional non-steroidal anti-inflammatory drugs (NSAIDs) and Coxibs resp.  Several human mPGES-1 inhibitors have been developed in the recent years.  However, they were all shown to be considerably less active on rodent mPGES-1, precluding the study of mPGES-1 inhibition in rodent models of inflammation and pain.  The aim of this study was to characterize the new mPGES-1 inhibitor compd. II, a pyrazolone that has similar potency on rat and human recombinant mPGES-1, in exptl. models of inflammation.  In cell culture, compd. II inhibited PGE2 prodn. in synovial fibroblasts from patients with rheumatoid arthritis (RASF) and in rat peritoneal macrophages.  In vivo, compd. II was first characterized in the rat air pouch model of inflammation where treatment inhibited intra-pouch PGE2 prodn.  Compd. II was also investigated in a rat adjuvant-induced arthritis model where it attenuated both the acute and delayed inflammatory responses.  In conclusion, compd. II represents a valuable pharmacol. tool for the study of mPGES-1 inhibition in rat models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCqs3q8nycd7Vg90H21EOLACvtfcHk0lj25N4gLd0i3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVGgt7w%253D&md5=e00007f3fe1312007db2979a37b8915f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2013.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2013.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DLeclerc%26aufirst%3DP.%26aulast%3DPawelzik%26aufirst%3DS.-C.%26aulast%3DIdborg%26aufirst%3DH.%26aulast%3DSpahiu%26aufirst%3DL.%26aulast%3DLarsson%26aufirst%3DC.%26aulast%3DStenberg%26aufirst%3DP.%26aulast%3DKorotkova%26aufirst%3DM.%26aulast%3DJakobsson%26aufirst%3DP.-J.%26atitle%3DCharacterization%2520of%2520a%2520new%2520mPGES-1%2520inhibitor%2520in%2520rat%2520models%2520of%2520inflammation%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2013%26volume%3D102%25E2%2580%2593103%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.prostaglandins.2013.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span>Due to the inability of <b>8</b> and <b>26</b> to inhibit rat or mouse <i>m</i>PGES-1, <i>in vivo</i> efficacy studies in those species were untenable. However, efficacy studies were performed in guinea pigs and will be reported in due course. See: <span class="NLM_contrib-group">Chandrasekhar, S.; Harvey, A. K.; Yu, X.-P.; Chambers, M. G.; Oskins, J. L.; Lin, C.; Seng, T. W.; Thibodeaux, S. J.; Norman, B. H.; Hughes, N. E.; Schiffler, M. A.; Fisher, M. J.</span> Manuscript in preparation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Due+to+the+inability+of+8+and+26+to+inhibit+rat+or+mouse+mPGES-1%2C+in+vivo+efficacy+studies+in+those+species+were+untenable.+However%2C+efficacy+studies+were+performed+in+guinea+pigs+and+will+be+reported+in+due+course.+See%3A+Chandrasekhar%2C+S.%3B+Harvey%2C+A.+K.%3B+Yu%2C+X.-P.%3B+Chambers%2C+M.+G.%3B+Oskins%2C+J.+L.%3B+Lin%2C+C.%3B+Seng%2C+T.+W.%3B+Thibodeaux%2C+S.+J.%3B+Norman%2C+B.+H.%3B+Hughes%2C+N.+E.%3B+Schiffler%2C+M.+A.%3B+Fisher%2C+M.+J.+Manuscript+in+preparation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DChandrasekhar%26aufirst%3DS." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Brouwers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brewster, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustijns, P.</span><span> </span><span class="NLM_article-title">Supersaturating drug delivery systems: The answer to solubility-limited oral bioavailability?</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">2549</span><span class="NLM_x">–</span> <span class="NLM_lpage">2572</span><span class="refDoi"> DOI: 10.1002/jps.21650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1002%2Fjps.21650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=19373886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1eqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2009&pages=2549-2572&author=J.+Brouwersauthor=M.+E.+Brewsterauthor=P.+Augustijns&title=Supersaturating+drug+delivery+systems%3A+The+answer+to+solubility-limited+oral+bioavailability%3F&doi=10.1002%2Fjps.21650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Supersaturating drug delivery systems: The answer to solubility-limited oral bioavailability?</span></div><div class="casAuthors">Brouwers, Joachim; Brewster, Marcus E.; Augustijns, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2549-2572</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Contemporary pharmaceutical pipelines are often highly populated with poorly water-sol. drug candidates necessitating novel formulation technologies to provide dosage forms with appropriate biopharmaceutical properties.  The configuration of supersaturating drug delivery systems (SDDS) is a promising concept to obtain adequate oral bioavailability.  SDDS contain the drug in a high energy or otherwise rapidly dissolving form such that intraluminal concns. above the satn. soly. of the drug are generated.  For the strategy to be useful, the formed supersatd. soln. must then be stabilized to allow for significant absorption and eventually sufficient bioavailability.  The stabilization of a supersatd. soln. can be accomplished by adding pptn. inhibitors which may act through a variety of mechanisms.  The goal of this review is to assess methods and excipients assocd. with the development of SDDS and provide some context for their use.  In addn., the future directions and factors likely to contribute to or detract from optimal dosage form selection are assessed.  This includes a discussion on the potential effect of the gastrointestinal physiol. on the ability to attain and maintain supersatn. as this information is essential in designing useful formulations based on the supersaturating concept.  © 2009 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci 98:2549-2572, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjyLXZB5OgNLVg90H21EOLACvtfcHk0lj25N4gLd0i3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1eqt7s%253D&md5=f5de4aee34adef042e124f061b36534e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fjps.21650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21650%26sid%3Dliteratum%253Aachs%26aulast%3DBrouwers%26aufirst%3DJ.%26aulast%3DBrewster%26aufirst%3DM.%2BE.%26aulast%3DAugustijns%26aufirst%3DP.%26atitle%3DSupersaturating%2520drug%2520delivery%2520systems%253A%2520The%2520answer%2520to%2520solubility-limited%2520oral%2520bioavailability%253F%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D98%26spage%3D2549%26epage%3D2572%26doi%3D10.1002%2Fjps.21650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Takano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aso, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, S.</span><span> </span><span class="NLM_article-title">Quantitative Analysis of the Effect of Supersaturation on in Vivo Drug Absorption</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1431</span><span class="NLM_x">–</span> <span class="NLM_lpage">1440</span><span class="refDoi"> DOI: 10.1021/mp100109a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp100109a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVSmsLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=1431-1440&author=R.+Takanoauthor=N.+Takataauthor=R.+Saitoauthor=K.+Furumotoauthor=S.+Higoauthor=Y.+Hayashiauthor=M.+Machidaauthor=Y.+Asoauthor=S.+Yamashita&title=Quantitative+Analysis+of+the+Effect+of+Supersaturation+on+in+Vivo+Drug+Absorption&doi=10.1021%2Fmp100109a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative Analysis of the Effect of Supersaturation on in Vivo Drug Absorption</span></div><div class="casAuthors">Takano, Ryusuke; Takata, Noriyuki; Saito, Ryoichi; Furumoto, Kentaro; Higo, Shoichi; Hayashi, Yoshiki; Machida, Minoru; Aso, Yoshinori; Yamashita, Shinji</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1431-1440</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The purpose of this study is to clarify the effects of intestinal drug supersatn. on soly.-limited nonlinear absorption.  Oral absorption of a novel farnesyltransferase inhibitor (FTI-2600) from its cryst. free base and its HCl salt was detd. in dogs.  To clarify the contribution of supersatn. on improving drug absorption, in vivo intraluminal concn. of FTI-2600 after oral administration was estd. from the pharmacokinetics data using a physiol. based model.  Dissoln. and pptn. characteristics of FTI-2600 in a biorelevant media were investigated in vitro using a miniscale dissoln. test and powder X-ray diffraction anal.  In the in vitro study, the HCl salt immediately dissolved but pptd. rapidly.  The metastable amorphous free base precipitant, which did not convert into the stable cryst. free base in the simulated intestinal fluids for several hours, generated a 5-fold increase in dissolved concn. compared to the equil. soly. of the cryst. free base.  By computer simulation, the intraluminal drug concn. after administration of the free base was estd. to reach the satd. soly., indicating soly.-limited absorption.  On the other hand, administration of the HCl salt resulted in an increased intraluminal concn. and the plasma concn. was 400% greater than that after administration of the free base.  This in vivo/in vitro correlation of the increased drug concns. in the small intestine provide clear evidence that not only the increase in the dissoln. rate, but also the supersatn. phenomenon, improved the soly.-limited absorption of FTI-2600.  These results indicate that formulation technologies that can induce supersatn. may be of great assistance to the successful development of poorly water-sol. drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruX0KFuq6W67Vg90H21EOLACvtfcHk0ljDUAb8sWhvgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVSmsLjM&md5=f77bb6b9ed56b857b85a1866bc539eaa</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fmp100109a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp100109a%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DR.%26aulast%3DTakata%26aufirst%3DN.%26aulast%3DSaito%26aufirst%3DR.%26aulast%3DFurumoto%26aufirst%3DK.%26aulast%3DHigo%26aufirst%3DS.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DMachida%26aufirst%3DM.%26aulast%3DAso%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DS.%26atitle%3DQuantitative%2520Analysis%2520of%2520the%2520Effect%2520of%2520Supersaturation%2520on%2520in%2520Vivo%2520Drug%2520Absorption%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2010%26volume%3D7%26spage%3D1431%26epage%3D1440%26doi%3D10.1021%2Fmp100109a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><div class="note"><p class="first last">Performed per the procedure described in:</p></div><span class="NLM_contrib-group">Bhattachar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, L. J.</span><span> </span><span class="NLM_article-title">Effect of gastric pH on the pharmacokinetics of a bcs class II compound in dogs: Utilization of an artificial stomach and duodenum dissolution model and gastroplus, simulations to predict absorption</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4756</span><span class="NLM_x">–</span> <span class="NLM_lpage">4765</span><span class="refDoi"> DOI: 10.1002/jps.22669</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1002%2Fjps.22669" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4756-4765&author=S.+Bhattacharauthor=E.+J.+Perkinsauthor=J.+S.+Tanauthor=L.+J.+Burns&title=Effect+of+gastric+pH+on+the+pharmacokinetics+of+a+bcs+class+II+compound+in+dogs%3A+Utilization+of+an+artificial+stomach+and+duodenum+dissolution+model+and+gastroplus%2C+simulations+to+predict+absorption&doi=10.1002%2Fjps.22669"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fjps.22669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22669%26sid%3Dliteratum%253Aachs%26aulast%3DBhattachar%26aufirst%3DS.%26aulast%3DPerkins%26aufirst%3DE.%2BJ.%26aulast%3DTan%26aufirst%3DJ.%2BS.%26aulast%3DBurns%26aufirst%3DL.%2BJ.%26atitle%3DEffect%2520of%2520gastric%2520pH%2520on%2520the%2520pharmacokinetics%2520of%2520a%2520bcs%2520class%2520II%2520compound%2520in%2520dogs%253A%2520Utilization%2520of%2520an%2520artificial%2520stomach%2520and%2520duodenum%2520dissolution%2520model%2520and%2520gastroplus%252C%2520simulations%2520to%2520predict%2520absorption%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4756%26epage%3D4765%26doi%3D10.1002%2Fjps.22669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Bartroli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turmo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alguero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boncompte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vericat, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Rafanell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forn, J.</span><span> </span><span class="NLM_article-title">Synthesis and Antifungal Activity of New Azole Derivatives Containing an <i>N</i>-Acylmorpholine Ring</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3918</span><span class="NLM_x">–</span> <span class="NLM_lpage">3932</span><span class="refDoi"> DOI: 10.1021/jm00020a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00020a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaK2MXnvFSqs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3918-3932&author=J.+Bartroliauthor=E.+Turmoauthor=M.+Algueroauthor=E.+Boncompteauthor=M.+L.+Vericatauthor=J.+Garcia-Rafanellauthor=J.+Forn&title=Synthesis+and+Antifungal+Activity+of+New+Azole+Derivatives+Containing+an+N-Acylmorpholine+Ring&doi=10.1021%2Fjm00020a005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antifungal Activity of New Azole Derivatives Containing an N-Acylmorpholine Ring</span></div><div class="casAuthors">Bartroli, Javier; Turmo, Enric; Alguero, Monica; Boncompte, Eulalia; Vericat, Maria L.; Garcia-Rafanell, Julian; Forn, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3918-32</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of azole derivs. carrying an N-acylmorpholine ring are described.  The compds. were chem. designed to simulate the lanosterol D ring, taking advantage of the conformational preferences of 2-alkyl-1-acylmorpholines.  Three structural variables, the nature of the N-benzoyl group, the Ph substituents, and the degree of oxidn. at carbon 2 of the morpholine, were optimized for max. activity.  Only the (5R,6R) isomers showed antifungal activity.  Cyclic hemiacetal (-)-6-(2,4-difluorophenyl)-5-methyl-6-[(2H-1,2,4-triazol-2-yl)methyl]-4-[4-(trifluoromethyl)benzoyl]-2-morpholinol (UR-9746) (I) and cyclic ether (-)-2-(2,4-difluorophenyl)-3-methyl-2-[(2H-1,2,4-triazol-2-yl)methyl]-4-[4-(trifluoromethyl)benzoyl]morpholine (UR-9751) (II) were selected for further development.  In vitro, II was clearly more active than (-)-39 and somewhat less active than the acyclic counterpart (-)-N-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-(trifluoromethyl)benzamide.  In vivo activity was assessed by a systemic (mouse) and a vaginal (rat) candidiasis model.  In the former, I, II, and (-)-N-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-(trifluoromethyl)benzamide at 1 mg/kg given 1, 4, and 24 h postinfection displayed 90-100% protection from mortality on day 9.  Compd. I was slightly more potent than II and similar in potency to (-)-N-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-(trifluoromethyl)benzamide.  The three compds. were superior in potency to fluconazole and similar in potency to SCH-42427 in this test.  In the vaginal model, I and II given daily during 3 days after infection at 0.5 mg/kg showed high levels of protection on days 10 and 15.  At 0.25 mg/kg, I was slightly more potent than SCH-42427 and (-)-N-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-(trifluoromethyl)benzamide and superior in potency to II and fluconazole in this model.  Preliminary 28-day toxicity tests at 100 mg/kg/day po in rats indicated no or very mild adverse effects for the two UR compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFsd4wq91fsLVg90H21EOLACvtfcHk0ljDUAb8sWhvgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnvFSqs7k%253D&md5=102892e57052be2334ac20f2f3776965</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm00020a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00020a005%26sid%3Dliteratum%253Aachs%26aulast%3DBartroli%26aufirst%3DJ.%26aulast%3DTurmo%26aufirst%3DE.%26aulast%3DAlguero%26aufirst%3DM.%26aulast%3DBoncompte%26aufirst%3DE.%26aulast%3DVericat%26aufirst%3DM.%2BL.%26aulast%3DGarcia-Rafanell%26aufirst%3DJ.%26aulast%3DForn%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Antifungal%2520Activity%2520of%2520New%2520Azole%2520Derivatives%2520Containing%2520an%2520N-Acylmorpholine%2520Ring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3918%26epage%3D3932%26doi%3D10.1021%2Fjm00020a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Fajgelj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanovnik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tišler, M.</span><span> </span><span class="NLM_article-title">Transformations of <i>N</i>-Heteroarylformamidines. A Novel Synthesis of Imidazo/2,1-b/thiazole and Imidazo/2,1-b//1,3,4/thiadiazole Derivatives</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span><span class="refDoi"> DOI: 10.3987/R-1986-02-0379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.3987%2FR-1986-02-0379" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1986&pages=379-386&author=S.+Fajgeljauthor=B.+Stanovnikauthor=M.+Ti%C5%A1ler&title=Transformations+of+N-Heteroarylformamidines.+A+Novel+Synthesis+of+Imidazo%2F2%2C1-b%2Fthiazole+and+Imidazo%2F2%2C1-b%2F%2F1%2C3%2C4%2Fthiadiazole+Derivatives&doi=10.3987%2FR-1986-02-0379"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3987%2FR-1986-02-0379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FR-1986-02-0379%26sid%3Dliteratum%253Aachs%26aulast%3DFajgelj%26aufirst%3DS.%26aulast%3DStanovnik%26aufirst%3DB.%26aulast%3DTi%25C5%25A1ler%26aufirst%3DM.%26atitle%3DTransformations%2520of%2520N-Heteroarylformamidines.%2520A%2520Novel%2520Synthesis%2520of%2520Imidazo%252F2%252C1-b%252Fthiazole%2520and%2520Imidazo%252F2%252C1-b%252F%252F1%252C3%252C4%252Fthiadiazole%2520Derivatives%26jtitle%3DHeterocycles%26date%3D1986%26volume%3D24%26spage%3D379%26epage%3D386%26doi%3D10.3987%2FR-1986-02-0379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Desirant, Y.</span><span> </span><span class="NLM_article-title">Ethyl difluoroacetylacetate</span> <span class="citation_source-journal">Bull. Soc. Chim. Belg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1930</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">143</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADyaA3cXjslalug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1930&pages=143-156&author=Y.+Desirant&title=Ethyl+difluoroacetylacetate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Ethyl difluoroacetylacetate</span></div><div class="casAuthors">Desirant, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin des Societes Chimiques Belges</span>
        (<span class="NLM_cas:date">1930</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">143-56</span>CODEN:
                <span class="NLM_cas:coden">BSCBAG</span>;
        ISSN:<span class="NLM_cas:issn">0037-9646</span>.
    </div><div class="casAbstract">See C. A. 24, 3493.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDaNhIW19K-7Vg90H21EOLACvtfcHk0ljYJkGpMDTHxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA3cXjslalug%253D%253D&md5=509fed338703e77bb46e157c4d9e2b54</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDesirant%26aufirst%3DY.%26atitle%3DEthyl%2520difluoroacetylacetate%26jtitle%3DBull.%2520Soc.%2520Chim.%2520Belg.%26date%3D1930%26volume%3D39%26spage%3D143%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Vorbrueggen, H.</span><span> </span><span class="NLM_article-title">Esterification of Carboxylic Acids and Etherification of Phenols with Amide Acetals</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">1603</span><span class="NLM_x">–</span> <span class="NLM_lpage">1617</span><span class="refDoi"> DOI: 10.1055/s-2008-1077882</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1055%2Fs-2008-1077882" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2008&publication_year=2008&pages=1603-1617&author=H.+Vorbrueggen&title=Esterification+of+Carboxylic+Acids+and+Etherification+of+Phenols+with+Amide+Acetals&doi=10.1055%2Fs-2008-1077882"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1055%2Fs-2008-1077882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2008-1077882%26sid%3Dliteratum%253Aachs%26aulast%3DVorbrueggen%26aufirst%3DH.%26atitle%3DEsterification%2520of%2520Carboxylic%2520Acids%2520and%2520Etherification%2520of%2520Phenols%2520with%2520Amide%2520Acetals%26jtitle%3DSynlett%26date%3D2008%26volume%3D2008%26spage%3D1603%26epage%3D1617%26doi%3D10.1055%2Fs-2008-1077882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span><span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lhppzeHow_wdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damu, G. L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, R.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, C.-H.</span><span> </span><span class="NLM_article-title">Comprehensive Review in Current Developments of Imid-azole-Based Medicinal Chemistry</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">340</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span><span class="refDoi"> DOI: 10.1002/med.21290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1002%2Fmed.21290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=23740514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVaqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=340-437&author=L.+Zhangauthor=X.-M.+Pengauthor=G.+L.+V.+Damuauthor=R.-X.+Gengauthor=C.-H.+Zhou&title=Comprehensive+Review+in+Current+Developments+of+Imid-azole-Based+Medicinal+Chemistry&doi=10.1002%2Fmed.21290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive Review in Current Developments of Imidazole-Based Medicinal Chemistry</span></div><div class="casAuthors">Zhang, Ling; Peng, Xin-Mei; Damu, Guri L. V.; Geng, Rong-Xia; Zhou, Cheng-He</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">340-437</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Imidazole ring is an important five-membered arom. heterocycle widely present in natural products and synthetic mols.  The unique structural feature of imidazole ring with desirable electron-rich characteristic is beneficial for imidazole derivs. to readily bind with a variety of enzymes and receptors in biol. systems through diverse weak interactions, thereby exhibiting broad bioactivities.  The related research and developments of imidazole-based medicinal chem. have become a rapidly developing and increasingly active topic.  Particularly, numerous imidazole-based compds. as clin. drugs have been extensively used in the clinic to treat various types of diseases with high therapeutic potency, which have shown the enormous development value.  This work systematically gives a comprehensive review in current developments of imidazole-based compds. in the whole range of medicinal chem. as anticancer, antifungal, antibacterial, antitubercular, anti-inflammatory, antineuropathic, antihypertensive, antihistaminic, antiparasitic, antiobesity, antiviral, and other medicinal agents, together with their potential applications in diagnostics and pathol.  It is hoped that this review will be helpful for new thoughts in the quest for rational designs of more active and less toxic imidazole-based medicinal drugs, as well as more effective diagnostic agents and pathol. probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb3kIrWVjpNbVg90H21EOLACvtfcHk0lhppzeHow_wdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVaqtrw%253D&md5=459b5fc9e1789d5880a7396512844b51</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fmed.21290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21290%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DX.-M.%26aulast%3DDamu%26aufirst%3DG.%2BL.%2BV.%26aulast%3DGeng%26aufirst%3DR.-X.%26aulast%3DZhou%26aufirst%3DC.-H.%26atitle%3DComprehensive%2520Review%2520in%2520Current%2520Developments%2520of%2520Imid-azole-Based%2520Medicinal%2520Chemistry%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2014%26volume%3D34%26spage%3D340%26epage%3D437%26doi%3D10.1002%2Fmed.21290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Ritchie, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, S. D.</span><span> </span><span class="NLM_article-title">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span><span class="refDoi"> DOI: 10.1016/j.drudis.2010.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1016%2Fj.drudis.2010.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=21129497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=164-171&author=T.+J.+Ritchieauthor=S.+J.+F.+Macdonaldauthor=R.+J.+Youngauthor=S.+D.+Pickett&title=The+impact+of+aromatic+ring+count+on+compound+developability%3A+further+insights+by+examining+carbo-+and+hetero-aromatic+and+-aliphatic+ring+types&doi=10.1016%2Fj.drudis.2010.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types</span></div><div class="casAuthors">Ritchie, Timothy J.; MacDonald, Simon J. F.; Young, Robert J.; Pickett, Stephen D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">164-171</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The impact of carboarom., heteroarom., carboaliph. and heteroaliph. ring counts and fused arom. ring count on several developability measures (soly., lipophilicity, protein binding, P 450 inhibition and hERG binding) is the topic for this review article.  Recent results indicate that increasing ring counts have detrimental effects on developability in the order carboaroms. » heteroaroms. > carboaliphatics > heteroaliphatics, with heteroaliphatics exerting a beneficial effect in many cases.  Increasing arom. ring count exerts effects on several developability parameters that are lipophilicity- and size-independent, and fused arom. systems have a beneficial effect relative to their nonfused counterparts.  Increasing arom. ring count has a detrimental effect on human bioavailability parameters, and heteroarom. ring count (but not other ring counts) has increased over time in marketed oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYPC7hkoyv7Vg90H21EOLACvtfcHk0lhppzeHow_wdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVyqsr0%253D&md5=8e2d0e4e499d2f07d66ca2f385defb2d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DRitchie%26aufirst%3DT.%2BJ.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DPickett%26aufirst%3DS.%2BD.%26atitle%3DThe%2520impact%2520of%2520aromatic%2520ring%2520count%2520on%2520compound%2520developability%253A%2520further%2520insights%2520by%2520examining%2520carbo-%2520and%2520hetero-aromatic%2520and%2520-aliphatic%2520ring%2520types%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D164%26epage%3D171%26doi%3D10.1016%2Fj.drudis.2010.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Einhorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischkopff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szelinski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schupp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spröngerts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladisch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauermayer, T.</span><span> </span><span class="NLM_article-title">Über die N-Methylolverbindungen der Säureamide [Erste Abhandlung]</span> <span class="citation_source-journal">Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1905</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span><span class="refDoi"> DOI: 10.1002/jlac.19053430207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;key=10.1002%2Fjlac.19053430207" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=1905&pages=207-305&author=A.+Einhornauthor=E.+Bischkopffauthor=B.+Szelinskiauthor=G.+Schuppauthor=E.+Spr%C3%B6ngertsauthor=C.+Ladischauthor=T.+Mauermayer&title=%C3%9Cber+die+N-Methylolverbindungen+der+S%C3%A4ureamide+%5BErste+Abhandlung%5D&doi=10.1002%2Fjlac.19053430207"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fjlac.19053430207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlac.19053430207%26sid%3Dliteratum%253Aachs%26aulast%3DEinhorn%26aufirst%3DA.%26aulast%3DBischkopff%26aufirst%3DE.%26aulast%3DSzelinski%26aufirst%3DB.%26aulast%3DSchupp%26aufirst%3DG.%26aulast%3DSpr%25C3%25B6ngerts%26aufirst%3DE.%26aulast%3DLadisch%26aufirst%3DC.%26aulast%3DMauermayer%26aufirst%3DT.%26atitle%3D%25C3%259Cber%2520die%2520N-Methylolverbindungen%2520der%2520S%25C3%25A4ureamide%2520%255BErste%2520Abhandlung%255D%26jtitle%3DLiebigs%2520Ann.%2520Chem.%26date%3D1905%26volume%3D343%26spage%3D207%26epage%3D305%26doi%3D10.1002%2Fjlac.19053430207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Tscherniac, J.</span><span> </span><span class="NLM_article-title">Verfahren zur Darstellung von Benzylphtalimiden</span>. German Patent 134,979, Jun 2,<span class="NLM_x"> </span><span class="NLM_year">1901</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1901&author=J.+Tscherniac&title=Verfahren+zur+Darstellung+von+Benzylphtalimiden"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTscherniac%26aufirst%3DJ.%26atitle%3DVerfahren%2520zur%2520Darstellung%2520von%2520Benzylphtalimiden%26date%3D1901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="note"><p class="first last">As of September 2015, available from AstaTech, Inc. (catalog no. CL9222) and Zylexa Pharma (catalog no. ZP-DC002387), among other suppliers.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BQG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BQG','PDB','5BQG'); return false;">PDB: 5BQG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BQH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BQH','PDB','5BQH'); return false;">PDB: 5BQH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BQI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BQI','PDB','5BQI'); return false;">PDB: 5BQI</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i31"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01249">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_36830"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01249">10.1021/acs.jmedchem.5b01249</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Procedures for the preparation of <b>5</b>–<b>7</b>, <b>9</b>–<b>10</b>, <b>20</b>–<b>25</b>, and <b>27</b>–<b>30</b>, crystallization and structural determination, A549 assay PGI<sub>2</sub> data, HWB assay TXB<sub>2</sub> and PGF<sub>2α</sub> data, and CEREP panel results (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01249/suppl_file/jm5b01249_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01249/suppl_file/jm5b01249_si_001.pdf">jm5b01249_si_001.pdf (2.47 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors are available from the Protein Data Bank with accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BQG">5BQG</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BQH">5BQH</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5BQI">5BQI</a> for <i>m</i>PGES-1/<b>4</b>, <i>m</i>PGES-1/<b>5</b>, and <i>m</i>PGES-1/<b>8</b> binary complexes, respectively.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01249&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-1%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01249" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01249" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997c878efb3ca6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
